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Abstract 
Interactions between proteins are a central concept in biology, and 
understanding and manipulation of these interactions is key to advancing 
biological science. Research into antibodies as customised binding molecules 
provided the foundation for development of the field of protein “scaffolds” for 
molecular recognition, where functional residues are mounted on to a stable 
protein platform. Consequently, the immunoglobulin domain has been 
describes as “nature’s paradigm” for a scaffold, and has been widely 
researched to make engineered antibodies better tools for specific applications. 
However, limitations in their use have lead to a number of non-
immunoglobulin domains to be investigated as customisable scaffolds, to 
replace or complement antibodies. To be considered a scaffold, a protein 
domain must show an evolutionarily conserved hydrophobic core in diverse 
functional contexts. The study presented here investigated the 
oligosaccharide/oligonucleotide-binding (OB) fold as scaffold, which is a 5-
standed β-barrel seen in diverse organisms with no sequence conservation. The 
term “Obody” was coined to describe engineered OB-folds. This thesis 
examined a previously engineered Obody with affinity for lysozyme (KD = 40 
μM) in complex with its ligand by x-ray crystallography (resolution 2.75 Å) 
which revealed the atomic details of binding. Affinity maturation for lysozyme 
was undertaken by phage display directed evolution. Gene libraries were 
constructed by combinatorial PCR incorporating site-specific randomised 
codons identified by examination of the structure in complex with lysozyme, or 
by random generation of point mutations by error-prone PCR. Overall a 100-
fold improvement in affinity was achieved (KD = 600 nM). To investigate the 
structural basis of the affinity maturation, two further Obody-lysozyme 
complexes were solved by x-ray crystallography, one at a KD of 5 μM 
(resolution 1.96 Å), one at 600 nM (resolution 1.86 Å). Analysis of the 
structures revealed changes in individual residue arrangements, as well as 
rigid-body changes in the relative orientation of the Obody and lysozyme 
molecules in complex. Directed evolution of Obodies as protein binding 
reagents remains a challenge, but this study demonstrates their potential. The 
structures presented here will contribute invaluable insights for the future 
design of improved Obodies. 
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1 General Introduction 
1.1 Proteins as scaffolds for functional residues 
 Molecular recognition is a central concept in biology. Cellular 
metabolism is critically dependant on specific interactions between proteins 
and their substrates or ligands, interactions which range from transient 
regulatory adjustments to practically irreversible binding. Although a growing 
body of evidence is showing the importance of natively unfolded proteins 
(which typically fold on binding), this process depends generally on the 
versatility of proteins to adopt well-defined folds in order to present the 
chemistry required. 
Compared to the number of possible DNA coding sequences there are 
relatively few (~2500) unique folds known. Many folds are disproportionately 
populated, which suggests that they occupy especially useful minima in the 
energy landscape, or that they were discovered first by evolution and have had 
longer to diversify. Sequence conservation, which is often used as a proxy for 
fold conservation, implies homology, but in the absence of detectable sequence 
conservation, structural comparison is used, as by the Structural Classification 
of Proteins (SCOP) database, to identify analogous or homologous proteins 
which possess similar folds (Murzin et al. 1995; Lo Conte et al. 2000; Lo 
Conte et al. 2002; Andreeva et al. 2004; Andreeva et al. 2008). For example, 
the known structures showing an immunoglobulin (Ig)-like fold are divided 
into 28 superfamilies, each defined by a different set of distinct structural and 
sequence features. 
A common fold that is used for many different functions indicates 
evolutionary utility, in the sense that it can accommodate many mutations 
while retaining stability, allowing it to either diverge widely or be 
independently discovered by convergent evolution. Regardless of proposed 
evolutionary origin, the unifying fold of a cluster of superfamilies can therefore 
be considered a “scaffold” on which different functions and binding sites can 
be mounted through the introduction of point mutations, extended loops and 
even entire domain insertions. Based on this concept, proteins amenable to 
engineering can, in principle, be identified and manipulated to perform useful 
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functions (Ku and Schultz 1995). Engineering efforts utilising the scaffold 
concept essentially fall into two main categories; tailored enzyme catalysis and 
custom molecular recognition.  
In the first part of this chapter I introduce the concept of the protein 
scaffold, its application to antibody engineering and the immunoglobulin (Ig) 
fold, expansion to alternative non-Ig domains and propose a new alternative 
scaffold domain, the olisaccharide/oligonucleotide (OB)-fold. The second part 
of this chapter introduces the most powerful technique currently employed in 
protein engineering, namely directed evolution. Lastly, specifics of protein-
protein interactions are discussed, with reference to discovering the important 
residues of a newly engineered interface. 
1.2 Scaffolds for General Molecular Recognition 
Applications in diagnostics, therapeutics and experimental biology 
require tools for specific and sensitive binding to targets of interest. 
Traditionally, antibodies are the gold standard for customisable molecular 
recognition. But while the antibody format has proved especially useful in 
many contexts, limitations of antibodies along with the development of 
molecular techniques for manipulation of mutant gene libraries have prompted 
a range of protein scaffolds to be investigated as alternatives. 
1.2.1 Antibodies 
Antibodies are multi-chain complexes of immunoglobulin (Ig) fold 
domains, stabilised by inter- and intra-molecular disulfide bonds. The Ig-fold 
consists of a densely packed β-sandwich of 7-9 strands (Bork et al. 1994) and 
has been described as nature’s paradigm for a scaffold. At each end of the 
domain the β-strands are linked in a Greek-key motif with loops of varying 
lengths. In antibodies, these loops form the complementarity-determining 
regions (CDR) for specific recognition of antigens. Although antibodies come 
in several isotypes, the most common form in biotechnology is IgG, which 
consists of two four-domain heavy chains and two two-domain light chains, 
linked covalently with disulfide bridges (Figure 1.1 A). 
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Figure 1.1 Antibody construction 
(A) An IgG antibody (PDB accession 1HZH) displaying the classic “T” shape, with the different 
fragments labelled. The heavy chains are coloured in yellow, the light chains in red and purple. Each 
intact IgG antibody consists of two Fab and one Fc fragment. The Fab (antibody) fragment is the scaffold 
on which the CDR loops are mounted (indicated by arrows) and is further divided into the Fv (variable) 
region, where almost all of the variation between antibodies is located. The Fc region doesn’t contain 
variable residues and is the binding site for other immune-associated proteins. The inset grey surface 
model of the same molecule shows the 14 disulfide bonds present in this antibody (red). The other three 
molecules show the major structural formats of engineered antibodies, coloured according to secondary 
structure; (B) a VH camelid domain (PDB accession 3K81), (C) a single-chain Fv fragment (PDB 
accession 1DZB) and (D) an Fab fragment (PDB accession 1MRF). 
 
18 
 
The immune system generates diversity in the CDR loops, mounted on 
the variable domains, by shuffling gene segments (denoted VDJ) and somatic 
hypermutation (French et al. 1989; Rajewsky 1996). The initial germ line-
encoded generation gives rise to a population of 10
7
-10
8
 lymphocytes 
containing unique sequences which are routinely exposed to potential antigens. 
On repeated exposure to an antigenic ligand, a subset of positively-selected 
lymphocytes is re-mutated to generate tighter, more specific antibodies. The Ig-
fold can accommodate these drastic sequence changes and remain stable by a 
virtual decoupling of folding from loop sequence and length, although surface 
turns have been shown to influence stability of a folded domain (Predki et al. 
1996; Nagi and Regan 1997). The scaffold residues of the Ig-domain, rather 
than being directly involved in binding, serve to support and impose 
conformational restrictions on the loop residues (AlLazikani et al. 1997). Loop 
sequence plasticity is highlighted by CDR grafting experiments, where affinity 
for a ligand can be stably transferred by transplant of the CDR loops from one 
antibody to another (Kettleborough et al. 1991; Foote and Winter 1992). The 
first true use of antibodies as a scaffold produced fully “humanised” antibodies 
by transplanting both heavy and light chain CDR regions of a mouse antibody 
into a human IgG scaffold  (Riechmann et al. 1988a).  
1.2.1.1 Limitations 
Before molecular techniques to produce synthetic genetic diversity were 
developed, the lymphocyte repertoire and in vivo selection occurring naturally 
in the immune system was the most readily accessible source of selectable 
diversity for production of molecular recognition reagents. Consequently, 
antibodies became the default format for binding reagents. While successful in 
many ways, in vivo immunisation and harvesting of anti-serum posed several 
problems, particularly in therapeutic contexts.  
The polyclonal nature of antiserum can result in a high level of 
non-specific, or otherwise unwanted, reactivity. This prompted development of 
technology to produce monoclonal isolates, both to increase specificity and to 
isolate a particular binding profile to a particular sequence (Kohler and 
Milstein 1975). Further, while the immune complement is extensive, it is the 
result of a negative selection for anti-self activity, which necessarily excludes 
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many otherwise potentially useful sequences. PCR amplified B-cell derived 
phage libraries sought to increase the diversity for selection beyond that 
available in vivo (Marks et al. 1991; Gram et al. 1992; Hoogenboom and 
Winter 1992; Akamatsu et al. 1993; Vaughan et al. 1996). Potential target 
ligands were also limited by their toxicity, serum lability and their ability to 
elicit a sufficiently vigorous immune response. In vitro immunisation of 
lymphocytes sought to bypass the problems of antigen toxicity and in vivo 
degradation (Borrebaeck et al. 1988).  
Finally, natural antibodies are large, multi-chain constructs, requiring 
post-translational assembly and multiple cloning events to introduce required 
specificity, as well as specialised cell lines for expression. Because of the high 
cost of expression in tissue culture, alternative hosts for antibody expression 
have been investigated (Skerra 1993; Verma et al. 1998) and today antibody 
libraries are routinely produced in microbial expression/selection hosts, as well 
as completely in vitro systems. Tissue penetration and antigenicity of a protein 
therapeutic is directly related to molecular weight, so different formats were 
investigated to improve antibodies as drugs. Murine monoclonal antibodies 
tend to draw an immune response when administered as a drug, reducing 
effectiveness (Kuus-Reichel et al. 1994). Murine/human chimeric antibodies 
incorporating recombinant human heavy chains and native mouse light chains 
were developed to reduce antigenicity (Jones et al. 1986; Better et al. 1988). 
Smaller but still functional antibody fragments were explored as an alternative 
to intact antibodies, where an intact light chain and the variable domain and 
first constant domain of a heavy chain are expressed (Fab) or just the variable 
domains (Fv) (Riechmann et al. 1988b)(Figure 1.1 A,D).  
The non-covalent association of co-expressed domains in Fv fragments 
reduces stability compared to larger fragments incorporating disulfide bonds 
(Reiter et al. 1994a; Reiter et al. 1994b). These stability and ease-of-
manipulation limitations were partially circumvented by fusion of the light and 
heavy chain variable regions for production as a single polypeptide (scFv, 
Figure 1.1 C) (Huston et al. 1988; Bird and Walker 1991), although in practise 
these constructs exhibited a tendency to aggregate, probably because of 
transient dissociation of the two domains when not covalently stabilised (Reiter 
et al. 1994a; Reiter et al. 1994b). Recently, aggregation-resistant scFv 
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antibodies were developed by shuffling fragments of antibodies known to be 
thermally resistant (Christ et al. 2007). Stand-alone variable domains from 
heavy chains (VH) were also trialled, but were plagued by problems of 
aggregation  and non-specific adsorption, presumably due to exposure of  the 
relatively hydrophobic dimerisation face (Ward et al. 1989) (Glockshuber et al. 
1990). The later discovery of naturally occurring heavy chains without light 
chain partners in camelids (camels and llamas, denoted VHH) revitalised this 
effort (Hamerscasterman et al. 1993; Ghahroudi et al. 1997; Muyldermans 
2001). Efforts in overcoming these limitations and applications of products of 
recent antibody engineering developments have been the subject of recent 
reviews (Weiner and Carter 2005; Almagro et al. 2006; Sidhu and Fellouse 
2006; Zafir-Lavie et al. 2007).  
1.2.1.2 Immune system independence 
All of these developments mentioned above have resulted in a gradual 
dissociation of antibody selection from the immune system. Today, artificially-
generated diversity can be introduced into synthetic, consensus-designed Ig 
domains by biasing libraries towards sequences that allow for the maximum 
proportion of correctly folded proteins while maintaining diversity (Knappik et 
al. 2000).  
Perhaps the single most important development in non-immune antibody 
generation was phage display technology (Smith 1985). Whereas the immune 
system (and other cell-based systems) performs selection by expression of an 
antibody on the surface of a cell, in phage display the selectable unit is a virus 
displaying a fusion protein, allowing selection for binding outside of the 
immune system (Clackson et al. 1991; Hawkins et al. 1992; Figini et al. 1994; 
Nissim et al. 1994; Winter et al. 1994), initially with antibody libraries based 
on “primed” B-cell diversity complements and later with completely naïve 
diversity. Compared to cell-based systems, phage libraries are more robust, 
cheaper and capable of handling much higher levels of diversity. Phage display 
is described in more detail in section 1.5, along with other directed evolution 
methods. Drawing on evolutionary principles and modelled on the immune 
system, phage display technology, coupled with techniques for artificial 
introduction of diversity, has been instrumental in the development of non-
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immune directed evolution as an engineering technique for producing specific 
binding proteins. In addition to selection for binding, aspects of the scaffold 
itself can be evolved for other properties (Worn and Pluckthun 2001), such as 
thermostability (Ueda et al. 2004). Critically, once the immune system was 
removed as the limiting factor, so too was the reliance on antibodies and the Ig 
fold as the sole scaffold, and over the last twenty years the rapid increase in 
available structural information has provided a fertile source of potential 
scaffolds for investigation. 
 
1.2.1 Constrained Peptide Carriers 
Perhaps the simplest molecular recognition scaffold is a rigid 
independently folding domain displaying a single peptide loop.  This 
expression context compared to a free peptide allows for some protection 
against proteolytic attack and imposes a degree of conformational restriction, 
reducing entropic penalties by loss of degrees of freedom on binding (Oneil et 
al. 1992). Phage display of oligopeptide libraries was used to identify antibody 
epitopes and ligand mimics for specific targets (Smith 1985; Cortese et al. 
1994; Burritt et al. 1996) and this technology was adapted to generate new 
enzyme-specific inhibitors, using a Kunitz domain displayed as a stable protein 
scaffold to support a selected peptide (Markland et al. 1991). A Kunitz domain 
is a small, disulfide-stabilised fold, commonly found in protease inhibitors 
where an extended loop is inserted in the active site of the target protease 
(Marquart et al. 1983). To alter enzyme specificity, target-biased mutations 
were introduced into the active loop of bovine pancreatic trypsin inhibitor and 
selected for inhibition of human neutraphil elastase (Roberts et al. 1992a; 
Roberts et al. 1992b). Similar experiments have used Kunitz domain scaffolds 
based on Alzheimer’s amyloid β-precursor inhibitor (Dennis and Lazarus 
1994a; Dennis and Lazarus 1994b), human lipoprotein-associated coagulation 
inhibitor (Markland et al. 1996a; Markland et al. 1996b) and human pancreatic 
secretory trypsin inhibitor (Rottgen and Collins 1995) by introducing much 
broader artificial diversity in one or more surface loops. 
Other scaffold proteins have been adapted to display constrained, 
functional peptides, including staphylococcal nuclease as an application-
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specific inhibitor for dissection of biological pathways (Norman et al. 1999), 
tendamistat (McConnell and Hoess 1995) and the broad-spectrum protease 
inhibitor ecotin (Wang et al. 1995). 
1.2.2 Ig-like domains as scaffolds 
The same molecular library techniques which expanded antibody 
research so considerably also allowed other domains to be examined for 
potential as useful binding reagents. The goal was not necessarily to produce a 
direct replacement for antibodies, but to supplement the complement of 
antibodies with constructs that could be produced in greater quantities at lower 
cost and did not rely on disulfide bonds for stability, but were able to replicate  
binding at least as well as an antibody. In what could be seen as a natural 
progression, proteins with Ig-like domains were investigated as scaffolds in an 
effort to overcome some of the limitations of the antibody context.  
Human Cytotoxic T-Lymphocyte associated antigen 4 (CTLA-4) was 
investigated as a peptide carrier due to its monomeric nature and close 
homology to the human antibody variable domain (Nuttall et al. 1999). A 
library utilising a single CDR-like loop was generated, focusing on integrin 
specificity with moderate success (Hufton et al. 2000). In a similarly targeted 
project, CDR loops of the T-cell receptor (TCR) were randomised to gain 
insight into TCR-peptide-MHC complexes (Holler et al. 2001). 
1.2.2.1 Fibronectin type III domain 
Fibronectin is a large, multi-domain serum protein involved in 
extracellular matrix adhesion and wound healing. It consists of repeating 
modules of independently folding domains of three types, of which type III 
(FN3) is a monomeric Ig-like β-sandwich (Baron et al. 1991). While the 
topology of FN3 domains is very similar to Ig domains found in antibodies, 
with exposed loops analogous to CDR loops, it has two fewer β-strands and 
does not contain an intra-molecular disulfide bond. Based on the diversity of 
observed function and the tangible advantages over classical antibody libraries, 
the tenth FN3 domain from fibronectin (Figure 1.2) was investigated by Koide 
and co-workers as a scaffold for the presentation of structurally constrained 
peptides in CDR-analogous loops (Koide et al. 1998). 
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 The authors constructed a synthetic, codon-optimised gene for 
expression and display testing, on which was based the subsequent generation 
of the library for selection. Diversity was introduced into two of the three 
CDR-like loops, identified by sequence alignment, using oligonucleotides with 
degenerate codons. From a transformed library with ~10
8
 members, binders to 
the model target human ubiquitin were enriched by phage display, with 
solubility and stability profiles worse or no better than the template domain. 
Affinity was not quantitatively determined, but competition ELISA suggested a 
KD of 5 μM. Several strategies were employed to improve affinity. For 
example, classical antibodies increase binding by an increase in avidity. This 
principle was replicated with a non-covalent pentameric construct with affinity 
for integrins, oligomerised via a so-called assembly domain which improved 
apparent affinity from 2 μM to 10 nM (Duan et al. 2007). 
 
 
Figure 1.2 Engineered FN3 domain 
The Fibronectin type 3 domain, shown here as a cartoon diagram, is an Ig-like fold, with two fewer 
β-strands. At one end of the domain are two loops analogous to CDR loops found in antibody Fv regions. 
The CDR-like loop residues are highlighted with blue stick diagrams. Structure coordinates are from PDB 
accession 3K2M. 
 
The FN3 domain has been further developed as a scaffold and labelled 
monobodies, with a highest reported affinity of 1 pM (Hackel et al. 2008). 
Studies have shown the potential of the loops available for mutation (Koide et 
al. 2001) and basic improvements of the template protein have been made for 
increased stability (Batori et al. 2002). As stability of the FN3 domains is not 
dependent on the redox state of the solvent, they can be produced as active 
intracellular species. For example, monobodies were used to probe 
conformation state variation in the estrogen receptor bound to different ligands 
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by yeast 2-hybrid, where receptors in an unbound state and in complex with 
two different ligands were distinguished (Koide et al. 2002). 
1.3 Non-Immunoglobulin-like Scaffolds 
Even as technology improves to produce better antibodies, it has become 
apparent that antibody-based (and Ig-like) tools may not be the best option in 
every scenario. For example, reliance of Ig domains on disulfide bonds for 
stability limits their utility as intracellular reagents, due to the reducing 
environment in the cytoplasm, although examples of functional intracellular 
antibodies (“intrabodies”) have been produced (Worn et al. 2000) and an 
ongoing research effort to improve intrabody performance has met with 
considerable success (Stocks 2004).  Also, the CDR-loop format of the binding 
region probably represents an incomplete sample of possible binding 
interfaces, and may be a sub-optimal choice for a custom binder, depending on 
the target ligand and the projected circumstances for use (Hudson and Souriau 
2003). As a result, alternative scaffolds drawn from other fold families have 
been investigated for their utility as a tool for general molecular recognition 
duties. 
1.3.1 Identification of a scaffold candidate 
It is not always possible to predict with any accuracy the effect of 
mutations on a given protein, and therefore its utility as a scaffold, as the 
sequence-fold link has yet to be fully elucidated. Ig-like scaffolds share an 
advantage in that CDR-like loops may be readily identified as potential sites 
for mutation by comparison with antibody domains. However, when widening 
the scope to non-immunoglobulin domains, a new paradigm for introducing 
diversity must be considered, particularly when dealing with secondary 
structure-based interaction surfaces.  
Skerra (2000) identified proxy characteristics that a protein fold family 
should possess as a minimum to be considered a viable scaffold for engineering 
as a generic molecular recognition template: A structurally super-imposable 
hydrophobic core across the fold family, where a sufficiently densely-packed 
core will contribute enough to the free energy of folding that the exterior can 
be mutated almost at will and still fold correctly; a solvent-exposed pocket or 
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face, ideally spatially separated from the hydrophobic core to minimise 
disruption from mutations. In addition the fold should have roles in 
biochemically diverse contexts, ideally using the same section of the fold to 
effect the function.  
These three core characteristics can be considered basic requirements, 
with any additional properties application specific, such as low antigenicity and 
very small size in a therapeutic protein, or thermostability and pH tolerance in 
a research reagent. A later review outlined further ideal characteristics, 
dependant on the intended function (Binz and Pluckthun 2005). A relatively 
small, robust scaffold would possess increased diffusivity, decreased potential 
for antigenicity and reduced chances of non-specific interactions. Single chain 
scaffolds have obvious benefits over multi-domain constructs in relative ease 
of engineering and handling. Single domain scaffolds are even better, 
especially with specifically selected fusion partners for effector or detection 
functions. A universally useful fold should also lack disulfide bonds to allow 
for expression and activity under reducing conditions, facilitating efficient 
bacterial production (Nord et al. 1997) and potential intracellular expression. 
In recent years a number of candidate domains have been investigated as 
template for use as molecular recognition scaffolds, with varying degrees of 
success. For a comprehensive review, see (Binz et al. 2005). Examples include 
ankyrin repeat domains (Binz et al. 2003; Binz et al. 2004), the Z domain from 
staphylococcal protein A (Nord et al. 1995; Nord et al. 1997), the lipocalin fold 
(Beste et al. 1999), zinc finger repeats (Rebar and Pabo 1994), a carbohydrate 
binding domain (Gunnarsson et al. 2004; Gunnarsson et al. 2006a; Gunnarsson 
et al. 2006b), armadillo repeat proteins (Parmeggiani et al. 2008), 
neocarzinostatin (Heyd et al. 2003) and an SH3 domain (Mouratou et al. 2007; 
Krehenbrink et al. 2008). It should be noted that the last example mentioned, 
the SH3 domain, was initially incorrectly identified as an OB-fold. The domain 
in question is classified by SCOP as an SH3 domain, and it was referred to as 
such in a recent review of scaffold engineering (Gebauer and Skerra 2009). 
26 
 
 
 
Figure 1.3 Engineered Non-Ig Domains 
Four of the most successful non-immunoglobulin scaffold domains engineered for specific binding, 
shown as cartoons. Residues mutated in the library producing the particular example shown are coloured 
dark blue. DARPin domains (A) utilise a combination of varied residues (primarily in one loop) and a 
shuffled ankyrin repeat format to generate a protein binding surface. This example has 3 repeat modules 
and two capping modules (Schweizer et al. 2007). Zinc finger repeats (b) use a similar process to produce 
a DNA sequence-specific binder (bound DNA shown as surface representation), but the varied residues 
are located on the helix of each zinc finger. The structure shown actually has six domains, but one is 
disordered (Segal et al. 2006). Anticalins (c) mount functional residues to form a hapten binding pocket, 
in this case with fluorescein (orange) bound (Korndorfer et al. 2003), while Affibodies (d) utilise the 
combined surface of two helices to bind protein targets (Eigenbrot et al.).  
 
 
1.3.2 Anticalins 
Whereas most other examples of engineered proteins are searching for 
binding to various biological macromolecules, anticalins are specialised for 
high-affinity hapten binding (Skerra 2001). The domain is based on the 
lippocalin fold, which is part of a well-conserved structural superfamily with 
little sequence conservation (Flower 1996). The fold itself is an eight-stranded 
β-barrel with a deep hapten binding pocket (Figure 1.3C). Family members are 
primarily involved in small molecule transport and sequestration, such as fatty 
acids (Young et al. 1994a) and  retinol (Cowan et al. 1990), with one member 
forming part of the human complement system (Ortlund et al. 2002).  
A C 
D B 
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In the first libraries, the authors randomised a series of loops at the 
binding site of the template gene (a bacterial bilin receptor), which form a 
pocket at one end of the β-barrel. Phage display selection yielded variants with 
mid nM-range affinity for model targets fluorescein (Beste et al. 1999) and 
digoxigenin (Schlehuber et al. 2000). In addition to the binding pocket, surface 
loops were also varied and selected, generating a molecule with specificity for 
two separate ligands (Schlehuber and Skerra 2001) and the potential as a drug-
delivery tool was immediately recognised (Schlehuber and Skerra 2005). 
Accordingly, a human scaffold was developed along the same lines, based on 
apolipoprotein D, and successfully panned against a model protein target, with 
a resulting KD of ~2 μM (Vogt and Skerra 2004). 
Because of their demonstrated ability to bind simultaneously both small 
molecule ligands and protein ligands, engineered anticalins have been proposed 
as drug-focusing vehicles and toxin scavengers, as well as the more traditional 
binding-mediated receptor modulation (Skerra 2007b). 
1.3.3 Affibodies 
Staphylococcal protein A (SPA) is a surface receptor which binds to the 
Fc region of IgG. A synthetic version of the Z domain from SPA was used as a 
template scaffold for production of specific binding proteins, termed an 
affibody (Nord et al. 1995; Nord et al. 1997). The domain is very small, with 
only 58 residues, forming a closely packed three helix bundle with the Fc 
binding region on the surface of two of the helices (Figure 1.3D).  
In contrast to the CDR loops of Ig and Ig-like domains the alpha helical 
nature of the binding face provides a much larger degree of conformational 
rigidity. In principle this reduces degrees of freedom entropy loss on binding 
compared to a restrained loop, but this benefit may be partially offset by 
limitations of residue choice due to negative effects on domain stability. First 
generation affibodies from a naïve phage library showed affinity for a protein 
target of  ~2 μM (Nord et al. 1997). 
In an analogous process to antibody maturation, a second generation 
affibody domain was affinity-matured by selective re-randomisation of 
approximately half of the binding face, resulting in a 100-fold improvement in 
affinity for its ligand (Gunneriusson et al. 1999). A lesser though still 
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significant improvement was gained by dimerisation of selected domains 
(Gunneriusson et al. 1999; Steffen et al. 2005).  The highest reported affinity 
achieved using affibodies is 22 pM, to the HER2 cancer marker (Orlova et al. 
2006). Affibodies have been successfully deployed in affinity-dependent 
applications, such as tumour imaging and targeting (Orlova et al. 2006; Steffen 
et al. 2006; Engfeldt et al. 2007; Magnusson et al. 2007; Tolmachev et al. 
2007b; Vernet et al. 2008) and protein purification or analysis (Nord et al. 
2000)  (Eklund et al. 2002; Eklund et al. 2004; Renberg et al. 2007).  
1.3.4 Repeat Proteins 
A recent development in protein engineering for molecular recognition 
has been the use of protein repeats as a modular architecture for entirely 
synthetic scaffolds (Forrer et al. 2003), where the interaction surface 
composition as well as size can be varied. Scaffolds based on ankyrin repeats 
domains (Binz et al. 2003) and leucine-rich repeats (Stumpp et al. 2003) have 
proved remarkably successful in terms of achieved protein binding affinity and 
stability.  
1.3.4.1 DARPins 
Designed ankyrin repeat proteins (DARPins) were constructed from 
modules of helix-turn-helix consensus designed repeats, with variable residues 
located on the β-turn loops between the helices (Binz et al. 2003). Each domain 
contains between two and six such modules, with N and C-terminal capping 
modules (Figure 1.3A). Combinatorial libraries of DARPin domains were 
constructed by trinucleotide randomisation of six residues on the surface then 
random ligation into an expression vector, giving variation in repeat residue 
complement and repeat order. DARPins have proved a highly stable platform, 
with extensive hydrogen bonding evident between surface residues, including 
those in the variable β-turns (Kohl et al. 2003). Specific binders were selected 
by ribosome display to nM-range affinities to protein targets (Binz et al. 2004). 
Selected DARPins have since been demonstrated in practical uses, such as co-
crystallisation (Warke and Momany 2007; Bandeiras et al. 2008; Grubisha et 
al. 2010), enzyme inhibitors (Amstutz et al. 2005; Kohl et al. 2005) and as 
potential therapeutics (Zahnd et al. 2007), with affinities in the low nM to pM 
range. 
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1.3.4.2 Zinc Finger Domains 
Zinc finger domains are metal-stabilised small modular units of 
approximately 30 residues which represent the most common DNA binding 
motif identified (Jacobs 1992). They were investigated as scaffolds for specific 
nucleic acid binding by consensus-driven designation of critical structural 
residues, based on the concept that all zinc fingers share a common binding 
mode in the major groove of the DNA double helix ((Jacobs 1992), Figure 
1.3B). Using modestly randomised constructs of two or three repeats, binders 
were generated by phage display for both DNA (Rebar and Pabo 1994) and 
RNA (Friesen and Darby 1998) sequences with affinities in the nM range. 
Subsequently it was shown that high-affinity binding (19 nM) could be 
achieved with only a single zinc finger (Friesen and Darby 2001), making it 
amongst the smallest engineered domains currently known.  
1.4 The OB-fold as a Scaffold 
The OB-fold is a 5-stranded β-barrel domain arranged in a Greek-key 
motif (Murzin 1993). It commonly presents an external concave binding face 
mounted directly on the β-sheet of the barrel and in most cases where the 
domain is present the same face is used for binding. A survey of the SCOP 
database displays many OB-folds which are heavily modified with additional 
loops or entire new domains inserted (Murzin et al. 1995). Examples of OB-
folds can be found in diverse organisms, including archea, yeast and mammals, 
with no detectable sequence conservation across the superfamily. They boast a 
diverse range of natural ligands, including proteins, oligonucleotides and 
oligosaccharides (Figure 1.4). Affinity data on OB-folds for their natural 
ligands is sparse, but shows nM-range or better (Theobald et al. 2003). These 
combined factors led to the suggestion that the OB-fold is ancient and tolerant 
to mutation, with an easily adaptable binding face (Murzin 1993). More 
recently, hydrogen exchange studies have shown that an OB-fold can be 
correctly folded by multiple pathways, suggesting that the fold is not reliant on 
certain seed folding nuclei (Watson et al. 2007). Rather, correct folding comes 
from a “diffuse network of interactions” making up the hydrophobic core, 
which are distributed throughout the primary structure, stabilising the entire 
fold.  
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Ultimately the unifying feature of the OB-fold is topology, with 
architecture capable of supporting a very wide range of sequences and 
modifications while still folding correctly. Examples of the diversity of OB-
fold proteins include ssDNA-binding in the oncogene BRCA2 (Yang et al. 
2002), anticodon recognition in aspartyl- and lysyl-tRNA synthetases 
(Commans et al. 1995; Schmitt et al. 1998; Rees et al. 2000; Moulinier et al. 
2001), telomere end binding domain from the yeast protein Cdc13 (Mitton-Fry 
et al. 2002; Mitton-Fry et al. 2004; Wuttke et al. 2004) and the cell-surface 
oligosaccharide binding domain of the shiga toxin from Shigella dynsenteriae, 
as well as related AB5 toxins (Fraser et al. 1994; Stein et al. 1994; Zhang et al. 
1995; Fraser et al. 2004). Nucleic acid/OB-fold interactions have been the 
subject of a recent review (Theobald et al. 2003). OB-fold domains also 
mediate protein-protein interactions in superantigens during bacterial attack on 
the human immune system (Arcus et al. 2000; Arcus et al. 2002). These 
observations suggest that the versatility of the OB-fold might be emulated in 
vitro through protein engineering for tailor-made molecular recognition, 
potentially involving protein, nucleic acid and oligosaccharide targets (Arcus 
2002). In addition, the β-sheet mounted character of the binding face represents 
relatively unexplored territory in engineered protein-protein interactions, with 
most examples using constrained loops and helical residues. 
The central aim of the research for this thesis is to develop the OB-fold 
as a specific, high-affinity binding reagent by selection from a combinatorial 
library by phage display, for which we have chosen the term “Obody”. Based 
on previous proof-of-principle work, the research reported in this thesis shows 
affinity maturation for a model target by both rational and random methods, 
biophysical characterisation of binding and the engineered domains 
themselves, and structural analysis of an Obody during the affinity maturation 
process to reveal the nature of the binding faces developed.  
31 
 
 
Figure 1.4 OB-fold diversity 
All structures are oriented so that the first three β-strands of the barrel are visible to the front. Although 
they display wide variation in ancillary additions, including helix insertions and additional β-strands, the 
core five-stranded fold is clearly recognisable despite no detectable sequence conservation. These 
examples exhibit diversity in biochemical function, as well as wide occurrence of OB-folds in 
evolutionarily diverse organisms; (a) anticodon-binding domain from Escherichia coli aspartyl tRNA 
synthetase (Moulinier et al. 2001), (b) OB-fold from staphylococcal nuclease (Hynes and Fox 1991), (c) 
oncogene BRCA2 (Yang et al. 2002), (d) OB-fold “B” subunit from shiga toxin (Fraser et al. 1994), (e) 
human TIMP-1 inhibitory domain (Iyer et al. 2007), (f) domain from Thermus thermophilus inorganic 
pyrophosphatase (Teplyakov et al. 1994), (g) a homohexameric molybdate binding protein  from 
Sporomusa ovate (Wagner et al. 2000). (h) DNA-binding domain from yeast cdc13 (Mitton-Fry et al. 
2004). 
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1.5 Directed Evolution Technology 
Rational approaches to protein engineering have proved successful, 
especially where detailed structural information is available. For example, 
critical residues for folding and stability have been determined by structural 
consensus in a limited number of well known examples, most pertinently the Ig 
fold (Knappik et al. 2000) and the ankyrin repeat domain (Mosavi et al. 2002). 
Semi-rational approaches have also been used, for example loop exchange 
between enzymes of the same fold to introduce targeted variation (Park et al. 
2006; Ochoa-Leyva et al. 2009).  
However, a rational or semi-rational approach cannot always be applied. 
In a situation where information about the target ligand or substrate is limited, 
rational choices for design of a binding region are not always available. To deal 
with the lack of target data, an evolutionary screening process has been 
adopted. Developments in combinatorial genetics and selection techniques 
have allowed researchers to efficiently manipulate genes of interest towards a 
particular goal by utilising the evolutionary principles of selection from a 
diverse population, to increase the frequency of an “allele” with desirable 
properties. Examples include new and modified enzymes (Arnold and Volkov 
1999; Hibbert et al. 2005; Park et al. 2006; Seelig and Szostak 2007), 
antibodies  and antibody fragments (Huse et al. 1989; Gram et al. 1992; 
Griffiths et al. 1994), synthetic domains (Braisted and Wells 1996; Knappik et 
al. 2000; Binz et al. 2003) and de novo proteins (Keefe and Szostak 2001; 
Chaput and Szostak 2004). Typically these processes use a combination of 
rational design of a template scaffold and combinatorial screening of 
specifically or randomly mutated variants for a particular function, hence the 
term “directed” evolution.  
Discovery of binding to an arbitrary target where structural or functional 
information isn’t available requires a great deal of diversity from which to 
select in order to be successful. The vertebrate immune system was the 
immediately available source of selectable diversity, so in conjunction with 
hybridoma technology (Kohler and Milstein 1975), monoclonal custom 
antibodies became the gold standard for specific detection. While a great deal 
of success was garnered this way, limitations in the toxicity and 
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immunogenicity of targets drove development of alternative methods for 
selection from diversity. Genotype-phenotype linking techniques, such as yeast 
display (Boder and Wittrup 1997), bacterial display (Charbit et al. 1986; 
Charbit et al. 1988) and especially phage display (Smith 1985; Scott and Smith 
1990) allowed selection of combinatorial libraries of peptide antigens, and 
later, antibodies (Figini et al. 1994; Nissim et al. 1994; Winter et al. 1994) 
outside of the immune system. 
Three factors must be present in gene library design and selection for 
affinity. First, diversity must be introduced in a manner that does not destroy 
the template fold, but creates a randomised, solvent-exposed face, pocket or 
loop. Second, phenotypic selection requires a physical linkage between the 
phenotype (folded protein) and genotype. Lastly, because of the large numbers 
of unique sequences in gene libraries (up to 10
13
 in the largest libraries), 
successfully selected genes must be able to be amplified while 
compartmentalised from the rest of the library. This preserves the phenotype-
genotype link across multiple rounds of selection which promotes the chances 
of isolation of high-affinity binder from the remainder of the library. 
1.5.1 Diversity Generation 
The introduction of diversity into a domain for future selection is affected 
by several competing factors, such as the nature of the binding region, potential 
targets and library size limits. The optimum strategy is not obvious when 
considering a new domain. A variety of methods have been developed for 
efficiently mutating loop regions, but relatively few deal with secondary 
structure-based regions. In vitro recombination, termed DNA shuffling or 
sexual PCR (Stemmer 1994; Coco et al. 2001; Stemmer 2001) has been used 
extensively to generate chimera libraries from two or more related genes. This 
approach, inspired by the recombination that takes place in lymphocyte 
diversification, has been subject to various refinements such as the staggered 
extension process (Zhao et al. 1998), and degenerate oligonucleotide shuffling 
(Gibbs et al. 2001).  
While DNA shuffling works well where a family of related genes are 
available, as found in enzyme families, introduction of site-specific naïve 
diversity to form a defined binding face or pocket is better done by other 
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means. Two main methods are employed to produce diverse libraries with site-
specific mutant residues: PCR incorporation of oligonucleotides with 
randomised codons into a synthetic gene (Derbyshire et al. 1986), or whole 
gene synthesis of as many different variants as practically possible. 
Consideration must also be given to the possible residues at each selected 
position, where, for example, an inappropriately placed proline may be 
detrimental to fold stability or affinity. Similarly, cysteines and stop codons are 
usually excluded, if possible, by different combinations of possible nucleotides 
at each position in the codon. The recent development of codon-based 
oligonucleotide synthesis (Yanez et al. 2004) has allowed researchers to 
specify a unique codon subset at each mutational position, but this method 
remains expensive. 
Perhaps the single most common method for introducing diversity is the 
very simple error prone PCR method (Cadwell and Joyce 1992), where a non-
proof reading polymerase enzyme is induced into a higher error rate than 
normal during amplification. Errors are promoted by the addition of Mn
2+
 to 
reduce enzyme specificity, and spiking the reaction with disproportionate 
amounts of two of the four nucleotides, promoting miss-incorporation. This 
results in a distribution of mutation rates that can be difficult to calculate 
accurately, but can be modelled as a stochastic distribution of single nucleotide 
mutations (Moore and Maranas 2000; Pritchard et al. 2005). A gene mutated in 
this manner covers a broad, sparse sampling of sequence space, making it ideal 
for maturation of an existing function or biophysical characteristic.  
1.5.2 In vivo selection methods 
To ensure that the genotype-phenotype linkage is stable across several 
generations, the gene must be compartmentalised in some manner. The 
immune system achieves this by storing immune diversity in dedicated cell 
lines, expressing antibodies and related proteins on the cell surface for 
selection. This process has been replicated with alternative hosts such as 
bacteria (Freudl 1989; Skerra 1993) and yeast (Boder and Wittrup 1997). In 
vivo display methods are separated into two broad categories: cell surface 
display, where a peptide or protein library is displayed as the fusion of the 
extracellular domain of a membrane protein and the cell is the selectable unit; 
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and phage display, where a secreted phage particle bearing a fusion protein is 
the selectable unit. 
1.5.2.1 Phage Display 
Phage display has been used in phenotypic selection strategies for 30 
years, starting with peptide display for identifying epitopes (Smith 1985; Scott 
and Smith 1990), then expanding into whole proteins. Most pertinent to this 
study are antibodies (Winter et al. 1994), as well as new scaffolds, such as 
monodies (Koide et al. 1998) and affibodies (Nord et al. 1997). Phage libraries 
have been built, for various purposes, using lambda (Huse et al. 1989), M13 
(Sidhu 2000)  and T7 (Dai et al. 2008) phage. 
Generally, a gene library is inserted into an expression plasmid modified 
to contain a phage packaging signal and origin, or “phagemid”. Individual 
library members are expressed as the fusion product of a phage coat protein, 
engineered so that the introduced protein is solvent exposed. After 
transformation, the bacterial cells are induced for fusion expression and 
infected with a “helper” phage to begin production of transducing particles 
(TDP); that is, phage containing a copy of the phagemid instead of the phage 
genome. The result is, ideally, a diverse population of TDPs displaying at least 
one fusion product, with the protein-encoding gene in the encapsulated 
plasmid. 
M13 filamentous phage are stable and can easily be produced in large 
quantities with the appropriate bacterial host. Samples can remain almost 100% 
infectious after months in solution at 4°C, are highly resistant to proteolytic 
attack and can withstand a wide pH range without losing viability (Barbas III et 
al. 2001). Compared to the in vitro technologies, phage display imposes 
relatively little set up cost in terms of specialised equipment or expensive 
reagents. However, there are two major limitations. Firstly, the upper limit of 
the naïve gene library is determined by successful transformation rates. 
Consequently, library sizes larger than 10
9
-10
10
 are possible, but rarely 
achieved. Secondly, because of the highly robust nature of M13 phage, cross-
contamination issues are a common hazard when working with multiple 
libraries. 
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A number of different formats for selection using filamentous phage 
display have been investigated, the most important of which are pIII and pVIII 
fusions. Major coat protein pVIII is the most abundant in M13, forming the 
bulk of the protein coat (Armstrong et al. 1981; Grant et al. 1981). Thus a 
library fused to it can expect many copies of the fusion protein displayed on 
each phage, greatly increasing avidity-driven selection pressure and allowing 
variants with low affinities to be discovered (Sidhu et al. 2000). However, this 
approach is greatly limited by phage assembly processes, and has recently 
fallen out of favour.  
Minor coat protein pIII, responsible for infection, is present in only low 
numbers, from three to five per particle (Grant et al. 1981), so selection 
pressure is geared more towards affinity of individual variants compared to 
pVIII display systems. Display of phagemid-encoded pIII fusion protein can be 
promoted by deletion of the native pIII gene in the rescuing helper phage, 
ensuring that all copies present come only from the phagemid (Rakonjac et al. 
1997) (Rondot et al. 2001). However even at that level, multivalent display is 
thought to allow retention of moderate-affinity variants, even where higher-
affinity, but lower avidity, variants are present (Cwirla et al. 1990).  
“Monovalent” pIII fusion libraries, so called because the library fusion 
protein must compete with native pIII derived from the helper phage for 
inclusion into phage particles, result in a mixed population from each cell, 
containing on average one or less fusion pIII proteins per TDP (Lowman et al. 
1991). The expectation is that a lower display count will increase the chances 
of high affinity variant being discovered due to increased emphasis on 
selection for affinity of individual domains. 
As pIII is responsible for infection of a new host cell, infectivity has been 
used as a selection filter with pIII fusion libraries, independent of, or in 
addition to, the primary selection for binding or other property. As infectivity is 
dependent on the close proximity of the three pIII domains to each other, 
efficient selection can be produced by linking protein stability with pIII domain 
association. This has been shown by “rescue” with a separate construct 
containing the required pIII N-terminal domains and a binding site, to which 
those library variants remaining folded after a thermal challenge can bind 
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(Spada et al. 1997). The same effect has been observed by cloning the gene 
library between pIII domains and selecting with proteolysis, where 
proteolytically sensitive variants will lose infectivity (Kristensen and Winter 
1998; Sieber et al. 1998). Using the same principle, selective infection 
approaches have been shown to enhance selection for binding in monovalent 
phage display. Introduction of a helper phage with trypsin-sensitive pIII 
(Kristensen and Winter 1998) and treatment with trypsin following affinity-
based selection of fusion reduces background by biasing reinfection to those 
particles displaying a phagemid-derived (and therefore trypsin resistant) pIII 
(Goletz et al. 2002). 
1.5.2.2 Cell-surface display 
Similar to phage display, cell-surface display of heterologous proteins 
and peptides relies on expression as a chimeric “receptor” with the 
extracellular domain of a membrane protein, primarily in bacteria but also in 
yeast. The methodology was first conceived as a tool for probing membrane 
protein arrangements (Charbit et al. 1986), and to look for antigenic epitope 
peptides (Agterberg et al. 1987; Charbit et al. 1988), but has been expanded 
into whole proteins, including scFv libraries (Fuchs et al. 1991; Francisco et al. 
1993a; Gunneriusson et al. 1996) and enzymes (Francisco et al. 1993b). 
Perhaps the most popular use for bacterial display is in development of live 
vaccines, where the bacteria itself acts as an adjunct to promote activation of an 
immune response to a displayed antigen (Nguyen et al. 1993; Stover et al. 
1993; Nguyen et al. 1995; Georgiou et al. 1997). Maximum library sizes are 
small compared to phage display (10
5
-10
6
, depending on the system used), and 
affinity isolation of cells is generally more problematic. The attraction of cell-
surface display seems to lie in the great range of options available, in terms of 
surface-exposed proteins for insertion of a gene library. Cell-surface display 
has been the subject of a recent review (Jostock and Dubel 2005). 
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1.5.3 In vitro selection methods 
1.5.3.1 Ribosome Display 
Ribosome display was developed as an entirely cell-free method for 
evolutionary selection, to avoid transformation and the bottleneck it imposes 
on maximum diversity. First developed by Mattheakis et al (1994) to screen for 
peptide epitopes, the authors claimed library sizes of 10
12
 members. Hanes and 
co-workers showed its use for the display of antibody fragments (Hanes and 
Pluckthun 1997; Schaffitzel et al. 1999). The technique involves cell free 
expression, where the ribosomes are stalled on messenger RNA (mRNA) 
library transcripts by the absence of a stop codon to prevent peptide release and 
a combination of a sudden drop in temperature with the addition of 
chloramphenicol to stabilise the complex. Thus, the mRNA transcript library, 
translating ribosomes and unreleased polypeptides form a complex (or 
“polysome”) which can be selected for affinity for a new ligand. After 
selection the mRNA is recovered and amplified by reverse transcription PCR. 
The manual style of amplification between rounds lends itself to efficient, 
controlled introduction of small numbers of mutations without the necessity of 
building a new library from scratch. While ribosome display is a very powerful 
technique and has been used to select various binding proteins (in some cases 
to pM-range affinities), including antibodies (Rothe et al. 2006) and DARPins 
(Binz et al. 2004), it remains technically very challenging, involving multiple 
step of reverse-transcription, and handling of large quantities of RNA. 
1.5.3.2 mRNA/DNA display 
These display technologies, like ribosome display, removed cells as the 
method of compartmentalisation. Here the nascent polypeptide is usually 
covalently coupled to the nucleic acid it was translated from, forming an in 
vitro virion suitable for phenotypic selection, as opposed to the much larger 
non-covalent polysome of ribosome display.  
mRNA display was developed first (Nemoto et al. 1997; Roberts and 
Szostak 1997). The model library was built and modified for translation and 
selection, starting with a 3` puromycin and a DNA oligo linker. Synthetic 
mRNA containing the gene of interest and a 5` untranslated region (UTR) was 
then ligated to complete the “virion” genome. To produce the protein encoded 
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by each mRNA, in vitro synthesis was used. Coupling of the peptide to its 
template was achieved by the ribosome stalling as it reached the DNA portion 
of the template, allowing the 3` puromycin, a tRNA-mimic antibiotic, to enter 
the ribosomal A site and form an amide bond with the C-terminal residue of the 
peptide.  
DNA display was developed to overcome the inherent susceptibility to 
enzymatic degradation that comes with the use of RNA as a template. Tabuchi 
et al (2001) used the same puromycin-dependant covalent link to the 
polypeptide. However, the puromycin was instead attached 5` to a ssDNA 
oligonucleotide that annealed to the 3` end of the mRNA library. After 
translation and formation of the puromycin-peptide amide bond, the oligo was 
extended to form a double stranded cDNA-peptide virion. Although the virion 
contained a dsDNA gene, the library used separately transcribed & labelled 
mRNA as the input into a cell-free expression system for production of the 
protein for display. 
In both of the cases above, the covalent attachment mechanism also 
served as a compartmentalisation mechanism, preventing the template gene 
from separating from the translated polypeptide. Alternatively, emulsion 
droplet encapsulation in tandem with other linking methods allowed the 
translation complex to dissociate naturally before assembling into virions for 
selection. In this vein, Doi and co-workers used biotinylated DNA to express a 
streptavidin fusion product, making a high-affinity, non-covalent linkage (Doi 
and Yanagawa 1999; Yonezawa et al. 2003). Another method expressed the 
encoded gene as the fusion of Hae III methylase and coupled the DNA to a 
covalent bond-forming inhibitor (Bertschinger and Neri 2004). While 
conceivably either of these techniques could be used in conjunction with 
mRNA display, their major advantage lies in the more stable dsDNA format of 
the template. 
Display and selection using in vitro virions has been used in selection of 
peptide aptamers (Wilson et al. 2001), FN3 binding domains (Xu et al. 2002; 
Olson et al. 2008; Liao et al. 2009) and de novo proteins (Keefe and Szostak 
2001). 
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1.5.3.3 Other in vitro methods 
Recently a number of other techniques have been developed for selection 
of proteins of interest from large, diverse gene libraries. Atomic force 
microscopy, developed as a method for visualising and quantifying molecular-
scale interactions, has been adapted for screening libraries looking for 
functional DNA aptamers (Miyachi et al. 2010). In this case, no 
compartmentalisation is required, as the selection is based on binding by the 
DNA itself. Display and evolution using proteins attached to microbeads has 
also been used in engineering, where single beads are isolated in oil emulsions 
for in vitro synthesis for evolution of enzyme function (Tawfik and Griffiths 
1998; Ghadessy et al. 2001). This technique was adapted for selection of 
binding proteins by linking successful binding to association with fluorescein, 
allowing discrimination by virtue of increased fluorescence, and sorted using a 
flow cytometer (Feldhaus et al. 2003). 
1.6 Protein-Protein Interactions 
Interfaces between proteins have been an area of intense research over 
decades. Virtually all proteins contact other proteins at some point in their life, 
ranging from transient signal transduction, to practically irreversible binding. 
Understanding regulatory networks is therefore reliant to some extent on 
comprehension of the nature of binding sites. Although the biophysics of 
affinity of one protein for its binding partner are not yet fully understood, it can 
be broken down to a combination of factors: electrostatic, hydrophobic, polar 
(including hydrogen bonds, van Der Waals interactions) and geometric.  
Evolutionary conservation has been used as a method for finding 
important residues for binding (Lichtarge et al. 1996; Zhou and Shan 2001; 
Lichtarge and Sowa 2002; Ma et al. 2003) and structural conservation is a 
common component of prediction algorithms. In stark contrast, newly 
engineered domains have no equivalent evolutionary relationships in the 
sequence databases from which to draw conclusions. Consequently, 
computational analysis of an engineered domain in complex with its non-native 
ligand becomes an exercise in docking in reverse, where a binding site is 
known, but the determinants of binding are not. Based on known protein-
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protein interaction properties, new interfaces can be computationally analysed 
to determine the structural basis of binding. 
1.6.1 Geometric complementarity and polar bonds 
Each potential interaction between binding partners is heavily influenced 
by the ability of the individual components to be presented in an orientation 
that is favourable, i.e. that the interaction does not require a residue to deviate 
from its allowable conformations. Residues which form a surface that is 
complemented closely in a binding partner are more likely to be binding hot 
spots (Li et al. 2004), and interface geometric complementarity is currently 
used as an evaluation of docking quality (Mitchell et al. 2001; Ban et al. 2006).  
Electrostatic interactions and hydrogen bonds are particularly important 
in determining interaction specificity, as shown by evolutionary preservation of 
intermolecular bonds in the conservation of function (Xu et al. 1997b). 
Electrostatics are commonly accepted as the first long-range orientation filter 
for attraction between two potential partners (Schreiber and Fersht 1995) and 
are especially important in protein-DNA interfaces (Shanahan et al. 2004). 
While both these types of interaction can contribute to the overall affinity of a 
complex, any contributed decrease in the free energy of binding is offset to 
some degree by the desolvation effect, defined as the free energy increase due 
to unsatisfied polar bonds following occlusion of solvent during binding. 
Indeed, theoretical studies indicate that intermolecular electrostatic bonds are 
actually most often destabilising due to the high desolvation penalty (Novotny 
and Sharp 1992; Hendsch and Tidor 1994; Sheinerman and Honig 2002; Dong 
and Zhou 2006).  
To some extent the pattern recognition function of hydrogen bond 
networks is similar in both intra- and inter-molecular interactions (Xu et al. 
1997a). Where they differ is in the degree to which they can be optimised. 
Norel and co-workers (Norel et al. 1995; Norel et al. 1999) showed that 
geometric complementarity can be used successfully as the sole docking 
criteria for finding binding sites, even when using structures of monomers not 
solved in the presence of their ligand. This strongly implies that, at least in the 
cases examined, the binding surface shape is largely determined before 
binding, essentially restricting unsatisfied hydrogen bonds on the interface of a 
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folded structure to a rigid-body search. Consequently, bonds formed between 
proteins present a much broader range of angles and distances than found in 
other contexts (Lin et al. 1995; Xu et al. 1997b), impacting negatively on bond 
stability as it diverges from the theoretical ideal. There are cases where large 
conformational shifts can be seen on binding, most obviously in domain-
swapping dimers or natively unfolded proteins (e.g. βγ-crystallin on calcium 
binding (Srivastava et al. 2010)), but it has been noted that antibody-antigen 
complexes exhibit comparatively little conformational changes caused by 
binding (Lo Conte et al. 1999), and that amongst the available degrees of 
freedom for a particular residue, a strongly binding but infrequently sampled 
conformational aspect contributes poorly to the free energy of binding  
(Gallicchio et al. 2010).  These data support the idea that pre-arrangement of 
binding residues into favourable conformations is a general property of high 
affinity protein interactions. 
1.6.2 Hydrophobic interactions 
Hydrophobic interactions influence binding via exclusion of solvent from 
hydrophobic residues resulting in a free energy loss on binding. Patch theory of 
protein interactions posits that interfaces are influenced by hydrophobic 
complementarity, organised into discrete “patches” on the surface of each 
protein (Korn and Burnett 1991), surrounded by more polar residues that may 
remain solvent exposed on binding. Detection of these patches was proposed as 
a method for identification of possible interaction sites (Young et al. 1994b), 
with significant success (Jones and Thornton 1997). A general gain in atomic 
hydrophobicity was found to be correlated with an increased chance of finding 
particular residues in the core of binding patches, which tend to be enriched for 
hydrophobic and aromatic residues (Lo Conte et al. 1999). A survey of protein 
interfaces showed that interfaces of 2000 Å
2
 or less tend to have only one 
hydrophobic patch, with each patch defined as a collection of atoms with an 
average hydrophobicity less than the protein surface average, surrounded by a 
rim of residues more representative of the surface average (Chakrabarti and 
Janin 2002). This conclusion was supported by a larger, more recent study 
(Yan et al. 2008). 
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1.6.3 Hot spots 
It has become evident that the contributions to binding by individual 
residues involved at interfaces are not uniform, even within the same patch. 
Using alanine scanning mutagenesis, calculation of contributions to binding at 
a single residue resolution show disproportionate changes in the free energy of 
binding (Castro and Anderson 1996; Clackson et al. 1998). These positions, 
labelled hot spots, are critical for binding and are often highly conserved, 
aromatic and closely packed in the interface (Li et al. 2004).  
Hot spot prediction by various methods based on structural data can 
provide useful information about an interface. Virtual alanine scanning gives a 
change in free energy difference (ΔΔG) of binding estimate and can be used 
qualitatively to predict critical residues in a protein-ligand interface by the in 
silico mutation of residues to alanine (Massova and Kollman 1999). This 
method has been implemented in the Robetta web server, which combines 
computational alanine scanning with Rosseta structure prediction (Kim et al. 
2004). Unsurprisingly, prediction of hot spot residues tends to become more 
accurate when different metrics are used in combination. For example, the 
KFC web server (Darnell et al. 2007) combines shape complementarity 
calculated by fast atomic density evaluation (FADE) (Mitchell et al. 2001) and 
satisfaction of biochemical bonds in conjunction with virtual alanine scanning 
(calculated by Robetta as a separate input) to make hot spot predictions. Using 
these three methods, the authors claim an accuracy rate of 72%. In an 
alternative model, change in accessible solvent area has also been included 
(Tuncbag et al. 2009; Tuncbag et al. 2010). A major drawback of most 
predictive computational models is that explicit solvent molecules are not 
included in the analysis. Although protein-protein interfaces are typically 
hydrophobic and mostly “dry”, a recent structure survey showed that water 
does play an important role in many interfaces (Rodier et al. 2005); waters 
buried in interfaces may not always contribute to binding directly, but may 
play a cooperative role in stability of individual monomers or residues 
(Reichmann et al. 2008). A study incorporating ordered solvent molecules in 
the prediction showed an incremental improvement in accuracy over less 
comprehensive benchmark models (Li and Li 2010). 
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1.6.4 Thesis Outline 
This thesis, divided into six chapters, describes the development of an 
Obody, derived from a nucleic acid binding domain, engineered for affinity for 
hen egg white lysozyme (HEWL). Chapter two details the methods used in the 
subsequent chapters. Chapter three presents the first structure of an Obody, in 
complex with its ligand, and discusses the binding determinants. Chapter four 
describes the directed evolution by phage display of three focused and one 
naïve gene library based on the same domain, with a view to improve Obody 
binding to a model protein target. Chapter five presents two further crystal 
structures as products of two of gene libraries in chapter four, followed by a 
general discussion in chapter six. 
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2 Materials and Methods 
2.1 General methods 
2.1.1 Clone Storage 
Isolated clones and naïve library stocks were stored either as transformed 
glycerol stocks indefinitely at -80°C, or as purified plasmid indefinitely at -
20°C. Streaked clones on ampicillin-containing agar plates were stored at 4°C 
for a maximum of one month, then discarded. 
2.1.2 Primer Design 
Primers for dissection of the template gene and incorporation of 
mutagenic oligonucleotides were designed using Vector NTI Advance 
(Invitrogen, Carlsbad CA, U.S.A.). The primers were selected for position, 
with little room for optimisation of primer pairs. In some cases, the original 
template was modified to accommodate more efficient priming. A list of 
primers used in the course of this study is available in Appendix A1.3. 
2.1.3 Sequence Analysis and Alignment 
Sequence data were stored and manipulated using Geneious (Biomatters, 
Auckland, New Zealand) and Vector NTI Advance (Invitrogen). 
2.1.4 Common Buffers 
2.1.4.1 Phosphate-buffered saline (PBS) pH 7.4 
10 mM  Na2HPO4 
1.76 mM  KH2PO4 
2.7 mM  KCl 
137 mM  NaCl 
The PBS recipe was taken from Sambrook and Russel (2001), prepared 
as a 10x stock and diluted as needed. 
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2.1.4.2 Wash buffer (PBS-T) 
1x PBS pH 7.4 
0.1% (v/v) Tween-20 
 
2.2 DNA Manipulation and Analysis 
2.2.1 PCR 
All PCRs involved with library production and cloning were performed 
using Platinum Pfx DNA Polymerase (Invitrogen), using the standard recipe 
formulation as provided with the product (Enzyme at 1 U per 50 μL reaction, 
1.5 mM MgSO4, dNTPs at 0.2 mM each, primers at 100 nM each), except that 
the provided 10x buffer was used routinely at 1.5x concentration in the 
reactions. Screening PCRs were performed using Taq DNA Polymerase 
(Invitrogen) according to the information provided with the product (Enzyme 
at 0.2 U per 50 μL reaction, 1 mM Mg Cl2, dNTPs at 0.2 mM each, primers at 
100 nM each). 
2.2.1.1 Nested PCR 
Nested PCR was used to attach 3` and 5` attB recombination sites for 
Gateway cloning (section 2.2.4.4). The procedure was as follows: the template 
gene was amplified in a 25 μL standard PCR reaction, with 100nM of each 
gene-specific primer (Oligos 155/156 were used for all Obody cloning, 
appendix A1.3) for 25 cycles with an annealing temperature of 55 °C. This first 
primer pair added a short (12 bp) linker at either end of the insert for the 
second step. A second reaction was then made, with 100 nM each of the 
generic gateway adapter primers (sequence adapted from (Moreland et al. 
2005)), which anneal to the linkers added in the first step, with 1 μL of 
unpurified reaction mix as the template. The reaction was cycled 25 times, with 
an annealing temperature of 45 °C in the first step, and 55 °C in the second. 
PCR product was purified by gel extraction. 
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2.2.2 Agarose Gel Electrophoresis 
All DNA electrophoresis was performed using horizontal-format 
submerged gels, using Mini-sub Cell GT Cells. (Bio-Rad Laboratories Pty, 
California, U.S.A.) 
2.2.2.1 TAE 50x Stock, 1 L 
242 g   tris(hydroxymethyl)aminomethane (tris) 
57.1 mL  glacial acetic acid 
18.6 g   ethylenediamine tetra acetic acid (EDTA) 
All agarose gels were run in 1x Tris-Acetate-EDTA (TAE) 
2.2.2.2 Gel Preparation 
Agarose gels varied between 0.8 and 2% (w/v) and were always prepared 
fresh in 1x TAE buffer. The agarose was melted with intermittent stirring in a 
microwave, then cooled to <50°C and poured into the caster. The gel was 
allowed at least 20 minutes to set then transferred, complete with casting tray, 
into the running apparatus. The gel was submerged in 1xTAE before loading 
samples and run at 100 V for 45 min 
2.2.2.3 DNA loading Dye 10x 
 0.05% (w/v)  Bromothymol Blue 
 0.25% (w/v)  Xylene cyanol 
 30% (v/v) Glycerol 
2.2.2.4 DNA Standards 
To estimate the size of double stranded DNA (dsDNA) fragments on an 
agarose gel, the 1KB Plus DNA ladder (Invitrogen) was used (Appendix 
A1.1.2). The commercial stock was diluted 1:10 in 1x TAE with 1x DNA 
loading dye and stored at -20°C until needed. 
2.2.2.5 DNA Detection 
Detection of DNA on an agarose gel used ethidium bromide or SYBr 
Safe (Invitrogen). Small-scale gels for confirmation of a correctly amplified 
PCR fragment were stained for ~10 min in a 0.1% (w/v) ethidium bromide 
solution and visualised with a UV transilluminator and a digital camera. 
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Preparative gels for purification of PCR products were run with 1x SYBr Safe 
in the gel and visualised on a Safe Imager blue light (470 nm) transilluminator 
(Invitrogen) for excision of DNA bands for purification. 
2.2.3 DNA Purification 
2.2.3.1 High Pure PCR Purification Kit 
PCR products were purified either straight from the PCR mix or from 
excised gel bands using a High Pure PCR Product Purification Kit (Roche, 
Basel, Switzerland). The High Pure kit was also used to purify DNA following 
enzyme treatment. Binding buffer was 3 M guanidine-thiocyanate, 10 mM Tris 
pH 6.6, 5 % ethanol. Wash buffer was 80% (v/v) ethanol, 20 mM NaCl, 2 mM 
Tris pH 7.5.  Elution buffer was 10 mM Tris pH 8.5. 
For agarose gel extraction, the required band was excised with a clean 
scalpel and weighed in a 1.5 mL centrifuge tube. Binding buffer was added to 
the gel piece at 300 μL per 100 mg agarose. The agarose was melted by 
shaking at 50°C. After melting, isopropan-2-ol (IPA) was added at 150 μL per 
100 mg agarose and mixed thoroughly. The solution was loaded on to a silica 
spin-column provided in the kit and centrifuged at maximum speed for 1 min. 
The column was washed with 500, then 200 μL of wash buffer, taking care to 
keep the column dry after spinning. The DNA was eluted with 50 μL of elution 
buffer into a clean micro centrifuge tube. 
For purification without gel extraction, the method was the same, except 
for the initial binding conditions: Binding buffer was added at 500 μL per 100 
μL of DNA solution and IPA at 250 μL per 100 μL. 
2.2.3.2 “Freeze „n Squeeze” Gel Extraction 
DNA fragments less than 70 bp were purified by Freeze and Squeeze, 
due to poor retention on the High Pure PCR Product columns. The required 
band was excised from an agarose gel with a clean scalpel, wrapped in a small 
square of parafilm and incubated at -80°C for 15 min. The frozen gel pieces 
were partially unwrapped and squeezed between thumb and finger, without 
touching the gel piece. The drops containing the DNA were collected by 
pipette as they emerged and transferred to a new 1.5 mL centrifuge tube.  
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2.2.3.3 Isopropyl Alcohol Precipitation 
The sample containing DNA to be precipitated was acidified by the 
addition of 1:10 volume of 3 M sodium acetate pH 4.8. The DNA was 
precipitated by the addition of an equal volume of 100 % analytical grade IPA 
and incubation on ice for at least 1 hr. Precipitate was harvested at 13,000 g for 
10 min at 4°C, washed three times with 70% (v/v) ethanol, dried at 37°C for 30 
min and re-dissolved in 10 mM Tris pH 8.0. 
2.2.4 DNA Cloning 
2.2.4.1 Restriction Enzymes 
Restriction enzyme digestion was carried out at 37°C for at least 1 hr, at 
a concentration of at least 1U enzyme per 1 μg DNA. After digestion, samples 
were purified using the High Pure PCR kit. 
Table 2.1 Restriction enzymes used 
The symbol ^ in the sequence denotes the position of the enzymatic cleavage. Note that the React buffers 
distributed with Invitrogen restriction enzymes have been discontinued. 
Name Cut site Buffer 
NcoI 5` C^CATGG REact 3† 
NotI 5` GC^GGCCGC REact 3† 
BamHI 5` G^GATCC REact 3† 
EcoRI 5` G^AATTC REact 3† 
BsrGI 5’ T^GTACA NEB 2‡ 
† Invitrogen 
50mM Tris-HCl, pH 8.0 
10mM MgCl2 
100mM NaCl 
‡New England Bioloabs 
10 mM Tris-HCl pH 7.4 
50 mM NaCl 
10 mM MgCl2 
1 mM Dithiothreitol 
 
 
2.2.4.2 Restriction/Ligation 
Basic cloning was carried out using ligation of “sticky end” restricted 
inserts and vectors with T4 DNA ligase (Invitrogen). After restriction enzyme 
digestion, vectors were treated with shrimp alkaline phosphatase 
(SAP)(Roche). SAP removes 5` phosphates, reducing vector self-ligation.  
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Ligation reactions were performed according to the manufacturer’s 
specifications; 30 fmol of vector, 90 fmol on insert, 1 U of ligase per 20 μL 
reaction. Reactions were incubated for at least 6 hr at room temperature, or 
overnight at 14°C before transforming 1 μL of undiluted reaction mix. 
2.2.4.3 pProEx Htb 
For general cloning, expression and sequence confirmation, pProEx Htb 
(Invitrogen) was the standard vector used. All library constructs were cloned 
into this vector using BamHI and EcoRI restriction sites, amplified by primer 
pair 005/006. pProEx Htb is a non-T7 vector, expressing the inserted gene with 
an N-terminal recombinant tobacco etch virus protease (rTEV) cleavable His-
tag for immobilised metal affinity chromatography purification. See Appendix 
A1.2.1 for cloning site map. 
2.2.4.4 Gateway Cloning 
Some gene cloning for expression was done using the Gateway system 
(Invitrogen). This system uses site-directed, direction specific in vitro 
recombination (Hartley et al. 2000). Inserts for cloning were amplified by 
nested PCR (section 2.2.1.1) to introduce attB recombination sites, an rTEV 
cleavage site and a 3` TGA stop codon. The amplified constructs were inserted 
into host “donor” vector pDONR221 (Invitrogen) by BP reaction, transformed 
into a DH5α E. coli host, plasmid mini-prepped and the presence of insert 
confirmed by digestion with BsrGI. Successful clones were used in LR 
reactions for insertion into expression (“destination”) vector pDEST15 
(Invitrogen), which was again transformed into a DH5α host. The successfully 
transformed clones were plasmid prepped, sequenced and re-transformed into 
BL21 (DE3) for expression. 
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2.2.5 Alkaline Lysis Plasmid Purification 
Large scale plasmid preparation was performed using an up-scaled  
alkaline lysis method, combined with PEG-precipitation, modified from 
Sambrook & Russel (Sambrook and Russel 2001). 
2.2.5.1 GTE Resuspension Buffer 
50 mM Glucose 
25 mM Tris pH 8 
10 mM EDTA pH 8 
Sterile filtered, stored at 4°C 
 
2.2.5.2 Lysis Buffer 
1% (w/v) SDS 
0.2 M NaOH 
Prepared fresh from separate 10x stocks. 
 
2.2.5.3 Method 
1. Inoculate a 100 mL 2YT culture with a single colony from a freshly 
streaked plate and grow overnight. 
2. Harvest the cells and discard the supernatant, removing as much of it as 
possible.  
3. Resuspend the pellet in 8 mL of cold GTE, ensuring there are no 
clumps of cells remaining. 
4. Add 12 mL of lysis buffer and mix thoroughly by gentle inversion. Do 
not allow lysis to proceed for longer than 5 min 
5. Add 12 mL of 3M sodium acetate pH 4.8 and immediately mix by 
inversion to prevent localised precipitation. Incubate on ice for 10 min. 
6. Centrifuge at 15,000 g for 10 min at 4°C and decant the supernatant. 
Add an equal volume of isopropan-2-ol (IPA) and incubate on ice for 
30 min. 
7. Pellet the precipitate at 15,000 g for 30 min at 4°C. Decant the 
supernatant and rinse the pellet once with 70% (w/v) ethanol. 
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8. Dissolve the pellet in 1 mL 10m M tris pH 8.0, centrifuge 1 min at 
13,000 g to remove insoluble material, then extract with 500 μL 
phenol/chloroform four times, or until no further precipitate is visible. 
Extract twice with 500 μL chloroform or until no further precipitate is 
visible. 
9. Precipitate the DNA by adding one tenth volume of 3 M potassium 
acetate pH 4.8, then an equal volume of IPA. Incubate on ice for 30 min 
and pellet at 13,000 g for 10 min at 4°C. 
10. Decant the supernatant, rinse the pellet twice with 70% ethanol and air-
dry at 37°C for 1 hr. Re-dissolve the pellet in 192 μL of 10mM Tris pH 
8.0 and transfer to a clean microfuge tube. 
11. Add 48 μL of 4 M NaCl and 240 μL of 13% (w/v) Polyethylene glycol 
8000 (PEG 8K) and mix thoroughly. Incubate on ice for 30 min, then 
pellet the precipitate at 13,000 g for 30 min at 4°C.  
12. The pellet formed is diffuse and difficult to dissolve. Dissolve in 250 
μL 10mM Tris pH 8.0 by scraping with a clean pipette tip and 
incubation at 50°C 
 
2.3 Microbiology 
2.3.1 Antibiotics 
Antibiotics were stored as 1000x stocks at -20°C 
100 mg/mL  Ampicillin 
50 mg/mL  Kanamycin 
2.3.2 Media 
2.3.2.1 5x M9 Salts 
233 mM Na2HPO4 
110 mM KH2PO4 
42.7 mM NaCl 
9.3 mM NH4Cl 
M9 salts were autoclaved and stored at room temperature 
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2.3.2.2 M9 Minimal Media 
1x M9 Salts 
7 mM  MgSO4 
0.3 mM  Thiamine 
44 mM  Glucose 
0.1 mM  CaCl2 
 
2.3.2.3 2YT 
16 g/L  Tryptone 
10 g/L  Yeast Extract 
5 g/L  NaCl 
 
2.3.2.4 SOC Media 
20 g/L  Tryptone 
5 g/L  Yeast extract 
10 mM  NaCl 
2.5 mM  KCl 
5 mM  MgS04 
10 mM  MgCl2 
20 mM  Glucose 
SOC media was prepared and autoclaved without glucose, which was 
added from a 40% (w/v) stock before use 
2.3.2.5 Agar plates 
Plates were prepared by supplementing the required nutrient media mix 
with 15 g/L granulated agar and autoclaving. The agar/media was kept at 50°C 
until used. 
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2.3.2.6 Bacterial Strains 
XL1 Blue and DH5α were used essentially interchangeably for the 
purposes of basic cloning and non-T7 expression, except in the case of 
Gateway cloning where DH5α was used exclusively. BL21 was used for 
expression with T7 vectors, and TG1 was used in all phage production. 
Table 2.2 Bacterial strains used 
Name Phenotype 
TG1 supE thi-1 Δ(lac-proAB) Δ(mcrB-hsdSM)5 (rK
– mK
–) [F´ traD36 proAB lacIqZΔM15] 
XL1 Blue endA1 gyrA96(nal
R) thi-1 recA1 relA1 lac glnV44 F'[ ::Tn10 proAB+ lacIq Δ(lacZ)M15] 
hsdR17(rK
- mK
+) 
DH5α F
- thi-1 endA1 recA1 relA1 gyrA96 Φ80lacZΔM15 Δ(lacZYA-argF)U169, hsdR17(rK
- 
mK
+), λ– 
BL21 (DE3) F
– ompT gal dcm lon hsdSB(rB
- mB
-) λ(DE3 [lacI lacUV5-T7 gene 1 ind1 sam7 nin5]) 
 
2.3.3 Electrocompetent Cells – General Cloning 
E. coli cells were prepared for single-gene cloning using the following 
method: 
1. Pick a single colony from a freshly streaked plate and inoculate a 5 mL 
LB culture. 
2. The following morning inoculate 500 mL of LB in a 2L baffled flask 
with the entire 5 mL overnight culture and grow at 37°C to OD
600
 of 0.6 
3. Harvest the cells by centrifugation at 3000 g, taking care to remove as 
much of the supernatant as possible, then gently resuspend in 500 mL 
of ice-cold sterile-filtered 10% glycerol. 
4. Repeat step 3 twice, each time reducing the resuspension volume to 250 
mL, then 20 mL. 
5. Harvest the cells in a 50 mL falcon tube at 3000 g and gently resuspend 
the pellet in 1.5 mL of ice-cold sterile-filtered 10% glycerol. 
6. Aliquot the prepared suspension into 1.5 mL cryotubes, 50 μL per tube, 
and flash-freeze in liquid nitrogen. Store the frozen aliquots at -80°C. 
2.3.4 Electroporation transformation of E. coli 
E. coli cells were transformed using the following method: 
1. Thaw an aliquot of electrocompetent cells on ice, add 1 μL of DNA to 
be transformed and mix gently by pipetting. 
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2. Transfer the aliquot of cells into a pre-cooled 0.2 cm GenePulser 
cuvette (Bio-Rad) and pulse at 2.5 V. Immediately dilute the 
transformed cells with 1 mL of SOC media and mix. 
3. Incubate the diluted cells at 37°C for 30 min, then spread 50 μL on a 
selective agar plate. Adjust plating volume for amount of DNA and cell 
competency so as to get individual colonies. 
 
2.4 Gene Libraries and Selection 
2.4.1 Phagemid vector 
All library screening was done using phagemid pRpsp2 (Beekwilder et 
al. 1999). Genes were inserted using restriction enzymes NcoI and NotI. 
pRpsp2 expresses the inserted gene as a fusion protein of the C-terminus of 
M13 minor coat protein pIII, with the C-terminal peptide from human Myc 
(cMyc) as an epitope tag located between pIII and the fused Obody. Expressed 
protein was targeted for secretion with an N-terminal pelB leader sequence, a 
sec pathway signal. See Appendix A1.2.2 for a map of the vector cloning site. 
2.4.2 Gene Library Construction 
2.4.2.1 Fragment Generation and Nomenclature 
Gene libraries were constructed by PCR dissection and combinatorial re-
assembly using internal and flanking primer pairs, which are listed in appendix 
A1.3. Each primer pair amplifies either an unmodified section of the template 
gene, or was used to double-strand and amplify a mutagenic single-stranded 
oligonucleotide. Gene fragments were labelled according to the flanking 
primers used during amplification and suffixed with the number of random 
codons it incorporated.  For example, the product of a reaction using primers 
005 and 006 which contains four mutant codons was labelled 005/006 4m. 
Mutational oligonucleotides were purchased as single-stranded templates, 
with specific codons randomised by replacing explicit bases with a random 
base (N) or a defined subset of the full four possibilities (Appendix A1.7). 
Before assembly into an intact gene, each oligo was first “filled in” to produce 
a double-stranded template, then amplified with flanking primers to promote 
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dominance of correctly-sized fragments with the correct overlaps for assembly 
with adjacent fragments.  
2.4.2.2 Fragment Assembly 
Assembly reactions were designed using a “super primer” principle 
(Figure 2.1), where the sense strand of the 5` template fragment and the 
antisense strand of the 3` template fragment act as a primers for each other, 
resulting in a double stranded product fragment, and two unincorporated single 
strands from the template fragments. Inclusion of a flanking primer pair that 
anneals to the 3` end of each residual single-strand regenerates double stranded 
template fragments and allows the cycle to begin again. Like any PCR based 
procedure, this method is not truly random and bias towards fragments which 
assemble first was expected. 
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Figure 2.1 Combinatorial gene assembly schematic 
In this hypothetical example, the PCR reaction contains two gene fragments that overlap. In the first cycle 
of denaturation and annealing (1), two species are produced; the first is the sense strand from fragment 1 
annealed to the complementary antisense strand from fragment 2. The second is the two remaining 
strands which can anneal, but do so at their respective 5` ends and therefore cannot use each other as 
templates during the extension step. In addition, flanking primers complementary to the 3` ends of this 
second species are annealed. The first extension step (2) produces three species; a full length product and 
regenerated copies of the original two fragments. Subsequent denaturation, annealing (3) and extension 
(4) cycles result in further production of newly combined fragments, regeneration product of the original 
fragments, as well as amplification of those full length products produced in previous cycles. 
 
Adjacent fragments were combined in equimolar amounts for assembly 
along with flanking primers in a PCR mix and cycled. The annealing 
temperature was varied according to which flanking primer pair was being 
used. For assembly reactions involving fragments with randomised codons, the 
amount of template fragments added into the reaction, as well as the size of the 
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reaction, was informed by the maximum theoretical diversity of the product 
fragment. Where possible, the amount of input fragments was set higher than 
the maximum theoretical diversity. Upper limits on the achievable diversity 
were imposed by PCR reaction sizes, the amount of mutational oligos available 
and practical concerns in handling large quantities of PCR fragments. When 
combining two fragments where both contain mutational oligos, the required 
quantity (in mols) was calculated as the product of the maximum theoretical 
diversity of both fragments, although practically the maximum output in mols 
from a reaction was limited by the amount of input flanking primers. Standard 
Platinum Pfx PCR assembly reactions always contained 50 pmol of primer pair 
per 50 μL reaction volume, which corresponds to a theoretical maximum of 
3.011x10
12
 molecules. As the largest PCR reactions used were 500 μL, the 
theoretical maximum diversity of any library assembled this way is 3.011x10
13
.  
The number of cycles for each assembly reaction was varied according to 
the concentration of the fragments being assembled, so as not to continue 
cycling once all of the primers in the mix had been incorporated into assembled 
gene fragments. This calculation was performed assuming that the 
concentration of assembled fragments after the first cycle is equal to the 
molarity of each fragment before cycling, and that each cycle after that doubles 
the number of assembled fragments. 
Where large reaction volumes were needed, 25 μL pilot reactions were 
run first to test the competency of the individual fragments for assembly. 
Product fragments were assessed by the presence of a dominant (80% or 
greater) band of the correct size on an agarose gel. Large-scale PCR reactions 
were separated into 25 or 50 μL aliquots for cycling. Correctly assembled 
fragments were excised from a preparative-scale agarose gel and purified on a 
HiPure PCR Product Purification column (Roche). 
2.4.2.3 Error-prone PCR library generation 
Error-prone (EP)-PCR (Cadwell and Joyce 1992) was used to generate a 
randomly mutated library for affinity maturation to a HEWL target. EP-PCR 
was performed using Taq DNA polymerase and primer pair 005 and 006. 
Errors were induced by the introduction of 0.5 mM MnCl2 to reduce 
polymerase specificity. Also, deoxynucleotide-triphosphates thymidine and 
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cytidine were disproportionately increased, from 0.2 mM to 1 mM, to increase 
the likelihood of miss-incorporation. MgCl2 was increased to 7 mM reduce 
primer specificity. To reduce the chances of non-specific products, the template 
gene was introduced as a freshly prepared PCR product, at 10 fmol per 100 μL 
reaction. Taq polymerase concentration was also increased, to 5 U per reaction. 
The mixture was split into 10 μL aliquots for cycling to prevent dominance of 
an early mutation in the library as a whole. 
The PCR product was gel purified and the whole amount amplified with 
phagemid cloning primers (192 and 040) to produce quantities amenable to 
library cloning. The final PCR product library was gel purified and digested 
with NcoI and NotI for cloning into the pRpsp2 phagemid. 
 
2.4.3 Phage Libraries 
2.4.3.1 Library Cloning 
Gene library cloning was done using an up-scaled classic 
restriction/ligation technique, using T4 DNA ligase (Invitrogen). The supplier-
recommended recipe for a single 20 μL ligation reaction was used as a small-
scale test to calculate the absolute number of transformable clones produced by 
the ligation. Before ligation, vector was freshly digested with NcoI and NotI, 
purified with a HiPure PCR Product Purification Kit (Roche) and 
desphosphorylated. Insert and plasmid were added at a ratio of 3:1 to a final 
concentration of 9 pmol insert and 3 pmol plasmid per 2 mL reaction. The 
ligation reactions were incubated overnight at 14°C.  
Ligated DNA was recovered by centrifuge ultrafiltration, using a 
Microcon 50,000 Da cut-off (Millipore, Massachusetts, U.S.A.). The sample 
was exchanged into MQ H2O by repeated dilution and concentration, then spun 
off of the ultrafiltration membrane. DNA was extracted by IPA precipitation 
(see section 2.2.3.3), then dissolved in 200 μL 10 mM Tris pH 8.0 and purified 
a final time using a High Pure PCR Product Purification kit (Roche). DNA 
concentration was measured by nanodrop.  
 
60 
 
2.4.3.2 Library Transformation 
Gene libraries were always transformed into freshly prepared TG1 E. coli 
electrocompetent cells, prepared using the following method: 
1. A single colony from a freshly streaked M9 minimal media agar 
plate was picked and grown overnight in 5 mL M9 minimal 
media broth.  
2. Two 2 L baffled conical flasks were rinsed in hot water and 
autoclaved full of MQ water to removed residual detergents. 
Each sterile flask was shaken with 400 mL of 2YT inoculated 
with 2 mL of the overnight culture at 30°C, to an OD600 of 0.4-
0.45.  
3. After attaining the correct OD600 the cultures were split into 50 
mL conical centrifuge tubes and incubated on ice for 2 hrs, then 
centrifuged at 3,000 g for 10 min to gently pellet the cells. The 
supernatant was removed by aspiration. 
4. The cell pellets were very gently resuspended in 10 mL of ice-
cold 1 mM HEPES pH 7.4, 10% glycerol by pipetting, making 
sure to keep them on ice as much as possible. Each pellet was 
diluted to 50 mL in the same buffer, incubated for 10 min on ice 
and centrifuged 3,000 g for 15 min. The supernatant was 
removed by aspiration. 
5. Step 4 was repeated, except resuspension was only by flicking 
and swirling the buffer, no pipetting. Again, keeping the cells on 
ice as much as possible. 
6. Each pellet was resuspended in 5 mL ice-cold 10% glycerol and 
pooled in groups of 4, to get 20 mL aliquots in each tube, always 
with care to keep the buffer cold. These aliquots were diluted to 
50 mL with cold 10% glycerol and incubated on ice for 10 min.  
7. The cells were harvested for a final time by centrifugation at 
3,000 g for 15 min. The supernatant was removed by aspiration 
and the pellet very gently resuspended in 450 μL of 10% 
glycerol per tube. The final cell suspension was used in 50 μL 
aliquots for Electroporation. 
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Following preparation of the electrocompetent cells, the volume was 
estimated and purified ligation DNA added to them to a ratio of 1 μL DNA per 
50 μL cells. One 50 μL aliquot was kept separate for competency estimation. 
The library was transformed according to the general method given in 
section 2.3.4, except that after dilution in 1 mL SOC, the whole transformed 
culture was transferred into a sterile 50 mL centrifuge tube and cuvette then 
rinsed twice with 1 mL SOC, pooling the rinses with the first lot of cells from 
the cuvette. 
This process was repeated until all of the competent cells containing the 
ligation DNA were transformed; typically 30-40 individual transformations, at 
which point the whole culture was diluted to approximately 100 mL with SOC 
and incubated at 37°C for 20 min. To estimate the transformation efficiency, 
10 μL of the culture was taken and immediately diluted into 90 μL of ice-cold 
10% glycerol. The total cell count was estimated by titration using a 10-fold 
dilution series spotted on to 2YT agar plates supplemented with 100 μg/mL 
ampicillin (2YT/amp plates). Total cell count was used as a proxy for library 
size, assuming that every transformant is unique and that the sample was taken 
before there was significant growth in the culture. 
Electro-competency was measured by transforming a separate 50 μL 
aliquot of cells with 5 ng of empty pRpsp2 and titration of transformed cell 
count to calculate the number of expected colony forming units (cfu) per μg of 
DNA transformed. 
After sampling, the transformed library was pelleted by centrifugation at 
3500 g for 10 min, then gently resuspended in ~5 mL 2YT and spread on to 
four 230 mm 2YT/amp plates. The inoculated plates were incubated overnight 
at 37°C and the resulting bacterial lawn scraped off gently with a sterile plastic 
spatula. The cells were resuspended in ~20 mL 2YT, then diluted 1:2 with 
sterile 50% glycerol. The library transformants were flash frozen in liquid 
nitrogen and stored at -80°C as 1.5 mL aliquots. 
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2.4.4 Phage Display 
2.4.4.1 Blocking Buffer 
1x PBS pH 7.4 
10 mg/mL Bovine serum albumin (BSA)(Invitrogen) 
 
2.4.4.2 5x Phage Precipitation Solution 
20% (w/v) Polyethylene Glycol (PEG) 8000 (Sigma) 
15% (w/v) NaCl 
 
2.4.4.3 Phage Titration 
Phage counts were measured using TG1 as reporter bacteria. A single 
colony was picked from a fresh TG1 agar plate and inoculated into 3 mL 2YT, 
which was allowed to grow to saturation (4-6 hr) at 37°C. A titre plate consists 
of 5 mL of “soft” agar (2YT with ~0.7% agar) inoculated with 150 μL of the 
saturated TG1 culture, layered on to the surface of a standard 2YT 1.5% agar 
plate, supplemented with ampicillin for transducing particle (TDP) counts, or 
no antibiotic for plaque forming units (PFU) counts. The prepared plates were 
allowed to dry standing open in a laminar flow cabinet for 30 min before use. 
The input, experimental and control phage samples from panning 
experiments were serially diluted 100-fold in sterile PBS or MQ water, up to 
10
-10
-fold for input phage, 10
-8
-fold for eluted experimental and control 
samples. 10 μL of each dilution was spotted on to a single titre plate, spaced 
out so that the spots did not overlap. The plates were allowed to stand 
uncovered in a laminar flow hood until the spots were absorbed, then covered 
and incubated at 37°C overnight. Phage titres per mL were calculated per by 
counting colonies (in the case of TDP titration) or plaques (in the case of helper 
phage titration) in the highest dilution where individual colonies or plaques 
were distinguishable. 
 
 
63 
 
2.4.4.4 Vcsm13 Helper Phage 
Vcsm13 (Agilent Biotechnology) is a derivative of m13 phage, with a 
kanamycin selectable marker. Helper phage stocks were produced at least once 
every 6 months and stored at 4°C as 1 mL aliquots.  
To produce a working stock, the source stock was titred (see section 
2.4.4.3 for phage titre method) on non-selective media to produce single 
plaques. A single plaque was picked, inoculated into a 5 mL culture of TG1 in 
2YT media at OD600 0.5 and allowed to stand for 1 hr at 37°C. The infected 
culture was transferred into a 2 L baffled conical flask with 500 mL 2YT with 
50 μg/L Kanamycin and grown overnight at 37°C. 
The following day the cells were pelleted by centrifugation for 10 min at 
10,000 g, and the supernatant decanted. Dissolved phage were precipitated 
from the supernatant with 0.4% PEG 8000/0.3% NaCl for 2 hr on ice. The 
precipitated phage were harvested at 15,000 g for 20 min, re-dissolved in 20 
mL sterile PBS and centrifuged at 15,000 g for 15 min to remove residual cells. 
The supernatant was filtered to 0.45 μm and precipitated with 1x phage 
precipitation solution overnight at 4°C. The precipitated phage were harvested 
at 15,000 g for 20 min, re-dissolved in 20 mL PBS and titred. The phage stock 
was aliquoted into 1 mL lots and stored at 4°C. 
2.4.4.5 KM13 helper phage 
KM13 is a trypsin-sensitive helper phage (Kristensen and Winter 1998). 
Briefly, a linker peptide containing a trypsin recognition site was added to the 
loop joining the second and third domains of minor coat protein pIII. Although 
it was first conceived as a tool for proteolytic selection for stability, KM13 
seems to benefit ligand-driven selection as well (Goletz et al. 2002). 
Preparation of KM13 helper phage was identical to the method described 
for Vcsm13 in section 2.4.4.4. After preparation, the titred stocks were tested 
for trypsin sensitivity by incubation with 1 mg/mL trypsin in PBS 
supplemented with 1 mM CaCl2 for 2 hr at 37°C then re-titred. The freshly 
prepared phage stock was judged sufficiently trypsin sensitive if a 10
6
-fold 
reduction in infectivity was observed after treatment. If the required drop was 
not seen, the preparation was discarded and new stock prepared. 
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2.4.4.6 Phage Library Production 
To generate the input phage for the first round of panning, a single 
aliquot of library transformants was thawed on ice. The entire aliquot was used 
to inoculate 1 L of 2YT/ampicillin, which was grown in a baffled 2 L conical 
flask at 37°C to an OD600 of 0.5 then infected with Vcsm13 helper phage, with 
multiplicity of infection (m.o.i.) of 20. The infected culture was incubated 
standing at 37 °C for 30 min, centrifuged at 4,000 g for 15 min, resuspended in 
1 L of fresh 2YT/amp/kan and grown overnight at 37°C with constant shaking. 
Phage secreted into the media supernatant were purified by centrifugation 
of the overnight culture at 10,000 g for 20 min and decanting the supernatant 
into a sterile 1 L Schott bottle containing 40 g PEG 8000 and 30 g NaCl for 
precipitation. The cell pellet was discarded. The precipitating phage were 
incubated on ice for 1-2 hr, then centrifuged at 15,000 g for 20 min in sterile 
500 mL centrifuge bottles. The supernatant was carefully removed and the 
centrifuge bottles allowed to stand inverted for 10 min to drain excess 
precipitant colution. Phage pellets were dissolved in 2 mL PBS and transferred 
to a 2 mL microfuge tube. The centrifuge bottles were rinsed with a further 2 
mL PBS, the rinse pooled with the first aliquot. The re-dissolved phage sample 
was centrifuged at 13,000 g for 15 min and filtered to 0.45 μm with a syringe 
filter. After filtration, the phage were precipitated a second time by the addition 
of phage precipitation solution to 1x and incubated overnight at 4°C. 
Immediately before use, the phage were pelleted at 15,000 g for 20 min and 
dissolved in 2 mL PBS. 
2.4.4.7 Immunotube Immobilisation 
Nunc immunotubes (ThermoFisher Scientific, Waltham MA, U.S.A.) 
were used as the only method of ligand immobilisation for panning 
experiments. Ligand in 2 mL PBS was incubated with constant shaking 
overnight at room temperature in parafilm-sealed immunotubes. Each tube 
containing ligand was matched to a control tube with an equal concentration of 
BSA. After the overnight incubation, each tube was blocked for 3 hrs in 4 mL 
blocking buffer (section 2.4.4.1), then rinsed five times with 5 mL PBS.  
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2.4.4.8 Panning 
Before panning, the 2 mL input phage was diluted with sterile PBS 
(750 μL into 2 mL) into two identical aliquots. The diluted phage solution was 
pre-adsorbed with 1 mg/mL BSA for 3 hrs with constant inversion, then added 
to the rinsed immunotubes, one into the ligand tube, the other into the BSA 
control tube, and incubated with constant gentle shaking for 1 hr at room 
temperature. After discarding the unbound phage supernatant, each tube was 
washed 10 times with PBS-T, then 10 times with PBS. Bound phage were 
eluted using either 1 mg/mL trypsin in 2 mL PBS with 1 mM CaCl2 or 1 
mg/mL ligand for 1 hr with constant gentle shaking. Eluted phage were 
decanted from the immunotubes, titred and stored at 4°C. 
2.4.4.9 Single Clone Isolation 
Single phage isolation was done on phage titre plates, as described in 
section 2.4.4.3. The phage sample was diluted in 10-fold serial dilutions, to get 
between 1 and 100 phage per 250 μL. Three titre plates per sample were 
infected with 250 μL of phage solutions at different dilutions, to ensure that 
some plates have single colonies in sufficient number. The plates were 
incubated overnight at 37°C, colonies picked and grown overnight for plasmid-
preparation. 
2.4.5 Western Blot Protein Detection 
2.4.5.1 Transfer buffer 
25 mM  Tris.Cl 
192 mM  Glycine 
20% (v/v)  Methanol 
0.01%  Sodium dodecyl sulfate (SDS) 
2.4.5.2 Ponceau Red Stain 
0.2% (w/v) Ponceau Red 
1% (v/v)  Glacial Acetic Acid 
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2.4.5.3 Membrane Blocking Buffer 
1x PBS pH 7.4 
10% (w/v) Skim milk powder 
0.1% (v/v) Tween-20 
 
2.4.5.4 Blotting and Detection Method 
Western blots use labelled antibody probes to detect specific proteins 
bound to a membrane. The primary antibody binds directly to the blotted 
protein; the secondary antibody binds to Fc region of the primary and is 
conjugated to horse radish peroxidise (HRP) which provides the detection 
signal. 
An SDS-PAGE gel of the samples for detection, pre-stained ladder and 
control samples were run and then added to the western blot transfer 
“sandwich” along with a square of nitrocellulose membrane large enough to 
cover the whole gel. The blot assembly was run at 100 V for 1 hr with constant 
stirring, with an ice-pack to keep the buffer cool. All western transfers were 
performed using a Mini Transblot Cell (Bio-Rad). After transferring, the 
membrane was removed and stained for 5 min in enough Ponceau Red Stain to 
cover it completely, then rinsed with tap water until bands were visible. The 
positions of the lanes and the bands of the ladder were marked with a pencil, 
and the membrane blocked for 1 hr with constant shaking in Blocking Buffer. 
After blocking, primary antibody was administered diluted in 2 mL of 
Blocking Buffer spotted on to a glass plate. The membrane was carefully 
layered on to the spotted antibody, covered and incubated at 21°C for 1 hr. 
Unbound antibody was removed with five washes of 5 min each with PBS-T. 
Secondary antibody was administered in the same way as the primary, with the 
same wash steps afterwards. 
Detection was achieved by chemiluminescence, using Pierce SuperSignal 
West Femto Maximum Sensitivity Substrate (Thermo Scientific, Rockford, 
USA), a binary peroxide substrate. The substrate components were mixed 1:1 
then diluted 1:2, layered on to the membrane and allowed to incubate for 1 
min. Excess substrate was carefully removed with blotting paper and the 
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membrane covered with a transparency. Visualisation was done with a 5 min 
exposure in a Fuji Intelligent Dark Box II, with a Fuji Las 1000 digital camera. 
2.4.6 Surface Plasmon Resonance 
All surface plasmon resonance (SPR) work was carried out using a 
Biacore 3000 SPR Instrument (GE Healthcare). SPR measures changes in the 
angle of diffraction off of the surface of a gold chip, brought about by mass 
variations on the opposite side. Output was in response units (RU).  
2.4.6.1 Running Buffer 
10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
 (HEPES) pH 7.4 
150 mM NaCl 
3 mM EDTA 
0.005 % (v/v) Tween-20 
 
2.4.6.2 Chip Surface Preparation 
For analysis of Obody-ligand interaction, CM5 chips were used, which 
covalently attach the ligand via amine groups on the protein. The exact 
concentration of ligand varied, but the general method was controlled by the 
Biacore software.  
Two surfaces were prepared in tandem, one with ligand the other as a 
reference blank. First, the surface was activated by injection of 1-ethyl 3-(3-
dimethylaminopropyl)-carbodiimide hydrochloride, followed by N-
hydroxysuccinimide. The ligand was injected into only one flow cell, typically 
at 10 μg/mL for 30 s at 5 μL/min. The remaining active surface was 
deactivated with 1 M ethanolamine, and the final response for the chip 
calculated to indicate the level of bound ligand. The target bound-surface 
response was 100-150 RU. 
2.4.6.3 SPR Analysis 
Affinity determination on the Biacore 3000 was performed using a 2-fold 
dilution series of the OBody, starting at a minimum concentration of 10-fold 
higher than the affinity, if it had previously been calculated. Each dilution was 
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injected at 15 μL/min, until equilibrium at the chip. The surface was 
regenerated with running buffer for 5 min after each injection. Each experiment 
utilised two flow-cells, one with bound ligand, the other as a reference. The 
final response curves for each injection were the reference subtracted from the 
flow cells with bound ligand. The KD was calculated by plotting the maximum 
response at each concentration vs. OBody concentration in mol/L and fitting a 
Langmuir saturation binding curve to the data (Equation 2.1), using GraphPad 
Prism modelling software. Fits with different stoichiometries of Obody and 
ligand were compared to test for applicability of a 1:1 binding model. 
 
  
        
           
 
Equation 2.1 Langmuir binding curve, fitted using Graphpad Prism 
This equation assumes the curve is the sum of a non-linear specific response and a linear non-specific 
response that increases with concentration, where Rmax is the maximum response, KD is the dissociation 
constant. For the linear component, m is the gradient and c is the y-intercept of the linear portion. 
 
 
2.4.7 Isothermal Titration Calorimetry 
Isothermal titration calorimetry (ITC) was carried out using a MicroCal 
VP-ITC instrument (GE Healthcare). ITC measures binding enthalpy by 
measurement of the required input of energy to bring a known volume of 
ligand solution back to the base temperature after each injection during titration 
of a concentrated analyte into a dilute ligand of known volume.  
As this technique is very sensitive to dilution effects, each protein was 
exhaustively dialysed into a single batch of PBS to minimise buffer 
differences. Two titrations were performed for each experiment; a control 
titration of concentrated analyte (HEWL at 350 μM) into buffer giving the 
enthalpy of dilution, and an experimental titration of the same analyte into 
Obody solution at ~30 μM. The control titration curve was subtracted from the 
experimental titration curve and the results analysed using Origin ITC Analysis 
software (Origin Lab, Northampton MA, USA).  
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The results were plotted as the molar ratio of the analyte and ligand on as 
the x variable, with change in energy in kcal/mol analyte on the y axis and 
fitted to Equation 2.2. Analysis was done using Origin ITC analysis software to 
give the enthalpy of binding and dissociation constant. 
  
    
         
 
Equation 2.2 ITC binding curve, fitted using Origin ITC 
This equation was fitted and the subsequent calculations carried out to determine the binding constant by 
Origin ITC analysis software, where Rmax is the maximum change in enthalpy (ΔH), h is the Hill Slope 
and m is the x-intercept at the point of inflection. The x intercept gives the stoichiometry of binding, and 
the KD is derived from the Hill Slope, taking into account the concentration of the two protein 
constituents. 
2.4.8 Differential Scanning Fluorimetry 
A method for determining the Tm of proteins using fluorescence has 
recently been published (Ericsson et al. 2006; Niesen et al. 2007). Briefly, the 
protein is mixed with a dye which fluoresces when bound to hydrophobic 
residues then subjected to a temperature gradient using a qPCR thermocycler. 
Here, Obodies were tested using SYPro Orange (Invitrogen) and a Corbett 
Rotor-Gene RT-PCR machine (Corbett Life Science, Concorde NSW, 
Australia). As the protein denatures, fluorescence increases, ideally in a 
sigmoidal cooperative unfolding curve, but usually until it precipitates and 
fluorescence drops, resulting in a discrete peak instead of a sigmoidal curve. 
Before fitting, the data is trimmed to exclude points past the peak maximum, 
forcing the fitting program to extrapolate. A curve is fitted using Equation 2.3, 
giving the Tm. This method is straightforward and seems to agree with more 
rigorous methods of determining Tm, such as differential scanning calorimetry.  
Equation 2.3 Fluorescence melt curve equation 
Where yMin and yMax are the minimum and maximum fluorescence values, h is Hill’s slope and Tm is 
the point of inflection. 
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2.5 Protein Expression and Purification 
2.5.1 SDS - Polyacrylamide Gel Electrophoresis (PAGE) 
2.5.1.1 Coomassie Blue Stain 
0.05% (w/v) Coomassie Brilliant Blue R-250 
25% (v/v) IPA 
10% (v/v) Acetic acid 
 
2.5.1.2 Destain 
10% Acetic acid 
 
2.5.1.3 Resolving Gel: 
12.1 mL ddH2O 
10 mL 30% (w/v) Acrylamide (37.5:1 acrylamide: N,N`-
methylene-bis-acrylamide) 
7.5 mL 1.5 M Tris pH 8.8 
0.3 mL 10% (w/v) SDS 
15 μL N,N,N',N'-tetramethylethylenediamine (TEMED) 
150 μL 10% (w/v) Ammonium persulfate (APS) 
 
2.5.1.4 Stacking Gel: 
17 mL ddH20 
4.25 mL 30% Acrylamide 
3.125 mL 1.0 M Tris pH 6.8 
0.25 mL 10% (w/v) SDS 
15 μL TEMED 
150 μL APS 
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2.5.1.5 Gel Preparation 
SDS-PAGE gels were made in batches of 5 and stored at 4°C for up to 1 
month. The resolving gel was made first and poured into the 5-gel caster, then 
covered with a layer of IPA to prevent bubbles setting at the top of the gel. 
Once the resolving gel was set and the IPA drained, stacking gel was made and 
poured on top along with well-forming combs. 
 
2.5.1.6 Denaturing Protein Loading Dye 
10 mL 1M Tris pH 6.8 
8 mL glycerol 
16 mL 10% (w/v) SDS 
4 mL β-mercaptoethanol 
1 mL 1% bromophenol blue 
 
2.5.1.7 Protein Standards 
To estimate the size of protein bands on gels stained with coomassie as 
well as a gel quality marker, Precision Plus Protein Unstained Standard (Bio-
rad Laboratories Pty, California, U.S.A.) was used. For gels to be used for 
western blotting, BenchMark Prestained Ladder (Invitrogen Corporation, 
California, U.S.A.) was also used to validate a successful blot. See appendix 
A1.1 for marker weights. 
2.5.1.8 Protein Detection 
All protein gel visualisation was done using coomassie blue stain. After 
removing the gel from the running apparatus and placing it in a suitable 
container, enough stain was added to completely cover the gel, then heated for 
~20 s in a microwave at its highest setting. The gel and stain was allowed to 
cool down with constant shaking, then the stain decanted. The gel was rinsed in 
tap water and again covered in destain. After heating on high for ~20 s, a rolled 
paper towel was wadded at one end of the container to absorb the coomassie 
dye. The gel and destain was allowed to cool with constant shaking, with 
destain and paper towel replaced if necessary. 
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2.5.2 General Protein Expression 
All engineered Obodies worked with over the course of this study 
behaved identically during purification, and purification was treated as a 
medium-throughput operation. Unless otherwise stated, protein production 
followed a general method. A single colony was picked from a freshly streaked 
plate and used to inoculate a small (~5 mL) 2YT overnight starter culture, with 
the appropriate antibiotic. The following day, 1 L of 2YT culture in a 2 L  
conical baffled flask was inoculated with 1 mL of the overnight culture and 
grown at 37°C with constant shaking to an optical density at 600 nm (OD600) 
~0.6. IPTG was added to 1mM and the induced cultured grown overnight in 
the same conditions. 
The following day, the cells were centrifuged at 10,000 g for 20 min at 
4°C, the supernatant discarded and the pellet re-suspended in ~40 mL PBS, 
with one Complete EDTA-free Protease Inhibitor Tablet (Roche). Lysis was 
achieved by sonication; 6 rounds of 30 s, with 30 s pause between them.  
The lysate was fractionated at 15,000 g for 20 min at 4°C and the 
supernatant decanted into a fresh 50 mL tube. The insoluble pellet was re-
suspended in 40 mL PBS and sampled for a later gel if necessary. The soluble 
fraction was filtered to 0.2 μm with sterile Minisart luer-lock syringe filters 
(Sartorius Stedium Biotech GmbH, Goettingen, Germany), then loaded on to 
the appropriate column, according to the affinity tag in use. 
Soluble protein concentration was calculated by UV absorbance at 
280 nm, giving concentration based on the extinction coefficient for individual 
proteins (Equation 2.4). 
 
Equation 2.4 Beer-Lambert Law 
The Beer-Lambert law, where A is absorbance at 280 nm, Ɛ is extinction coefficient in M-1cm-1, b is 
pathlength in cm and c is concentration in mol/L 
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2.5.3 Immobilised Metal Affinity Chromatography 
Immobilised metal affinity chromatography (IMAC) was used to purify 
His-tagged fusion proteins. All purifications were done using a General 
Electric (GE) Healthcare 5 mL HisTrap FF chelating column charged with 
Ni
2+
.  
2.5.3.1 Column Preparation 
Before protein binding, the column was washed with 5 column volumes 
of water. 5 mL of 100 mM EDTA pH 8.0 was pushed into the column and 
allowed to incubate for 5 min. The column was washed with PBS until no blue 
colour was visible, charged with 5 mL of 100 mM NiCl2, then washed again 
with 5 column volumes of PBS. 
Following lysis, soluble fractionation and filtration, the lysate was slowly 
pushed through the column with a syringe, collecting the flow-through. 
2.5.3.2 FPLC Purification 
IMAC purifications of new proteins were run using Fast Protein Liquid 
Chromatography (FPLC) instruments, either an ӒKTA Prime Plus or ӒKTA 
Basic (GE Healthcare, Waukesha WI, U.S.A.), which have 280 nm UV 
absorbance (UV280) and conductivity inline monitors. Before attaching the 
protein-charged column the instrument was equilibrated into PBS (Buffer A) 
then PBS + 1 M imidazole pH 7.4 (Buffer B). After equilibration the system 
was rinsed with Buffer A only and the column attached and washed with 1% 
Buffer B, effectively a PBS + 10 mM imidazole wash. Once the UV280 trace 
reached a plateau, a gradient of increasing levels of imidazole from 10 mM to 
500 mM was run (1% -50% Buffer B) over 100 mL, collecting 2 mL fractions 
along the full length of the gradient. Peaks visible in the UV280 trace were 
analysed by SDS-PAGE. 
2.5.3.3 Manual Purification 
IMAC purifications of known proteins were performed using syringes, 
without the use of an FPLC instrument. Based on the UV280 trace from FPLC 
runs, the imidazole levels required to elute the protein from the column were 
estimated. Protein levels in flow-through were monitored using Protein Assay 
Dye Reagent (PAD) (Bio-Rad), diluted 1:5 in MQ water. Fractions were 
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assayed in a 96-well microplate by mixing 5-20 μL of sample with 150 μL of 
diluted PAD and looking for development of a blue colour, indicating the 
presence of protein. 
Obody purification was done in 3 steps: first, the column was washed 
with 5 volumes of PBS +10 mM imidazole to remove non-specifically bound 
proteins; second, the column was washed with multiple column volumes of 
PBS + 100 mM imidazole in 2 mL fractions until no further protein was 
detected coming off the column using PAD. Bound protein was eluted with 
PBS + 250 mM imidazole in 2 mL fractions, assayed using the Bio-Rad dye to 
determine when elution had finished. 
2.5.4 GSH-Affinity Chromatography 
2.5.4.1 Column Preparation 
Glutathione-S-transferase (GST) binds specifically to reduced 
glutathione (GSH). All GSH-affinity purifications were performed using 
GSTrap HP 5 mL columns (GE Healthcare). Before use, the column was 
washed four times with three column volumes of alternating acidic/basic 
buffers (25 mM Acetate pH 4.5/25 mM N-Cyclohexyl-2-aminoethanesulfonic 
acid (CHES) pH 9.5), 5 column volumes of a high salt wash (500 mM NaCl), 
then equilibrated into PBS + 1mM β-mercaptoethanol (βme). 
2.5.4.2 Purification Method 
GSH-affinity chromatography was done either on an FPLC instrument or 
manually by syringe, but the method was essentially identical in both cases. 
Following loading the column with protein, it was washed with at least 5 
column volumes of PBS, or until no protein is detectable in the flow through 
(by UV280 trace on an FPLC or by PAD assay if done manually). Bound 
protein was eluted with at least 5 column volumes of PBS + 10 mM GSH + 
1mM βme in 2 mL fractions, again monitoring as above for the presence of 
protein in each fraction. If no peak was detected, fractions were checked on an 
SDS-PAGE gel. 
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2.5.5 rTEV Cleavage 
Recombinant Tobacco Etch Virus (rTEV) protease was used to 
specifically cleave between the protein of interest and fusion affinity tag (See 
Appendix A1.5 for cut site and production method). Following affinity 
purification, selected fractions were pooled and estimated for total protein 
concentration. rTEV was added to a ratio of 1 mg:20 mg of fusion protein and 
incubated at 21°C for 1 hr, then overnight at 4°C. Cleavage was tested by 
before/after comparison on SDS-PAGE. 
In the case that there was GSH present in the buffer with the fusion 
protein, rTEV digestion was carried out in a 6-8,000 Da cut-off dialysis tube 
during dialysis into 1 L of PBS with constant stirring at 4°C overnight. 
2.5.6 Size-Exclusion Chromatography 
Purification by size-exclusion was typically the second step in the 
purification process, following affinity purification and removal of the affinity 
tag. It was always performed on an ӒKTA FPLC. Size-exclusion 
chromatography separates a complex mixture according to hydrodynamic 
radius, which is often used as a proxy for molecular weight. The column bed 
consists of beads with a known average pore size. Smaller proteins are able to 
enter more pores then larger, so are retained for longer on the column. Proteins 
too large to fit into any pores in the column elute first, in what is known as the 
“void” volume. Actual resolution of the different sized proteins occurs between 
the void volume and the buffer front from the injected sample, which contains 
the smallest constituents. 
2.5.6.1 Preparative Grade Columns 
A Superdex 75 16/60 size exclusion prep-grade column (GE Healthcare) 
was used during the second step to remove residual contaminating E. coli 
proteins, cleaved affinity tag and uncleaved fusion protein as well as the added 
rTEV. Before use the column was washed with 1 column volume of filtered 
ultra pure water and equilibrated with 1 column volume of sterile-filtered PBS. 
After rTEV treatment the digested sample was concentrated using Vivaspin 
5,000 Da cut-off centrifugal ultrafiltration devices (GE Healthcare) to 5 mL or 
less, filtered to 0.2 μm and injected on to the column. Fractions were collected 
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(2 mL) after allowing the void volume to be discarded. Analysis was peformed 
by inline UV280 absorbance trace. 
2.5.6.2 Analytical Grade Columns 
A Superdex 75 10/300 size exclusion analytical grade column (GE 
Healthcare) was used as the final “polishing” step of purification, to remove 
aggregates and degraded proteins. The analytical grade columns are smaller, 
contain smaller superdex beads, run at higher pressure and provide better 
resolution then the prep-grade columns. Before use the column was washed 
with 1 column volume of water and equilibrated into sterile-filtered PBS. The 
sample to be purified was concentrated to 1 mL or less, filtered to 0.2 μm and 
injected in successive runs of ~200 μL lots. Each run was collected in 500 μL 
fractions and analyse by inline UV280 absorbance trace. 
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2.6 Protein Crystallography 
2.6.1 Sitting Drop Method 
All crystallisation screens were performed using a sitting-drop vapour 
diffusion format in Intelliplate (Hampton) 96-well trays. 
2.6.1.1 Naïve Screens 
A standard five-plate (480 conditions) screen was employed as the 
primary naïve screen for initial crystallisation conditions (Moreland et al. 
2005), using a MultiPROBE II HT/EX liquid handling robot (Perkin-Elmer) to 
mix and dispense the screens, and a Cartesian HoneyBee (Genome Solutions) 
robot to lay down 100 nL protein + 100 nL mother liquor drops. Completed 
plates were sealed and incubated at 18°C. Individual conditions were screened 
manually under a microscope for the presence of crystals or promising 
conditions. 
2.6.1.2 Crystal Optimisation 
Fine screens were designed around promising conditions from the initial 
naïve screens to improve crystal quality and increase the number of crystals 
available for experimentation. They were constructed in a two- or three-
dimensional array depending on the individual condition, varying salt 
concentration, precipitant concentration or pH. Protein and mother liquor drops 
were combined in a 1 μL + 1 μL format and incubated at 18°C. 
2.6.2 Crystal Diffraction Screening 
The cryogenic temperatures at which protein crystal x-ray diffraction is 
typically done (100 K) requires measures to prevent the formation of ice 
crystals, which can severely interfere with processing the protein-derived 
diffraction pattern. This necessitates inclusion of a cryoprotectant with the 
mother liquor so that on freezing it forms a non-crystalline and therefore 
minimally diffracting vitreous “glass” (Garman and Schneider 1997). To test 
for an appropriate cryoprotectant, the mother liquor condition for the desired 
condition was supplemented with a range of concentrations of glycerol, from 
5% to 30% in 5% steps. The cryoprotectant was selected on the basis of an 
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absence of ice ring diffraction, with minimum deviation for the original 
condition. 
Before mounting and testing for diffraction, each crystal was briefly (1 
min) soaked in a series of increasingly concentrated cryoprotectants, starting at 
5% glycerol and increasing in 5% steps until the desired concentration is 
reached. The crystal was then scooped on to a nylon mounting loop, flash 
cooled in liquid nitrogen and tested for diffraction with 5 min, 1° phi exposure 
at 0° and 90° relative to the initial orientation. The images were indexed and an 
appropriate collection strategy determined using Mosflm (Leslie 1992). 
2.6.3 Data Collection 
2.6.3.1 Home Source Data Collection 
Home source datasets were collected at 100 K using the Mar x-ray 
generator at the Maurice Wilkins Centre (University of Auckland, New 
Zealand). The instrument generates x-rays (λ 1.54179 Å) with a Rigaku 
rotating copper anode and records diffraction patterns using a Mar2300 image 
plate. 
2.6.3.2 Synchrotron Data Collection 
Synchrotron datasets were collected at 100 K at the Stanford Synchrotron 
Radiation Lightsource (SSRL) macromolecular crystallography beamline 9-1 
and the Australian Synchrotron MX1 beamline. 
2.6.4 Data Processing 
Data images were indexed and integrated using MOSFLM (Leslie 1992) 
or XDS (Kabsch 2010). Data reduction was carried out using SCALA (Evans 
2006) and TRUNCATE (French and Wilson 1978) from the CCP4 suite 
(Bailey 1994). 
2.6.4.1 Molecular Replacement Phasing 
Phasing of the crystallographic data was done by molecular replacement, 
using either MOLREP (Vagin and Teplyakov 1997) or Phaser (McCoy et al. 
2007) as provided as part of the CCP4 suite (Bailey 1994). 
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2.6.4.2 Model Building and Validation 
Model building was done exclusively with Coot molecular modelling 
software (Emsley and Cowtan 2004), including placement of ordered solvent 
molecules and validation of the final model. Refinement was done using 
alternately Refmac (Murshudov et al. 1997) and Phenix (Adams et al. 2010) 
restrained refinement. Phenix restrained refinement with simulated annealing 
was used early in the refinement to remove model bias. Refined models were 
analysed for biophysical characteristics using the Robetta virtual alanine 
scanning server (Kim et al. 2004), EBI PDBePISA interface prediction and 
analysis server (Krissinel and Henrick 2007), the KFC hot spot prediction 
server (Darnell et al. 2007) and the PROTORP interface comparison server 
(Reynolds et al. 2009). 
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3 Structure of an engineered Obody complex 
3.1 Introduction 
Structural studies provide unparalleled levels of information about a 
protein or complex and can be considered essential for an engineering project. 
Much of the information about major binding domains is based on high-
resolution structural data, allowing the researchers to make informed 
hypotheses about the position and utility of residues, down to conformational 
bias and atomic composition of an interface. Evolution of new binding proteins 
raises questions about the nature of the newly evolved face that cannot be 
answered by sequence data alone. Biochemical and biophysical techniques can 
provide answers, such as relative stability of engineered domains, individual 
contribution of residues to binding, affinity and specificity. Crystallographic 
and NMR protein structures provide atomic-resolution information, allowing 
the estimation of many of the important aspects of binding, as well as a basis 
for rationally improving binding with future libraries.  
Compared to the number of engineered binding proteins investigated, 
there are relatively few structures of engineered protein-protein complexes. 
Hogbom et al claim to have published the first such structure, with an affibody 
in complex with its wild-type (wt) template protein, the Z domain from 
staphylococcal protein A (Hogbom et al. 2003). Other examples include an 
Anticalin in complex with CTL-A (Schonfeld et al. 2009) and a DARPin in 
complex with maltose binding protein (Binz et al. 2004). 
3.1.1 Preliminary Obodies Work 
Previously, a phage library of randomised Obodies, based on the 
anticodon recognition domain (which adopts an OB-fold) of aspartyl-tRNA 
synthetase (aspRS) from Pyrobaculum aerophilum (Genbank accession 
AE009441), was selected for affinity for hen egg white lysozyme (HEWL). For 
a full description of the initial library design and selection, see the attached 
manuscript (Appendix A2). This particular domain from aspRS was selected 
from a panel of 8 OB-fold domains and was therefore denoted paOB3. Briefly, 
this library randomised 13 positions along the first three anti-parallel β-strands 
of the OB-fold β-barrel and four residues in a loop between β-strands 4 and 
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five (4/5 loop), giving a total of 17 randomised positions. Lacking structural 
data for paOB3, the was domain was modelled using the Swissprot homology 
modelling server (Peitsch 1995; Arnold et al. 2006; Kiefer et al. 2009) 
The general location of the binding face for the initial library was 
selected by comparison of the modelled domain with protein and nucleic acid 
binding OB-folds, specifically staphylococcal enterotoxin B (Swaminathan et 
al. 1992), streptococcal enterotoxin C (Roussel et al. 1997), yeast single-
stranded telomeric binding domain Cdc13 (Mitton-Fry et al. 2002; Mitton-Fry 
et al. 2004) and the N-terminal OB-fold of Asp-tRNA synthetases from 
Pryrococcus kodakarensis (Schmitt et al. 1998) and Escherichia coli (Rees et 
al. 2000). All of these proteins use an OB-fold to mediate some of their 
interactions, though not always via structurally equivalent residues. In order to 
create a randomised binding face with minimum perturbation of the structure, 
thereby preserving the hydrophobic core, specific positions on the OB-fold 
domain were identified for randomisation as codons on the basis of side chain 
interactions with its tRNA substrate, as determined using the crystal structure 
of the E. coli aspRS-tRNA complex (Eiler et al. 1999). 
By restricting the final nucleotide in each randomised codon to only two 
possibilities (NNK, where K= T/G) a full complement of 20 amino acids was 
allowed, but the UGA and UAA stop codons eliminated. The third stop codon, 
UAG or “amber”, was suppressed the by supE phenotype of the TG1 E. coli 
host used for phage display work, substituting a glutamine instead (Inokuchi et 
al. 1979). Single letter nucleotide codes are as per the IUPAC abbreviations 
(Appendix A1.7) This library was called 13mRL to reflect the number and 
distribution of randomised codons (13 on the β-sheet (13m), 4 in the  
randomised loop (RL)) and was panned against various model targets, the most 
successful of which was HEWL. Selected variants were analysed for affinity 
using surface plasmon resonance (SPR) and the variant with the highest 
measured affinity (13mRL L8, 40 μM) was used in crystal trials in the presence 
of HEWL.  
This chapter presents the crystallographic structure of that Obody in 
complex with HEWL and analysis of the interface for binding determinants. 
First, it is shown that the engineered Obody utilises its randomised face to bind 
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the target protein. Second, the interface is analysed for individual binding 
components; hydrogen bonds, hydrophobic patches, shape complementarity 
and binding hot spots. Lastly, the complex structure is used to construct a semi-
rational library for the purposes of affinity maturation. 
3.2 Results 
3.2.1 Expression and Purification 
The 13mRL HEWL-selected variant L8 was cloned into destination 
vector pDEST15 (Invitrogen) using the Gateway cloning system (section 
2.2.4.4), giving an expression construct with an N-terminal glutathione-S-
transferase (GST) fusion tag, cleavable with rTEV protease. The fusion protein 
was purified by hand on a 5 mL HiTrap GSH column (GE Healthcare) (see 
section 2.5.4 for method). The eluted protein (typically ca. 20 mL) was pooled 
and dialysed at 4°C in 6,000 Da cut-off dialysis tubing into 1 L PBS, with 
rTEV protease (section 2.5.5). 
The following day the dialysed sample was concentrated using a 
Vivaspin 5,000 Da cut-off ultrafiltration device, down to approximately 2.5 
mL. The entire sample was filtered through a 0.2 μm syringe filter and re-
purified on a Superose 75 16/60 preparative grade size exclusion column, to 
remove the GST tag and rTEV. 
As a final polishing step to remove residual small molecule 
contaminants, the Obody peak fraction was pooled and concentrated to 
approximately 1 mL with the same ultrafiltration device as above, then purified 
a final time using a Superose 75 10/300 analytical grade size exclusion column 
(Figure 3.1). 
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Figure 3.1 Sample purification of 13mRL L8. 
(A) Preparative scale size exclusion chromatography trace, showing elution of Glutathione-S-Transferase 
(GST, peak 1) and the digested Obody (peak 2) after treatment with rTEV protease. (B) Analytical-scale 
size exclusion chromatography trace of the Obody, re-purified after the preparative scale size exclusion 
column. (C) SDS-PAGE gel showing purified cleaved Obody (lane 1, expected size 12,500 Da) and intact 
Obody-GST fusion protein (lane 2, expected size 40,800 Da ). Protein markers are labelled in kDa. 
 
3.2.2 Crystallisation and Data Collection 
Obody 13mRL L8 was screened for crystallisation conditions at 
40 mg/mL in PBS pH 7.4 with equimolar HEWL (Roche/Sigma) in 10 mM 
sodium acetate pH 4.8, using a 480 condition screen (Moreland et al. 2005). To 
form the complex, the two proteins were mixed at high concentration, with 
13mRL L8 at 100 mg/mL and HEWL at 120 mg/mL, then diluted to bring the 
Obody to 40 mg/mL. A single diffracting crystal was observed in a condition 
containing the mother liquor 0.2 M HEPES pH 7.3, 7% methyl  polyethylene 
glycol (MPEG) 5000, diffracting to a resolution of approximately 2.7 Å 
(Figure 3.2).  
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Using the crystal from the wide screen condition above, a 360° dataset 
was collected with a phi of 0.5° per image, for a total of 720 images, on the 
home x-ray source at the Maurice Wilkins Centre. The same crystal was used 
to collect a second dataset with the same parameters at the Stanford 
Synchrotron Radiation Lightsource (SSRL). Both datasets were comparable in 
terms of maximum resolution, but the SSRL dataset was of considerably higher 
quality across all parameters (Table 3.1). Both showed the same P41212 
spacegroup and very similar unit cell parameters.  
 
 
Figure 3.2 13mRL L8-HEWL complex crystal 
(left) Grown in 0.2 M HEPES pH 7.3, 7% MPEG 5000 and measuring approximately 20 μm across at its 
smallest axis from this perspective, this crystal diffracted to ~2.7 Å and was used to collect 720 images at 
the Maurice Wilkins Centre X-ray facility and another 720 at the SSRL beamline. A sample image from 
the homesource dataset is shown on the right. Starting from the centre of the image, resolution circles 
mark 10.4, 5.2, 3.5 and 2.6 Å. 
 
3.2.3 Model building and Refinement 
The home source data was phased by molecular replacement using 
HEWL structure 193L and the OB-fold domain of aspartyl-tRNA synthetase 
from Pyrococcus kodakarensis (PDB accession 1B8A, pairwise sequence 
identity 39%). Using MolRep to look for two copies of each monomer, the 
phasing yielded an R-factor of 52.7%, although only one copy of lysozyme and 
two OB-folds were found. As the Matthews coefficient suggested the presence 
of two copies of an entity the size of an Obody-HEWL complex (2.36 Da/Å
2
, 
solvent content 47.8%, P = 0.99) and as the single HEWL appeared to be in 
complex with one of the OB-fold monomers, a second HEWL was introduced 
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by treating the OB-fold-HEWL complex as a rigid body and superimposing the 
OB-fold portion of that complex on to the second OB-fold monomer. The two-
complex model of the asymmetric unit was subjected to simulated annealing 
using Phenix, which dropped the R-factor below 50%. 
The OB-fold model was replaced with the correct 13mRL L8 sequence 
by manual residue mutation and refined by alternating rounds of Refmac 
restrained refinement and Phenix minimisation with simulated annealing. 
Because of the moderate resolution, strict non-crystallographic symmetry was 
imposed on the main chain atoms between the monomers of both 13mRL L8 
and HEWL. In addition, bond length and angle restriction weightings were 
increased as moderate resolution data reduced the ability of the model to 
accurately detect unusual conformations. The final R-free was 34%, though 
this does not reflect a completely refined structure. The complexes were 
labelled AD and BC, reflecting the chain ID, where chain A and B are HEWL 
and C and D are Obodies.  
A second dataset from the same crystal, collected at the SSRL, was used 
to further refine the structure complex derived from the home source data. The 
complexes were refined as described above, resulting in an R-factor of 22.9% 
and R-free of 29%. The final model was analysed with PROCHECK and the 
Ramachandran plot showed no residues in disallowed or generously allowed 
regions, 11.6% in allowed regions and 88.4% in favoured regions. Refinement 
statistics are summarised in Table 3.1. Data was cut off at 2.75 Å for 
refinement due to a deteriorating Rmerge statistic at the highest resolution 
shell. 
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Table 3.1 13mRL L8 complex structure statistics 
Figures in brackets represent the highest resolution shell 
    Home Source SSRL 
Data Collection & Integration 
  
 
Space Group p41212 p41212 
 
Unit cell (Å) 
  
 
a 76.585 76.759 
 
b 76.585 76.759 
 
c 166.15 166.344 
 
α, ,  90 90 
 
Wavelength (Å) 1.54179 0.95666 
 
Resolution Limits (Å) 50 - 2.8 (2.872-2.8) 34.9 - 2.69 (2.76 -2.69) 
 
Measured Reflections 267,952 144,772 
 
Unique Reflections 12,301 16,010 
 
Multiplicity 21 9 
 
Completeness (%) 95.3 (54.75) 99.15 (92.8) 
 
Rmerge (%) † 4.2 (59.0) 7.3 (54.3) 
 
<I/σ(I)> 50.14 (1.6) 32.5 (4.2) 
 
Wilson B (Å
2
) 85 65 
 
Mosaicity (°) 0.6 0.6 
    Molecular Replacement‡ 
  
 
Correlation Coefficient 66.2 - 
 
R-factor (%) 52.7 
 
    Refinement 
  
 
Resolution (Å) 25 - 2.8 (2.87 - 2.8) 27.5 – 2.75 (2.82-2.75) 
 
Reflections 11,629 (479) 12,789 (908) 
 
R work (%)* 26.5 (38.0) 22.9 (26.5) 
 
R free (%)* 34.0 (48.0) 29.64 (37.6) 
 
Free reflections 597 (22) 667 (55) 
 
Refined Atoms 3319 3379 
 
r.m.s.d. bond lengths (Å) 0.012 0.013 
 
r.m.s.d. bond angles (°) 1.541 1.452 
  <B factor> (Å
2
) 66.94 51.15 
† Rmerge = Σ|Iobs - <I>|/ ΣIobs 
‡ Ref. (Vagin and Teplyakov 1997) 
*R = Σ||Fobs| - |Fcalc||/ Σ|Fobs| 
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3.2.1 The  Obody-HEWL Complex 
The three-dimensional structure for the complex between the 13mRL 
variant L8 and HEWL shows in atomic detail the specific interactions between 
the two proteins. The expression construct sequence was 115 residues in 
length, including the 109 domain residues, a two-residue extension in the 2/3 
loop and an N-terminal four-residue remnant of an rTEV cleavage site. The 
final model had two Obody-HEWL complexes in the asymmetric unit, with 
HEWL chains A and B in complex with Obody chains D and C respectively. 
For each Obody monomer the first 22 residues were not visible; these are not 
part of the core OB-fold domain. In the full-length aspRS protein, the residues 
loop around the OB-fold domain and interact with the aspRS catalytic domain. 
The C-terminus of the core OB-fold is visible, but both monomers lack density 
for the final 10 residues of the construct. Four residues in the 4/5 loop were 
targeted for randomisation, but in both of the Obody monomers this loop is 
very poorly ordered, with only the backbone atoms visible. The selected 
sequence for these positions in this clone is GVGR, with no density visible for 
the arginine or valine side chains. In both cases the side chains were added 
with zero occupancy past Cβ and set to the most favourable rotamer that 
resulted in no clashes. 
The Obody binds to HEWL by wrapping its binding face around the 
surface of the protein and inserting the C-terminal end of -strand 1 and the 
short loop between it and β-strand 2 (residues 32-35) into the active site cleft of 
the enzyme (Figure 3.3). Of the 17 residues which were randomised to 
construct the library, ten are intimately involved at the protein-protein 
interface. These ten residues combine with a further 8 wild-type residues to 
form the interface.  
3.2.1.1 The Interface 
The interface between Obody 13mRL L8 and HEWL buries 838 and 805 
Å
2
 of the Obody in complexes AD and BC respectively (as determined by 
PDBePISA (Krissinel and Henrick 2007)), and is evenly divided between 
atoms with hydrophobic or hydrophilic character. Although individually the Cα 
superposition of the HEWL and Obody monomers in each complex shows 
effectively identical structures, the angle of interaction is noticeably different. 
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Overlaying the Obody monomers reveals changes in the cognate HEWL 
monomers of up to 1.0 Å in portions most distal to the interface, with lesser 
shifts of as little as 0.3 Å close to the HEWL active site. This corresponds to a 
binding angle difference of approximately 5 ° between the two complexes. 
This small degree of flexibility may be a consequence of the modest binding 
affinity of this complex, but the moderate data quality may also have 
introduced uncertainties sufficient to account for this difference. Between the 
Obody β-strand inserted into the HEWL active site is a large unfilled cavity 
(Figure 3.3E), which probably negatively impacts binding affinity. Although 
there is no evidence for ordered waters in the cavity at this resolution, it seems 
likely that they are present. 
89 
 
 
             
Figure 3.3 Interface Contacts vs. Library Mutations 
Schematic representations of the 13mRL L8-HEWL complex interface. (A)Contact by the Obody (blue 
cartoon) is mediated primarily by β-strand one and two (arrow), which inserts into the HEWL (green, 
solvent exposed surface) substrate binding cleft. Comparison of the library-targeted Obody residues (Β, 
highlighted green on blue surface model) with calculated contact residues (C, highlighted green) 
illustrates the extensive involvement of native residues in HEWL binding. The contact residues on HEWL 
(D, highlighted in blue) show the extent of the binding interface. (E) A cutaway diagram of surface 
representations of the Obody (blue) and HEWL (green) shows the position of a void at the interface 
between Y33 and R35. 
 
A B 
D C 
E 
R35 
Y33 
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3.2.1.2 Intermolecular polar bonds 
Analysis of the two interfaces using the PDBePISA web server shows 
two similar but different configurations of binding (Table 3.2). In the AD 
interface, 10 polar bonds are predicted, involving 7 residues from the Obody 
(D32, Y33, R35, K40, E55, K86, E93). Amongst the polar bonds are three salt 
bridges (D32, R35 and E93). The salt bridge formed by R35 is of particular 
interest as it involves the HEWL catalytic residues E35 and D52. Residues 
involved in predicted polar bonds form a ring around the hydrophobic centre of 
the binding face (Figure 3.4). Hydrophobic interactions also contribute to the 
binding, especially G31, Y33, G34, V36 and I38, and to a lesser extent Y53, 
F67, K86 and F95. Compared to the AD interface, the BC interface contains 
net fewer (9) polar bonds, which are accounted for by the loss of bonds to 
residues K86 (due to a 180° flip of the carbonyl oxygen) and E55 but gain of a 
single bond to S85. Hydrophobic interactions across the BC face are identical 
to the AD face. Inspection of polar and hydrophobic interactions across the 
interface shows a single patch of hydrophobic residues at the centre, consisting 
of Y33, V36 and I38, surrounded by a rough circle of residues mediating 
hydrogen and electrostatic bonds (Figure 3.4). 
 
Table 3.2 Intermolecular polar bonds between 13mRL L8 and HEWL 
Determined by the PBDePISA server, both chains in the asymmetric unit show a common motif of polar 
interactions centred on 5 residues at the interface. The remaining three residues listed below (E55, S85 
and K86) may represent alternative binding configurations, stabilised into two distinct complexes in the 
crystal structure. 
Residue Chain C Chain D Type† HEWL 
Partner(s) 
Asp 32 2 2 HS W63, R61 
Tyr 33 2 2 H D101, N103 
Arg 35 2 2 HS E35, D52 
Lys 40 1 1 H G102‡ 
Glu 55  1 H N113 
Ser 85 1  H K116 
Lys 86  1 H N113‡ 
Glu 93 2 2 HS R112, K116 
† H = hydrogen bond, S = salt bridge 
‡ Backbone-mediated interaction 
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Figure 3.4 Intermolecular Polar Bonds 
HEWL residues forming intermolecular polar bonds are shown as green stick diagrams, Obody as a blue 
Cα trace. Obody residues with buried solvent accessible surface area at the interface are shown as blue 
line diagrams. Polar bonds are indicated by dotted yellow lines, labelled with the bond length. Polar 
bonds are arranged in roughly a circle around a hydrophobic patch on the Obody at the centre of the 
binding face formed by Y33, V36 and I38. 
 
3.2.1.3 Hot spots 
Analysis of the complexes for “hot spot” residues was performed using 
Robetta (Kim et al. 2004) and KFC (Darnell et al. 2007) web servers,  which 
identified residues in each complex as hotspots using three metrics: The KFC 
server used Fast Atomic Density Evaluation (FADE) for shape 
complementarity and, independently, the satisfaction of biochemical contacts 
(Van der Waals polar/nonpolar, hydrogen bonds and electrostatics), while the 
Robbetta server used in silico alanine scanning. Residues identified as a 
predicted hot spot are summarised in Table 3.3 and shown graphically in 
Figure 3.5. Y33 was identified as the single most important residue at the 
interface; it was the only position consistently identified as a binding hot spot 
across all methods used.  
V36 
I38 
Y33 
R35 
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Surprisingly, R35 was not consistently picked, despite forming multiple 
hydrogen and electrostatic bonds with HEWL active site residues. It is also 
interesting to note that of the four residues most frequently picked as hot spots, 
two of them were not varied in the library (D32 and E93). D32 makes two 
separate contacts; one a hydrogen bond to the side chain nitrogen of HEWL 
W63 mediated by the D32 carbonyl oxygen, the other a salt bridge with HEWL 
R61. E93 also makes two contacts, to R112 and K116 on HEWL, both of 
which can potentially form an electrostatic or hydrogen bond. 
Table 3.3 Hot spot predictions for the 13mRL L8 HEWL complex 
Binding hot spots, calculated using web servers KFC and Robetta, are summarised below (A). Y33 is the 
only residue picked consistently as a hot spot binding residue across all three models and in both Obody-
HEWL complexes. N/P indicates a residue that was not picked as an interface residue in that complex. 
Average ΔΔG across both Obody monomers as calculated by Robetta is shown for contact residues in 
(B). Note the negative value for K37, indicative of a negative contribution to binding. 
 A Residue Chain K-FADE K-CON Robetta B Residue ΔΔG 
(kcal/mol) 
  Gly 31 C N/P N/P N/P  Asp 32 0.43 
   D  Yes   Tyr 33 3.76 
  Asp 32 C Yes    Arg 35 0.49 
   D Yes Yes   Val 36 0.95 
  Tyr 33 C Yes Yes Yes  Lys 37 -0.37 
   D Yes Yes Yes  Ile 38 0.82 
  Gly 34 C  Yes   Lys 40 0.85 
   D Yes Yes   Tyr 53 1.09 
  Arg 35 C Yes    Glu 55 0.31 
   D     Ser 85 -0.02 
  Tyr 53 C  Yes   Lys 86 0.42 
   D Yes    Glu 93 4.21 
  Glu 55 C N/P N/P N/P  Phe 95 0.10 
   D  Yes     
  Glu 93 C   Yes    
    D     Yes    
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Figure 3.5 Obody predicted hotspots 
Obody 13mRL L8 chain D, showing the location of hotspot predictions (red). Three predictions are 
contiguous residues on β-strand 1, which, together with R35, insert into the HEWL substrate binding 
cleft. 
 
3.2.2 The Obody-HEWL interface 
Superposition of the two Obody monomers shows little deviation (Cα 
r.m.s.d. = 0.44 Å), with a similar result for the HEWLs (Cα r.m.s.d. = 0.11 Å), 
which reflects the strict NCS adopted for backbone atoms during refinement. 
When the two Obody monomers are overlaid, the region around E55 and Y53 
shows evidence for differences in side-chain conformation, and is generally 
less well-defined compared to the rest of the interface (Figure 3.6). Y53 shows 
some evidence for multiple conformations within each monomer, but these 
were not modelled due to the moderate resolution of the data. Due to 
proximity, Y53 probably influences the conformational state of E55, which is 
visible as two different rotamers in the two monomers, despite being very close 
to the interface and actually participating in complex AD by forming an 
intermolecular hydrogen bond. The greatest degree of backbone deviations in 
the Obodies maps to the loops and terminal regions, where 13 out of a total of 
86 residues account for all r.m.s.d. values over 0.4 Å. These larger deviations 
can be at least partially accounted for by poor electron density leading to 
uncertain placement.  
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Interestingly, of the three disulfide bonds found in native HEWL, making 
a total of six in the asymmetric unit, only two, in HEWL chain A, were 
completely oxidised. Evidence for multiple conformations of the remaining 
cysteines indicates populations of HEWL monomers with different levels of 
oxidation in the crystal. It isn’t clear what effect this might have on the 
structure, as pertaining to the Obody-HEWL complex.  
 
Figure 3.6 Overlay of the Obody monomers 
The two Obody monomers are shown as blue Cα ribbons superimposed (Cα r.m.s.d. 0.44 Å). The 
residues shown in blue (monomer C) and green (monomer D) are those randomised in the 13mRL library. 
Those shown in yellow are the ancestral sequence, but are calculated to have some solvent exposed 
surface area buried at the formation of the complex. The regions which contribute most to the Cα 
deviations are the 4/5 and 2/3 loops. The 4/5 loop was very poorly defined by electron density, suggesting 
that it plays no direct role in complexation with HEWL, although long-range electrostatic interactions 
would not necessarily be reflected by electron density. Some electron density indicated multiple 
conformations of Y53, but the combination of a marginal data:parameter ratio and poor signal for the 
second conformers lead to the decision not to model them. 
 
R35 
2/3 loop 
4/5 loop 
K86 
Y53 
Y33 
E55 
I38 
K40 
P51 
E93 
D32 
V36 
 
S29 
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3.2.3 Comparison with the initial library model 
Because the original library design was based on a modelled template 
domain and not an experimentally determined structure, the modelled OB-fold 
domain was superimposed with the 13mRL L8 crystal structure, which shows a 
close match (Figure 3.7). The two Obody domains overlaid with the template 
OB-fold give an r.m.s.d. of 1.21 and 1.14 Å for chains C and D respectively. 
These figures were distorted upwards by large variation in loops, particularly 
the 4/5 loop. With the 4/5 and 2/3 loops removed, the r.m.s.d. dropped to 0.83 
Å. Similarly, the refined lysozyme model compared closely with the starting 
model, with a r.m.s.d. of 0.2 Å. Some minor differences were observed in side 
chain positioning at the Obody-HEWL interface. 
 
 
Figure 3.7 Superposition of 13mRL L8 with the library modelled domain 
Shown in wall-eye stereo, the starting model of paOB3 wt (pink) was constructed by homology modeling, 
but overlays the crystal structure 13mRL L8 (blue, chain D) with an r.m.s.d. of 0.83 Å, excluding the 4/5 
and 2/3 loops. The domains are oriented to show the three β-strand face targeted for randomisation to the 
front. Importantly, the residues selected for randomisation using the model were found in the correct 
position in the crystal structure. 
 
 
3.2.4 Comparison with Other HEWL complexes 
The natural bacterial inhibitor of HEWL, YkfE, binds on the opposite 
face of lysozyme when compared to the Obody. However, there is a surprising 
intersection of the inhibitory histidine from YkfE and the Obody R35 which 
β3 
β1 
4/5 loop 
2/3 loop 
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reaches into the active site of HEWL and bonds with the catalytic residues 
Glu35 and Asp52 (Figure 3.8A). 
The binding of the camelid single domain antibody to HEWL also has 
some similarities to the Obody-HEWL complex. A long CDR3 loop from the 
camelid antibody binds into the active site cleft of HEWL and presents ~70% 
of the binding interface. This CDR3 loop has been compared to substrate 
binding by HEWL (Transue et al. 1998) and there are striking similarities 
between the substrate and atoms in the CDR3 loop providing clear details for 
the mechanism of  inhibition. This is similar to the C-terminus of 1 and the 
short loop between 1 and 2 strands of the Obody, which inserts into the 
active site cleft and allows R35 to reach out and H-bond with the active site 
acidic residues of HEWL. The relative C positions of Y103 from the camelid 
antibody and Y33 from the Obody is striking (Figure 3.8B), as well as the 
similar hydrophobic interactions of Y103 and V36. While the Obody loop does 
not penetrate the active site cleft to the same degree as the camelid antibody, 
there are nevertheless sufficient similarities between this Obody loop and the 
camelid loop to suggest that efficient inhibition would be possible with higher 
affinity binding. Indeed, the larger Obody surface area presented to HEWL by 
way of the OB-fold binding face and the flanking variable loop (4/5 loop) 
points towards attainable tighter binding variants. Attempts to measure 
inhibition of HEWL by a binding Obody by digestion of killed Gram-positve 
bacteria (Parry Jr. et al. 1965)were inconclusive, probably due to the low 
affinity of this complex. 
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Figure 3.8 Comparison with other known HEWL binders 
(A) The lysozyme inhibitor protein YkfE from E. coli (Monchois et al. 2001) is shown in pink, Obody in 
blue and HEWL in green. The overlay of R35 and the inhibitory histidine from YkfE is highlighted in the 
zoomed inset picture. (B) Overlay of the CDR3 loop (yellow) from an inhibitory camelid antibody 
(Transue et al. 1998) with the Obody peptide (blue) in the active site cleft of HEWL (green). 
 
 
The Obody-HEWL interface is in line with typical antibody-antigen 
interfaces (in terms of buried surface area, number of H-bonds and the gap-
volume index), as shown in Table 3.4. This raises the question of the modest 
affinity of the Obody-HEWL interaction in comparison to 3-4 orders of 
magnitude greater affinity of antibody-antigen interactions, despite similar 
properties of the interaction interface. First, the fact that interfaces with similar 
properties achieve much higher affinities suggests that the Obody-HEWL 
interface can also be modified to generate much tighter binding. Secondly, it 
points towards the presence of unfavourable interactions decreasing the affinity 
between the Obody and HEWL when compared to other lysozyme complexes. 
To address this, I have inspected the interface for unfavourable interactions and 
have identified two residues that may be responsible for lowering the affinity 
of the complex, as well as two other non-contacting residues which, if re-
randomised and selected, may produce beneficial interactions to further 
stabilise the complex. 
 
A B 
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Table 3.4 Comparison of Obody-HEWL interface 
These data were calculated using the PROTORP server (Reynolds et al. 2009). The salt bridge count was 
defined as the number of charged residues on the Obody with an appropriately charged HEWL residue 
within 4Å. Gap volume index is the ratio between buried surface area and accumulated volume of gaps at 
the interface, as defined by Jones and Thornton (1996). 
 
13mRL L8 
Inhibitor YkfE, 
1GPQ 
Camelid  Ab 
1JTP 
Mouse Fab 
1FDH 
Buried surface area* 840 Å
2 (14%) 796 Å2 (11%) 800 Å2 (11%) 647 Å2 (3%) 
H-bonds 10 10 8 12 
Salt bridge interactions 3 2 0 0 
Polar:Non-polar atoms % 43:57 47:53 28:72 51:49 
Gap Volume Index‡ 2.94 3.06 2.22 3.27 
Kd 36 μM ~1 nM 50 nM 22 nM 
*Average antibody/antigen buried surface area = 950 Å2 
  
‡Average Gap Volume Index (antibody/antigen) = 3.0 
  
 
3.2.5 Structure-Based Library Design 
Based on the structure presented here, residues were identified and 
targeted for affinity maturation. The primary focus was the 4/5 loop; none of 
the randomised residues in the loop contact HEWL and it is poorly ordered. 
The four residues from the original 13mRL library were re-randomised, and 
two additional random codons were also added, bringing the total loop residues 
to six.  
On the face itself, four positions were identified; S29, K37, P51 and A56 
(Figure 3.9). S29 and A56 were identified as residues with small side chains 
close to the interface that did not make any significant contacts with HEWL. 
Re-selection of these positions was expected to result in bulkier residues with 
more bonding potential. P51 was found in the middle of the third β-strand of 
the binding face. The assumption was made that, as proline is a β-breaking 
residue (Chou and Fasman 1974), this may de-stabilise the barrel. However, 
the close match to the template model domain, which lacked a proline at that 
position, suggests that this may not be the case. 
K37 was in close proximity (3 Å) to R61 from HEWL in both 
crystallographic complexes, although no polar or hydrophobic interactions 
were predicted between the two. At neutral pH (crystals were grown in pH 7.3, 
phage display selection was performed at pH 7.4) both lysine and arginine 
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would be protonated and positively charged, suggesting that K37 may be 
detrimental to overall binding. Examination of the structure showed the 
majority of the K37 side chain buried in a highly hydrophobic region at one 
end of the β-barrel, with only the terminal amine group solvent exposed. This 
suggested that some of positive effects on binding could be attributed to intra-
molecular interactions, by fulfilling hydrophobic contacts on the opposite side 
of the binding face.  
 
Figure 3.9 Selected face residues for the L8 10m library 
Residues at the binding face identified as candidates for re-mutation for affinity maturation. A cartoon of 
Obody monomer chain D is shown in dark blue, the cognate HEWL is shown as a green surface. Residues 
S29 
P51 
A56 
K37 
β1 
 
A 
B 
4/5 loop 
 
β3 
 
K37 
HEWL R61 
A56 
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are shown as light blue stick diagrams (complex BC) or green (complex AD). (A) S29 makes no bonds to 
HEWL (surface representation), although a large polar patch is close. P51 was assumed to be potentially 
destabilising to the Obody itself as a β-breaker. (B) K37 appears to interact with R61 from HEWL (shown 
as green Cα trace), though no hydrogen bonds are predicted. A56 made no contacts with HEWL (surface 
representation) in either complex in the asymmetric unit and was not part of the original complement of 
mutated residues.  
 
3.3 Discussion 
3.3.1 Structural Validation of Library Design 
The 13mRL L8 structure demonstrates without doubt that engineering of 
the presented Obody was successful. The domain uses the engineered face to 
bind to its ligand and all of the targeted residue side chains are located on the 
exterior of the domain, as predicted by the homology model used to design the 
13mRL library. Indeed, the fact that the crystal structure Obody domain so 
closely resembles the homology model is testament to the high degree of 
structural conservation in OB-folds.  
The interface itself conforms to the general description of protein-protein 
interfaces: a hydrophobic centre, surrounded by a series of polar interactions, 
salt bridge interactions for long-range orientation and a buried surface area that 
can be compared to interface averages (total of ~1600 Å
2 
from both partners) 
from a protein-protein interaction survey (Lo Conte et al. 1999). Based on the 
presence of two non-crystallographic conformers, the interface appears to have 
two stable arrangements, though moderate data quality precludes certainty on 
this matter. Binding is focused on three major residues; Y33 is by far the most 
important and is the only residue to be consistently picked as vital across all 
hot spot analysis models employed. Surprisingly, though it makes several 
interactions with HEWL acidic active site residues, R35 was not picked as a 
hot spot consistently. This can probably be explained by the low degree of 
geometric complementarity it exhibits, due to both the unfilled cavity shown in 
Figure 3.3 and its location on the edge of the interface.  
In addition to the randomised library residues, there is extensive contact 
with HEWL by native residues, especially by those in β-strands 1 and 2, and, to 
a lesser extent, at the end of β-strand 4 and beginning of β-strand 5. Indeed, 
two of the three residues with predicted salt bridges to HEWL are native 
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Obody residues. As electrostatic interactions are thought to be the first “filter” 
for attraction that precedes tight binding (Schreiber and Fersht 1995), it appears 
that selection of the mutant face enriched for a composition that relied heavily 
on the non-varied periphery of the interface. This is hardly surprising, given the 
cooperative nature of the residues on the surface of β-barrels in general, 
although it does raise certain issues about limitations on targets with the current 
face design. The salt-bridge contributions by native residues are all acidic, 
which makes sense considering that HEWL has a pI of ~9, so at pH 7.4 
possesses a net positive charge. It does however raise the possibility that, with 
the current engineering scheme, targets with an acidic pI may be at a 
disadvantage. Consequently future naïve libraries may need to consider 
including D32 and E93 as randomised residues to broaden the applicability of 
the scaffold. 
3.3.2 Affinity maturation 
The structure was used as the basis for selecting residues for further 
mutation in an attempt to improve binding affinity by semi-rational design. 
Two residues, P51 and K37, were identified as negatively impacting binding. 
The remaining binding face sites were selected for the straightforward reason 
that they don’t make contacts with HEWL, but are in close enough proximity 
that a different residue may do so and thereby contribute to binding. The 4/5 
loop in particular can potentially form a large contact area if a complementary 
sequence is selected, and towards this end the four residues in the loop were 
selected for inclusion in an affinity maturation library. Because the loop is 
constrained by the extensive contacts made by flanking residues K86 and E93, 
it may be that failure of the loop to take direct part in binding is because it 
simply cannot reach across the interface. Consequently, extension by two 
residues may promote discovery of loop residue-mediated interactions, while 
allowing existing contacts to persist unaltered.  
At the interface there is a large cavity, presumably filled with water, 
between R35 and Y33. Lack of complementarity at this point probably imposes 
an affinity penalty, especially considering that Y33 is picked as the single most 
important residue at the interface. The cavity is formed because of the β-sheet 
nature of the Obody peptide binding into the relatively irregular HEWL 
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substrate binding cleft. Increasing geometric complementarity at this point has 
the potential of drastically increasing affinity. 
3.3.2.1 Amelioration of negative contributions 
K37 has a side-chain extending inwards towards the hydrophobic core 
and away from HEWL, but exposes its amine group to solvent adjacent to the 
underside of β-strand 1. It was the most obvious candidate as simple 
examination showed a like-charge clash with an arginine from HEWL. In 
support, Robetta virtual alanine scanning showed that substitution for alanine 
actually resulted in a reduction in free energy of binding.  Significantly, K37 
was not part of the original complement of library residues. Its inclusion in the 
HEWL contact table illustrates the nature of the selected binding; the interface 
doesn’t use the randomised face uniformly, and makes contact with HEWL 
using residues from both sides of the β-sheet inserted into the substrate binding 
cleft. 
P51 was a less certain inclusion. In principle a proline in the centre of a 
β-strand prevents continuous formation of β-sheet character. However, while 
this may actually destabilise the fold itself to some degree, its impact on 
binding isn’t altogether clear, as the presence of a proline imposes unique 
conformational restrictions that may be beneficial for binding. Of course, 
re-randomising the residue allows for the possibility of re-selection, but since 
the goal of affinity maturation is optimisation of the binding face, removing the 
restrictions on surrounding residues imposed by P51 will potentially increase 
the conformational search space of the library. 
The following chapter deals with affinity maturation attempts based on 
the structure presented here, in addition to an alternative naïve library, to 
improve Obody binding for the model protein target HEWL. 
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4 Gene Library Design and Selection 
4.1 Introduction 
The criteria outlined by Skerra (2000) and Binz & Pluckthun (2005)  for 
selecting a scaffold candidate for investigation are largely met by the 
oligosaccharide/oligonucleotide-binding (OB) fold; a small single domain with 
a compact hydrophobic core, a binding area available and competent for 
mutation and lack of disulfides. However, to validate it as a viable protein 
scaffold, a candidate domain must be demonstrated as capable of tolerating the 
mutations necessary to develop demonstrable affinity for a model target. 
Previous work has shown mutational tolerance and preliminary selection for 
affinity to hen egg-white lysozyme (HEWL) using a phage display library 
based on the anti-codon recognition domain of the aspartyl-tRNA synthetase 
from Pyrobacculum aerophilum (Appendix A2). The moderate affinity 
achieved (~40 μM) while adequate as a proof of principle, it is necessary to 
show tighter binding to bring the Obody scaffold up to a standard 
commensurate with other engineered proteins. 
4.1.1 Outline 
This chapter describes the experiments performed with the goal of 
producing an Obody with nM-range affinity for model target HEWL. First, the 
template gene was altered to facilitate more efficient combinatorial assembly. 
Second, two structure-based libraries were investigated, building iteratively on 
information gained during each step. Third, departing from structure-based 
library design, an affinity maturation library was investigated using randomly 
distributed mutations instead of site-directed mutations. Lastly, a new format of 
naïve library was produced. This library attempted to address the problem of 
the transformation bottleneck by limiting diversity at each mutant codon. The 
results of each of these experiments are presented and discussed below. 
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4.2 Results 
4.2.1 Library nomenclature 
Gene libraries were named according to the number of mutations, where 
in the gene the mutations are located and the template gene on which each 
library was based. Clones isolated during screening were suffixed with an 
alpha numerical code to indicate the panning stage and clone number. The 
general format is Template Gene:Number of Mutations:Clone Number. The 
naming scheme is summarised in Figure 4.1. 
 
Figure 4.1 Library nomenclature conventions 
Each library was named according to a systematic convention, as outlined above, consisting of the 
template gene clone number and the number of mutations. The exception is naïve libraries based on the 
wild-type domain from P. aerophilum, where the gene name has been omitted. Following screening of 
each library, clone numbers were assigned according to their status. Clones extracted from HEWL-
panned libraries were labelled “L” followed by a number, similarly for RNAse A-panned libraries with an 
“R”. Unselected variants examined during library quality control were prefixed with a “U” instead. 
 
4.2.2 Assessment of phagemid pRpsp2 
To get an estimate of the efficiency of the ligation procedure using 
phagemid pRpsp2, test ligations were performed. Of concern was the rate of re-
ligation of digested vector, efficiency of vector double digestion with NcoI and 
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NotI and efficiency of successful ligation of an Obody insert cut with the same 
enzymes.  
4.2.2.1 Double-Digestion Efficiency 
To test for the rate of vector re-ligation, eight ligations were run in 
parallel, as summarised in Table 4.1. These data showed that digestion of the 
plasmid was efficient, as no colony forming units (cfu) were observed from 
transformation of any of the cut vector samples that were not ligated. Where 
ligase was present in the reactions, there was significant vector self-ligation, as 
shown by the large cfu count obtained using untreated vector without the 
presence of insert. This effect was completely eliminated when the digested 
vector was dephosphorylated by SAP treatment, although it did seem to result 
in a reduction in efficiency when insert was present to be ligated. When taken 
together, these data suggested that while virtually all plasmid in the digestion 
was cut at least once, it seemed to be a mixed-sepcies population of doubly- 
and singly-cut. Consequently, a quantitative measure of the efficiency of 
ligation was needed in planning the appropriate ligation scale for library 
production. 
Table 4.1 Effect of dephosphorylated vector on transformation 
1 μL of each ligation reaction was transformed into DH5α and the colonies counted were extrapolated in 
to the total number of transformable plasmids per μL of ligation reaction. The results show that using 
dephosphorylated vector in ligation allows the assumption to be made that 100% of cfu contain plasmid 
with an insert. 
 Vector Insert No Insert 
Ligated Dephosphorylated 2940 0 
Untreated 8120 12000 
Dummy Dephosphorylated 0 0 
Untreated 0 0 
4.2.2.2 Insert ligation efficiency 
Ligation efficiency was estimated by comparison of the number 
transformants obtained from a ligation with the maximum number possible, 
where the maximum assumed that all plasmid in the ligation was 
transformable. Cell competency was calculated in cfu per ng of plasmid by 
transformation of a known quantity of pRpsp2.  
A standard 20 μL ligation was constructed using pRpsp2 cut with NcoI 
and NotI and dephosphorylated with shrimp alkaline phosphatase, mixed with 
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a wt paOB insert cut with the same enzymes. The ligation contained 116 ng of 
digested pRpsp2 (5.8 ng/μL). After incubation, 1 μL of the ligation (5.8 ng of 
plasmid) was used to transform an aliquot of electrocompetent DH5α cells with 
a known efficiency of 600 cfu/ng of pRpsp2. This transformation yielded 1061 
cfu, which equated to 1.8 ng of transformable plasmid per μL of ligation, 
giving a total of 35 ng per 20 μL ligation. Comparison with the total plasmid 
input gave a 31% ligation efficiency rate. As ligations using dephosphorylated 
plasmid but containing no insert did not yield any colonies, the assumption was 
made that all transformants obtained in this manner contained an insert. Also, 
colony PCRs using plasmid annealing primers routinely showed that an insert 
of the correct size was present in 100% of colonies tested. 
4.2.3 paOB3 wt template modification 
In order to facilitate the PCR assembly method chosen for generation of 
the gene libraries, modifications were made to the template paOB3 wt gene in 
two stages. A visual summary of the process is displayed in Figure 4.2. First, 
the wt with an extended loop (wtEL) was produced, with a 6 bp insertion 
(GGCGCG) between the second and third β-strands of the binding face. The 
insertion was introduced to allow for a sufficient overlap between the two 
mutational oligonucleotides used to mutate the three β-strands of the binding 
face. The wtEL intermediary was constructed by PCR assembly of fragments 
005/056 and 068/006. Second, three silent point mutations were introduced into 
paOB3 wtEL to improve amplification efficiency when using overlapping 
primer pair 058 and 059,  reducing self-annealing, hair-pins and melting 
temperature (Tm). The modified template was labelled paOB3 wtELMC. 
Subsequently the primers 058 and 059 were replaced with 168 and 169 
respectively, which annealed at the same position, but incorporated the 
sequence changes to significantly improve gene fragment PCR. After 
sequencing testing for successful display as a pIII fusion, paOB3 wtELMC was 
used as the template for all subsequent libraries. 
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 Primers (Fwd/Rev) Template Size (bp) 
 005/056 paOB3 wt 175 
 068/006 paOB3 wt 216 
 005/165 paOB3 wtEL 196 
 164/006 paOB3 wtEL 181 
Figure 4.2 paOB3 template modification 
 (Top) Alignment of paOB3 wt with sequenced paOB3 wtELMC. Primers used in the modification 
process are shown in green, altered nucleotides are shown coloured according to the base. The annealing 
site for primers 058/059 and 168/169 is indicated by a black rectangle. The single nucleotide substitutions 
are highlighted with blue arrows and labelled with the change each represents. All three mutations, made 
in the third positions of three codons, are silent. (Middle) Agarose gels of the fragments generated, 
labelled by the primers used in the amplification, and the intact wtELMC gene insert. (Bottom) Table of 
gene fragments use in the modification process, and their predicted size, in bp. The intact gene has an 
expect size of 362 bp. 
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4.2.4 Structure-based affinity maturation – L8 10m 
In order to improve affinity for HEWL, the structure of 13mRL L8 was 
used as the basis for selective re-randomisation of residues at the binding face 
and one flanking loop (section 3.2.5). 
To recapitulate briefly, four residues in the binding face were selected for 
randomisation. Serine 29 and alanine 56 were targeted because they are both 
on the periphery of the face and make no contact with HEWL. While most 
selected positions were granted a full complement of amino acids with NNK 
codons, in the case of serine 29 the randomisation was limited to a subset of 
residues with an NRK codon (see appendix A1.7 for IUPAC abbreviations). 
This reduced the maximum theoretical diversity to 12 possible amino acids and 
placed emphasis on large, polar residues. K37, which contacts HEWL on the 
periphery of the interface, appeared to make an unfavourable contact and was 
therefore targeted. P51 was also selected on the assumption that proline is a β-
sheet-breaking residue and the domain as a whole may be de-stabilised by its 
presence on the third β-strand of the binding face. Finally, the 13mRL L8-
HEWL complex structure showed that the loop randomised in the original 17-
mutation library made no contacts with HEWL and was poorly ordered. 
Consequently this loop was targeted for complete re-randomisation of the four 
original positions and extended by two additional residues to six randomised 
codons, making a total of 10 mutant codons over all. This new library design 
was therefore labelled L8 10m. 
4.2.4.1 Library design and assembly 
The mutant gene library was produced and assembled according to the 
general principles laid out in section 2.4.2. Long synthetic oligonucleotides 
183 2m, 184 2m and 163 6m were designed to introduce the mutant triplets at 
the selected positions, along with the various primers needed to dissect the 
gene properly to incorporate the mutational oligos (Figure 4.3), based on the 
template gene 13mRL L8.  
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Figure 4.3 L8 10m library design 
A schematic of the various primers used in PCR assembly of the L8 10m library. Short (18-21 bp) 
flanking primers are shown in green, long mutational oligos are shown in blue, with randomised codons 
highlighted in grey. Secondary structure annotations are shown in yellow (strand), pink (helix) and grey 
(coil). Nucleotide changes between the template gene and library plan are highlighted according to the 
base shown.  
 
Single-stranded oligos 183 and 184 were combined in equimolar amounts 
(10 pmol each) in a 25 μL PCR reaction and subjected to two cycles in a 
thermocycler, allowing each oligo to be extended by the other as a template. 
The cycles were as follows: 3 min at 94°C (denaturation), 1 min at 60°C 
(annealing), 1 min @ 68°C, 1 min at 80°C, 1 min at 60°C, 1 min at 68°C. This 
resulted in the generation of no more than 10 pmol of a double stranded 
segment incorporating all four mutant triplets, labelled 183/184 4m. The whole 
25 μL reaction was then used as a template for a larger-scale (100 μL) reaction 
to amplify correctly assembled 183/184 4m using flanking primer pair 055 and 
186 to yield the 055/186 4m fragment.  
The 163 6m oligo was incorporated into the gene library by generating a 
complementary strand with primer 063, amplifying with primer pair 061/063 
and gel purifying by freeze and squeeze.  
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The intact gene was assembled from PCR fragments in the following 
steps: 192/054 + 055/186 4m = 192/186 4m; 192/186 4m + 185/060 = 192/060 
4m; 061/063 6m + 062/193 = 061/193 6m; 192/060 4m + 061/193 6m = 
192/193 10m. The maximum diversity for this library was 5.6 x 10
12
, therefore 
at each stage of the process, the theoretical minimum amount of fragment 
needed in each reaction, to maintain full coverage of the diversity complement, 
was maintained. The various fragments generated and assembled during this 
process are shown in Figure 4.4. 
The library was assembled, gel purified, digested with restriction 
enzymes NcoI and NotI then test-ligated into pRpsp2. Positive clones were 
plasmid prepped and sequenced as the unselected representatives. A 2 mL 
library-scale scale ligation and transformation was performed as per section 
2.4.3, with a resulting library size of 10
7
. 
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 Fragment Template Size (bp) 
 192/054 paOB3 wtELMC 104 
 183/184 4m - 120 
 055/186 4m 183/184 4m 123 
 185/060 paOB3 wtELMC 90 
 163/063 6m - 54 
 061/063 6m 163 6m (ss oligo) 54 
 062/193 paOB3 wtELMC 87 
Figure 4.4 L8 10m library gel fragments 
(A-C)Agarose gels of the various gene fragments generated during the library assembly process, labelled 
for the flanking primers in the PCR reaction. (A) Fragments amplified directly from the template DNA, 
(B) partially assembled library in two fragments (209 bp and 195 bp, left to right) and (C) the final full-
length library (387 bp). DNA standards, labelled in bp, are the same for all gels, with 100bp as the lowest 
band shown in every case. A list of the primaryfragments used and their predicted sizes is also presented 
(D). 
D 
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4.2.4.2 Panning 
Phage library preparation and panning was performed as described in 
section 2.4.3, with helper phage Vcsm13. Ligand concentration for 
immunotube adsorption was varied through the rounds, beginning at 1mg/mL 
HEWL in rounds 1 and 2, 100 μg/mL in rounds 3 and 4, with the lowest 
concentration of 10 μg/mL in rounds 5 and 6. This allowed initial low-
stringency selection from a high-diversity, low copy number population, 
followed by increased competition for binding sites to select for the best 
members of the positively selected population (Xu et al. 2002). Phage were 
eluted with HEWL at 1 mg/mL. Analysis of the panning showed positive 
selection for binding, as well as for displayed Obody (Figure 4.5). 
 
 
Figure 4.5 Panning results with L8 10m phage library 
(A) Enrichment for binding phage is shown by the decreasing -log ratio of input:output phage titre over 6 
rounds of panning. Significant enrichment is seen by round 2 because the library was based on a pre-
selected lysozyme binder. The sudden increase in the ratio at round 3 reflects a reduction in immobilised 
ligand, with re-enrichment in the subsequent rounds of a population of tighter binding Obodies. (B) 
Enrichment for displayed Obody by western blot of input phage from each round. The western shows 
each sample as one or two bands. Controls are cMyc-tagged pIII with (+ve) or without (-ve) an N-
terminal paOB3 wt fusion. Enrichment is seen in an increase in the upper band compared to the lower 
band, indicating a higher proportion of phage displaying intact Obody-pIII fusion product. Approximate 
position of a molecular weight marker is indicated by the arrow (not visible on the western).  
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4.2.4.3 Selected Clone Analysis 
Although the library size (10
7
) was adequate for a non-naïve library, 
sequencing of unselected variants revealed that the region of the gene covered 
by the mutagenic primers 183 and 184 contained numerous point mutations 
and deletions (see Appendix A1.4.3.1 for sequences). As a consequence, the 
practical library size was estimated downward to 10
6
. Sequencing of individual 
clones from round six gave five unique sequences in 25 clones analysed 
(Figure 4.6). What is most striking about this selection is the prevalence of 
reversions back to the ancestral residue at positions S29 and K37. Proline 51 
was also re-selected in two of the six variants, and large residues (Tyr, Arg) 
were selected in three of six variants at position 56. There is virtually no 
consensus in the 4/5 loop residues, indicating that any contributions to binding 
at these positions were probably subordinate to changes at the binding face.  
 
Figure 4.6 Unique sequences from the L8 10m library 
A schematic showing the mutant positions in the clones selected for affinity to lysozyme, as compared to 
ancestor 13mRL L8. Residues changes are highlighted, coloured according to character (yellow = non 
polar, blue = basic, red = acidic, green = polar). 
 
Each of the unique genes was cloned and expressed in pProEx Htb as an 
N-terminal His-tag fusion protein and purified by IMAC (section 2.5). The 
His-tag was removed with rTEV protease and the cleaved Obody was re-
purified by a two step gel-filtration process, with a preparative-grade 16/60 S75 
column followed by an analytical grade 10/300 S75 column (GE). All Obodies 
purified showed identical purification profiles. Yield was between 10-15 mg of 
pure protein from 1 L of 2YT media (see Figure 5.1 for representative 
purification data). 
Affinity was determined by SPR analysis of saturation binding, based on 
a 1:1 Langmuir binding model. It was found that inclusion of a linear non-
specific component in the curve greatly increased the quality of the fit. It 
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seemed reasonable to include this factor, given that the high concentrations of 
Obody used in these measurements (up to 100 μM in most cases) most likely 
exacerbated an electrostatic non-specific effect, which would not be accounted 
for by subtraction of the reference flow cell. This non-specific effect can be 
seen in the data as an apparent failure to plateau at higher concentrations, the 
gradient of which was closely matched by the linear portion of the fitted model 
in all cases. The measured affinities ranged between 4 and 8 μM (Table 4.2, 
Figure 4.7 and Figure 4.8). SPR measurements were corroborated by ITC of a 
single variant, L8 10m L200. To elucidate the nature of the modified binding 
face, the crystal structure of L8 10m L10 in complex with HEWL was solved 
to a resolution of 1.95 Å (section 5.2). 
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Table 4.2 Affinity for HEWL of L8 10m library variants  
The affinity of selected variants, as determined by SPR analysis, including the linear non-specific portion, 
represented by the gradient of the line as calculated by GraphPad Prism with Equation 2.1 
Variant KD (M)* Linear NS† 
L05 6.9 (± 0.4) x 10
-6 6.7 x 10-6 
L06 8.2 (± 0.5) x 10
-6 2.4 x 10-6 
L18 7.1 (± 0.6) x 10
-6 2.2 x 10-6 
L200 (SPR) 6.2 (± 2.5) x 10
-6 4.1 x 10-6 
L200 (ITC) 4.1 (± 1.6) x 10
-6 - 
L10 4.6 (± 1.4) x 10
-6 9.8 x 10-6 
L10 (+10 mM glycerol) 6.2 (± 1.9) x 10
-6 6.6 x 10-6 
*Errors given are 95% confidence intervals for the model fitting only 
 
 
 
Figure 4.7 Raw SPR data 
A sample of the raw output SPR data from a Biacore analysis run of L8 10m L200. The graph overlays 
five relative response curves at different concentrations of Obody, each sample measured in triplicate. 
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Figure 4.8 Affinity analysis of variants from the L8 10m library 
Biacore analysis was performed as described in section 2.4.6.3, based on 1:1 binding stoichiometry and 
includes a linear non-specific component. Error bars show a 99% confidence interval for the mean of each 
data point. ITC analysis was performed as described in section 2.4.7, no error bars are shown as each data 
point is a single measurement. 
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4.2.4.4 Glycerol as a binding co-factor 
Although the L8 10m library improved binding affinity by approximately 
10-fold, persistence of a cavity at the interface not filled by the Obody was still 
considered a problem (Figure 3.3). This cavity was hypothesised to be a 
significant limitation to the specificity and affinity of this Obody lineage to 
HEWL, so was attempted to be filled by a small molecule. Glycerol was 
selected, as it possesses a combination of hydrophobic and polar atoms thought 
necessary to fill the cavity. The affinity of L8 10m L10 was re-measured with 
10 mM glycerol included in the Obody buffer, but no significant change in 
affinity was observed (Table 4.2). 
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4.2.5 Structure-based affinity maturation – 6m library 
Following from the library panned in the previous section, a new library 
was designed to try to fill the interface cavity. This structure-based library was 
designed using the crystal structure of L8 10m l0 in complex with HEWL, as 
presented in section 5.2. The library was conceived to attempt to fill a cavity at 
the interface with Obody atoms instead of waters. The loop between β-strands 
1 and 2 (1/2 loop) was re-randomised. Y33, which forms the lower edge of a 
hydrophobic patch, was nominated the N-terminal constant boundary. The 
randomised region extended from G34 to I38, retaining K37 and adding two 
additional codons to the 1/2 loop to produce a 6 mutation library denoted L10 
6m (Figure 4.9). K37 was not re-randomised in this library as it had been re-
selected as lysine in the L8 10m library. It was thought that expansion of the 
loop and removal of the interaction made by R35 would allow a new peptide 
with greater complementarity to be selected. 
 
Figure 4.9 L10 6m library design 
Based on the sequence of the L10 variant from the L8 10m library, this gene library was designed to alter 
the binding around R35, which reaches into the HEWL active site. Primer annealing sites and direction 
are shown in as numbered green arrows, the mutational oligo is shown in blue. 
 
4.2.5.1 Gene Assembly 
The L10 6m library was assembled by combinatorial PCR, as described 
in general principles in section 2.4.2, from three PCR generated fragments 
(Figure 4.10). Mutational oligo 211 was incorporated by double stranding with 
primer 210, then amplification with primer pair 207/10 to yield the fragment 
207/210 6m. The assembly order was as follows: 207/210 6m +209/192 = 
207/193 6m; 192/208 + 207/193 6m = 192/193 6m. Representative unselected 
variants are shown aligned in appendix A1.4.4. 
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 Fragment Template Size (bp) 
1 192/208 L8 10m L10 140 
2 207/210 6m 211 6m 57 
3 209/193 L8 10m L10 249 
Figure 4.10 L10 6m library assembly 
The assembly process is summarised in a table (Top) outlining the primary fragments and agarose gels 
showing the progression of fragment assembly (bottom). The numbers in the first column of the table 
correspond to the numbering of the first three lanes of the gels. Lanes 4 and 5 show fragments 207/193 
6m (expected size 288 bp) and the intact gene 192/193 6m respectively (expected 393 bp). Each fragment 
should be compared to the DNA ladder to the left. Where a space is visible between the sample lane and 
the ladder, the gel contained other unrelated samples which were excised from the picture. 
 
4.2.5.2 Panning 
The assembled library was cloned into pRpsp2 as per section 2.4.3 and 
yielded a 10
7
 transformant library, compared to a theoretical diversity of 6.4 x 
10
7
. Panning was done using a constant 100 μg/mL HEWL in immunotubes 
over four rounds, as per section 2.4.4. Panning showed successful enrichment 
HEWL-binding phage (Figure 4.11) but sequencing of selected clones revealed 
that only the ancestral L8 10m L10 was present, with no mutant variants 
selected. This line of investigation was not pursued further. 
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Figure 4.11 L10 6m library panning titre 
The graph shows enrichment for positively selected HEWL-binding phage library members over 4 rounds 
of panning by plotting the ratio of input:output phage as a negative log. The reducing value from round to 
round indicates relative increase in output phage counts compared to input phage.  
 
4.2.6 Random Mutation Library 
To discover mutations that improve affinity without specific structural 
information requires a random set of mutations distributed throughout the gene. 
To this end, a single variant (L8 10m L200) was subjected to error-prone PCR 
mutation (see section 2.4.2.3 for method). Although the actual number of 
mutations per gene is difficult to quantify without deep sequencing, it can be 
estimated at an average of 1-3 substitutions per variant (Cadwell and Joyce 
1992), though template dependent factors like GC content can cause this to 
vary widely (Pritchard et al. 2005). Sequencing of unselected variants showed 
an acceptable level of mutation in line with this estimation (Appendix 
A1.4.5.1). The library, named L200EP, was ligated into phagemid pRpsp2 and 
transformed to yield a library of 10
8
 transformants, then panned against 
HEWL. 
4.2.6.1 Panning 
Phage library panning was done in immunotubes, beginning with 
100 μg/mL HEWL in round one and dropping to 10 μg/mL in subsequent 
rounds. This panning experiment was the only one to use trypsin sensitive 
helper phage KM13 (Kristensen and Winter 1998). Consequently, output phage 
samples were treated with 1 mg/mL trypsin after specific elution with 1 mg/mL 
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HEWL in PBS. Panning showed a 100-fold enrichment in retained phage 
counts after a single round. Results are summarised in Figure 4.12. 
 
 
Figure 4.12 L200EP library panning titre 
Two indications for enrichment for HEWL binding. The graph (A) shows successful positive selection for 
HEWL binding phage from the error-prone PCR library based on 10m L200, over 5 rounds, by 
visualising a reduction in the ratio between input and output phage titres. A western blot (B) shows an 
increase in displayed Obody-pIII fusion (upper band) compared to pIII without an Obody fusion partner 
(lower band) in input phage samples over four rounds of panning. Controls are cMyc-tagged pIII (-ve) 
and paOB3 wt-cMyc-pIII fusion (+ve). The position of a 50 kDa marker is indicated by an arrow. 
 
4.2.6.2 Sequencing data 
Individual variants were isolated from output phage samples from rounds 
three and five for sequence analysis (protein sequences are shown in Figure 
4.13. The full gene sequences can be found in Appendix A1.4.5.2). The 
distribution of mutations in the selection genes appears non-random, as 
illustrated in Figure 4.13. One position in particular, V23F, stands out as 
virtually fixated. However, it is possible that this mutation is merely an artefact 
of the error-prone PCR process; incidence of this mutation occurs with high 
frequency in round three clones, but only in a single variant in round five. It 
isn’t located on or near the binding interface, although that in itself doesn’t 
preclude influence on binding. 
Most of the mutations located directly in the binding regions of the 
protein can be rationalised as trivial by examination of the crystal structure. For 
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example, K58R is moderately conservative and would present a similar profile 
to ancestor type; arginine and lysine are a similar size, are both positively 
charged at pH 7.4, they can both mediate hydrophobic interactions and there 
are no aromatics available on HEWL at that position for an arginine to stack 
with. 
Although it only occurs in less than a quarter of the sequences, 
substitution of M37 for lysine or arginine is interesting, considering that it was 
one of the original residues selected for randomisation in the L8 10m library. 
This mutation makes sense if the like-charge clash has been eliminated by 
rearrangement of the corresponding arginine, as in L8 10m L10.  
The 4/5 loop sequence showed the largest cluster of mutations located in 
an interface region, specifically at position 86, but also 88. Given that K86 
made extensive hydrophobic contacts with HEWL in the 13mRL L8 and L8 
10m L10 structures, mutation of this position almost certainly has impact on 
binding. Six variants from round five were selected to sample the all of the 
selected diversity in this region to express and measure affinity by SPR. 
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Figure 4.13 Mutation clustering in L200 EP variants 
Shown above are sequences selected from the L200EP library, from round 5 (RV) or round 3 (RIII). The 
first sequence in the list is ancestor type L8 10m L200, which has been annotated to show the position of 
secondary structure elements (pink cylinders are helices, light brown arrows denote β-strands). HEWL-
interface residues are outlined with black rectangles. The mutant sequences are listed below the ancestor 
and are highlighted according to residue changes, with reference to the ancestor. Colours are by residue 
character (Blue = basic, red = acidic, green = polar, yellow = non-polar).  
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4.2.6.3 Selected variant affinity analysis  
Sequencing of individual clones from various rounds did not reveal 
convergence towards a particular sequence, although this was to be expected as 
most mutations would have little effect on the binding. Certain positions were 
over-represented, indicating their importance, but this may also indicate 
dominance of particular mutations in the unselected population from early 
incidence during the EP-PCR. Mutations were clustered particularly in the 4/5 
loop and adjacent residues, less so in the non-binding face β-strands and very 
infrequently in the residues directly involved in binding (Appendix A1.4.5.2) 
for sequence data). Six variants from round five were selected on the basis of 
maximum diversity at those semi-conserved positions for expression and 
affinity measurement by SPR (Figure 4.14, Table 4.3), cloned into expression 
vector pProEx Htb and purified by IMAC and gel filtration. For a 
representative purification, see 5.3.1. Yield was 10-15 mg of purified protein 
per litre of culture for all variants except L200EP 06, which gave 45 mg per 
litre. 
However, due to sequencing errors, one variant tested for affinity 
(L200EP 07) was later discovered to not contain any amino acid mutations. 
This discovery significantly altered interpretation of the SPR data. Because 
L200EP 07 was ancestor type, the measured affinity of 1.2 μM must be 
considered to be within error of the previous measurements, 4.5 and 6 μM. 
That the affinity of the other, phenotypically-different variants were 
determined to be no different requires the conclusion that, taken individually, 
the various mutations gave no benefit to binding.  
L200EP 06 appeared to have an affinity approximately 2-fold tighter than 
the other 5 variants tested (Table 4.3), of  KD 612.8 nM, compared to 1.1-1.4 
μM found in contemporary variants, and 40 μM in the 13mRL L8 ancestor. To 
investigate the structural basis for the apparent increase in affinity, the structure 
of L200EP 06 in complex with HEWL was solved to 1.86 Å. See section 5.3 
for a full description and discussion of this structure. 
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Figure 4.14 Biacore analysis of L200EP round five variants 
Equilibrium affinity determination graphs, modelled as 1:1 Langmuir binding. Biacore measurements 
were performed as described in section 2.4.6. Data was fitted using Graphpad Prism. Error bars show 
99% confidence intervals for the mean of each data point (measured in triplicate). Calculated affinities are 
shown in Table 4.3. 
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Table 4.3 Affinities from L200EP library 
The affinity of six variants for HEWL as determined by SPR analysis, including the linear non-specific 
portion, represented by the gradient of the line as calculated by GraphPad Prism with Equation 2.1. 
Variant KD (M)* Linear NS gradient 
L200EP 05 1.3 ± 0.4 x 10
-6 7.46 x 10-7 
L200EP 06 0.6 ± 0.2 x 10
-6 6.55 x 10-7 
L200EP 07 1.2 ± 0.3 x 10
-6 8.40 x 10-7 
L200EP 09 1.2 ± 0.1 x 10
-6 5.74 x 10-7 
L200EP 10 1.1± 0.2 x 10
-6 4.36 x 10-7 
L200EP 11 1.2 ± 0.3 x 10
-6 6.23 x 10-7 
*Errors given are a 95% confidence interval for the model fitting only 
 
4.2.7 Limited Codon Library 
Towards the goal of investigating the capacity of paOB3 as a scaffold for 
general application as a binding molecule, a new naïve library was generated 
and panned against HEWL and bovine pancreatic ribonuclease A (RA). The 
limited codon library (denoted 13mLC) was designed (Figure 4.15) as a 
compromise between maximising available diversity at each randomised 
position and increasing the fraction of theoretical diversity represented in a 
phage library. The position of each randomised codon wasn’t altered from the 
original library design, but the NNK mutational codon format was replaced 
with DVK. This limited the number of possible residues to 12, while retaining 
a full complement of residue character. Other libraries have been built using 
limited complements, the most extreme example being only tyrosine and serine 
(Koide et al. 2007). The DVK mutational codon complement included 
aromatics Tyr and Trp, charged residues Lys, Arg, Asp and Glu, hydrophobic 
residues Ala and Gly and polar residues Asn, Thr and Ser. The residue sub-set 
also included Cys. 
In terms of diversity, 12 possible residues at each of 13 positions gave a 
maximum diversity of 1.06 x 10
14
, compared to the full 20 residue complement 
of 8.1 x 10
16
. This meant that during assembly, cloning and transformation, 
sampling of the sequence space in this library covered a larger fraction of the 
maximum theoretical diversity by more than two orders of magnitude, 
compared to a library with the full 20-residue complement. 
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Figure 4.15 13mLC library plan 
The 13mLC library was designed to incorporated mutational oligos 212 9m and 213 4m (blue) into the 
gene as templates for the first three β-strands (yellow, helix in pink). Flanking primer for gene fragment 
amplification are shown in green. Note the DVK codons at the mutated codon positions. 
 
4.2.7.1 Construction 
The limited codon library was built using 13 mutant codons on the first 
three β-sheets with oligos 212 9m and 213 4m (appendix A1.3). These two 
mutational oligos were incorporated into the gene in two separate fragments. 
First, each oligo was double stranded by primer extension, using the mutational 
oligos as the template in 100 μL single-cycle PCR-like reactions (3 min at 94 
°C, 1 min at 55 °C, 1 min at 68 °C), using reverse primers 056 (for 212 9m) 
and 168 (for 213 4m) in equimolar amounts (10 pmol each) to yield fragments 
212/056 9m and 213/168 4m. Oligo 212 9m had a maximum theoretical 
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diversity of 5.16 x 10
9
, which was covered 1000x by 10 pmol. Assembly of the 
intact gene followed the principles outlined in section 2.4.2 and proceeded as 
follows: 192/054 + 212/056 9m = 192/056 9m; 213/168 4m +169/193 = 
057/193 4m; 192/056 9m + 057/193 4m = 192/193 13mLC. The library was 
ligated in pRpsp2 phagemid and transformed into TG1, yielding 2 x 10
8
 
transformants. Results are summarised in Figure 4.16. 
 
 Fragment Template Size (bp) 
 192/054 wtELMC 104 
 169/193 wtELMC 192 
 212/056 9m 212 9m 81 
 213/168 4m 213 4m 57 
Figure 4.16 13mLC assembly process 
Shown here are agarose gels (top) with the various fragments generated during assembly. Fragments are 
labelled as follows: 1) 192/054, 2) 169/193, 3) 212/056 9m, 4) 213/168 4m, 5) 192/056 9m, 6) 057/193 
4m 7) 192/193 13mLC. The accompanying table lists the primary fragments, the template used in each 
case and their predicted size in bp. Remaining expected sizes are 5) 167 bp, 6) 231 bp and 7) 380 bp 
 
4.2.7.2 Panning 
The library was panned as described in section 2.4.4 against HEWL or 
RA over 6 rounds, using ligand immobilised in 5mL immunotubes with helper 
phage Vcsm13. Ligand concentration was varied, starting at 1 mg/mL for the 
for the first three rounds, dropping to 0.1 mg/mL in subsequent rounds. 
Panning against both ligands showed enrichment, both in output:input phage 
titre ratio and an increase in displayed Obody (Figure 4.17).  
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Figure 4.17 13mLC panning results 
The 13mLC  library showed enrichment panning against two model protein ligands. (A/B) Enrichment 
for phage retention with both ligands (as labelled) shown by the decreasing negative log of the ratio of 
eluted:input phage titres over six rounds of panning. (C) Western blot of input phage samples. Numbers 
indicated the panning round each sample came from. Only a single round 1 sample is included, as each 
ligand panning stream began from the same input phage sample. Both ligands showed enrichment of the 
level of displayed cMyc-tagged Obody-pIII fusion (upper band) as compared to cMyc-tagged pIII only 
(lower band. Controls are paOB3-pIII fusion (+ve) and pIII only (-ve), both cMyc tagged. The 
approximate position of the 50 kDa protein marker is indicated by an arrow. 
 
Sequence analysis of round six HEWL-selected variants showed fixation 
of a cross-contaminant species identical to L8 10m L200, the presence of 
which is hypothesised to have disrupted proper selection from this library. One 
variant from round three that was clearly descended from the 13mLC library 
(based on the sequence and mutation pattern) was qualitatively shown to bind 
HEWL in a Ni
2+
 pull-down assay, but attempts at quantitative measurement did 
not show binding. Round six RA-selected variants showed sequence 
convergence, but binding to RA could not be shown by soluble protein. This 
library was not pursued further. 
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4.2.8 Thermal stability of engineered Obodies 
To test the relative stability of mutant Obodies, a panel of purified 
variants were subjected to Differential Scanning Fluorimetry (DSF)-based 
temperature gradient melt assay, as described in section 2.4.8. The panel 
included an unselected variant from the 13mRL library, U81. This variant was 
included in the place of the wild-type (wt) domain, as it was found to express 
solubly and all 17 randomised positions were different from the wt sequence. 
The wt domain exhibited a toxic effect while expressing, and co-purified with 
quantities of RNA bound, making it problematic to handle. Thus, 13mRL U81 
was substituted as a comparison for subsequently selected variants. The results 
are summarised in Figure 4.18.  
 
Obody Tm (°C) 
L8 10m L10 80.2 
L8 10m L200 81.2 
13mRL U81 (unselected) 67.8 
13mRL L8 79.6 
L200EP 06 75.1 
Figure 4.18 Differential scanning fluorimetry thermal stability curves 
The fluorescence of five engineered Obodies denaturing along a temperature gradient is shown in the 
graph (top), with the Tm calculated by GrpahPad Prism shown in the table below. Each curve was 
measured in triplicate and the average is plotted above. 
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Conditions for the DSF conditions were determined by screening around 
protein and SYPro Orange dye concentration, to determine optimal conditions 
for the qPCR instrument detector. Experimental runs subsequently used protein 
at 100-200 μg/mL and SYPro Orange at 100x concentration. 
Although the unselected (13mRL U81) variant tested showed a 
considerably lower Tm (67.8 °C), the remaining four were very similar. At 
approximately the same temperature that 13mRL U81 begins to denature, all 
other Obodies also showed a marked increase in fluorescence which was then 
followed by a definite, much larger, peak. This may indicate at a difference in 
the process of unfolding, but further experiments to produce better quality data, 
such as differential scanning calorimetry, are needed before this might be 
expanded upon. 
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4.3 Discussion 
The over-arching goal of this part of the project was to demonstrate the 
ability of the selected template OB-fold domain, to be matured into a high-
affinity binding domain for a model target ligand. Towards this end, two broad 
streams were employed. First, an existing engineered Obody with moderate 
affinity for HEWL (~40 μM) was targeted for stages of affinity maturation by 
structure-based and random library design. This can be considered as the final 
stages of the proof of concept and domain validation that was begun with the 
work presented in the manuscript found in the appendix (A2). Second, a new 
format of naïve library was investigated to try to improve the achievable 
affinity from “single pot” libraries. This is the standard achieved by the best 
scaffolds discovered to date and must ultimately be the goal of wider Obody 
development project as well. 
4.3.1 Structure-based design 
4.3.1.1 L8 10m 
The first library investigated here was based on the structure of 13mRL 
L8 in complex with HEWL. It introduced four mutations on the β-sheet 
binding face, re-randomised four residues in the 4/5 loop and lengthened it by 
two additional randomised positions, giving a total of 10 mutant codons in the 
whole library. The residues targeted either made no contacts on HEWL or 
seemed to make a negative contact, as in the case of K37. 
Surprisingly, this library showed a similar ratio of successfully displayed 
Obody to degraded pIII fusion as libraries with larger numbers of mutations, 
despite the fact that most of the additional mutations were located at previously 
randomised positions, or in the 4/5 loop, which seemed more tolerant to 
mutation than other sections of the domain (Appendix A2 – manuscript). While 
the maximum library size was limited to ~10
7
 by the number of transformants, 
I estimated the practical library size downwards by one order of magnitude, 
due to the presence of extensive point mutations found in the mutational 
oligonucleotides (~90% of sequenced unselected cloned variants contained 
stop codons). Given these two large limitations, it is encouraging that even 
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with an estimated practical library size of 10
6
, panning still resulted in several 
different sequences with 10-fold improvement in affinity. 
Two of the four residues at the binding were re-selected as ancestor type. 
P51 was seen in 2 of 5 unique sequences, and K37 was seen in 3 of 5. While 
the restricted numbers of sequences and the small initial diversity limit the 
conclusions able to be drawn over this, it may indicate that P51 played a 
cooperative role in binding. In the case of K37, the crystal structure of the 
13mRL L8 ancestor clearly showed a like-charge clash with HEWL R61, 
which would remain unless the library produced significant re-arrangements in 
the interface. It may be that that lysine at this position contributes both to 
binding and stability of the Obody, given it is almost entirely buried in the 
hydrophobic core behind the binding face. This was supported by selection 
from the L200 error prone library; the library ancestor type had a methionine at 
position 37, and mutation to lysine was one of the substitutions seen in 
conjunction with a 2-fold improvement in affinity. 
4.3.1.2 L10 6m Library 
Following panning of the L8 10m library, a single variant (L10), selected 
as the variant with the best affinity, was solved in complex with HEWL 
(section 5.2). What this structure revealed was persistence of a cavity at the 
interface, filled with ordered waters. Thus the L8 10m L10 variant was used as 
the template for a new library to try to fill this cavity. 
Hotspot analysis indicated that the primary binding residues were located 
along the first β-strand of the Obody binding face, including three that were not 
part of the original library mutational complement, and the two residue turn 
into the second β-strand. The peptide of Y33, G34 and R35 inserted into the 
substrate groove and active site of HEWL, but geometric complementarity was 
poor in this region, with a water-filled cavity visible between the Y33 and R35 
side chains. It was hypothesised that in filling this cavity by extending the 1/2 
loop an improved affinity may be produced, but the central role in binding 
played by this region suggested that a simple extension of the loop would not 
be sufficient. In addition to the β-sheet character, conformational freedom to 
find a better binding mode would be severely curtailed by the close proximity 
of critical binding residues. Therefore, the entire region was permitted to be re-
134 
 
selected to accommodate any new residue combination that bound with greater 
complementarity to the HEWL binding groove. This rationale led to design of 
the L10 6m library, which mutated residues G34, R35, V36, I38 and added two 
random residues. The expectation was that with the extended loop, the peptide 
chain main-chain atoms would be free to bind closer to HEWL and residues 
with less bulky side chains would be selected. Unfortunately, the only 
sequence selected from this library was ancestor type and did not, therefore, 
produce variants with an improved binding affinity 
The failure of this library to select any mutant variants was surprising, 
especially in light of the almost complete coverage of the maximum theoretical 
diversity. While there are many possible causes for this, the two most probable 
scenarios in my view are: i) that binding-promoting conformations were in 
direct competition with the formation of stable β-sheet and ii) that the 
transformation count was not actually an accurate reflection of the library 
diversity. The second option cannot be commented on any further here, as it 
can’t be meaningfully validated without deep sequencing, although sequenced 
unselected variants did show diverse sequences (appendix A1.4.4). In addition, 
the presence of the ancestor gene in the library was almost certainly a 
contaminant, which would have inhibited selection of mutant variants with 
lower affinity, or those with higher affinity but poorer display profiles. 
Induction of conformational changes in proteins on binding is not 
energetically favourable, and critical residues are thought to be pre-arranged 
into binding-promoting conformations in their non-bound state (Li et al. 2004; 
Gallicchio et al. 2010). Thus, any new arrangement of the randomised peptide 
to fill the aforementioned cavity must compete with the inherent stability of the 
existing β-sheet. This suggests that the two residues added to the chain 
manifested as a loop outside of the binding region targeted, rather than as a 
broken β-strand in the HEWL active site, as was desired.  
Elimination of the arginine at position 35 removed a salt bridge from the 
interface. It was expected that a smaller residue would be needed to bind into 
the active site of HEWL, such as histidine in Ykfe (Figure 3.8). But at pH 7.4, 
the imidazole group on the histidine would only be partially charged, and 
would therefore be a less efficient mediator of long-range electrostatic 
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attraction. It could be that disruption of this important electrostatic interaction 
also contributed to the domination ancestor-type sequence over mutant library 
variants. 
4.3.2 Error-Prone Affinity Maturation 
During the immune response, there are two processes which serve to 
generate better antibodies for particular antibodies. The first is selection from a 
repertoire of recombined gene segments, commonly cited at 10
7
-10
8
 unique 
combinations (Rajewsky 1996). Virtually all of the diversity is located on the 
complementarity determining region (CDR) loops. The second process, known 
as somatic hypermutation (Griffiths et al. 1984; Malipiero et al. 1987), spreads 
point mutations through the variable domain to improve the affinity of a 
particular set of variants. This process doesn’t necessarily involve mutations of 
the residues directly involved with binding, but rather can allow the domain 
scaffold residues to better accommodate the binding residues by changing their 
environment and thus their charge, hydration or conformational freedom 
(Kettleborough et al. 1991). 
Based on this concept, a random distribution of mutations was induced in 
a single HEWL-binding Obody by error-prone PCR to search sequence space 
not explored by previous libraries. In order to improve affinity, mutant residues 
positively selected are required to contribute more to binding then the wt 
residues. This produces two competing forces, where mutations at the interface 
would be generally selected against, and mutations away from the face would 
generally be neutral.  
Several rounds of selection generated a bank of evolutionary descendants 
with different complements of point mutations. In a natural evolutionary 
relationship, frequent mutation at one position would indicate a lesser 
importance in function then conserved residues. The sequencing data produced 
here reflects that, with very few mutations seen at the positions previously 
identified as critical for binding in 13mRL L8. However, as they are the result 
of positive selection, frequent mutation can also indicate a site where a 
substitution can more often give a net benefit to binding. To a large extent, 
mutations in the selected genes appear to have little effect on affinity, but there 
appeared to be regions which have mutations more closely clustered, though no 
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formal statistical treatment was undertaken. Representation of these frequently 
mutated regions, particularly where it was a single position, was used during 
selection of individual variants for affinity measurement. 
4.3.2.1 Re-selection of ancestor-type Obody 
 During the clone isolation and selection process, a sequencing error 
resulted in the inclusion of one variant that, while it contained nucleotide 
substitutions, had an ancestor-type phenotype (L200EP 07). Unfortunately, the 
ancestor-type sequence showed an affinity that was not different from four out 
five of the confirmed mutant genes screened. This resulted in a revision of the 
apparent improvement in affinity from 10-fold to 2-fold, with only a single 
variant displaying the improvement (l200EP 06). While disappointing, this 
result does support the notion that the current binding mode may require a 
prohibitively large number of mutations to improve affinity by the extent 
desired.  
In the comparison of measured affinities across multiple libraries, it is 
necessary to consider the sources of experimental error in order to draw 
conclusions about statistically significant differences. The process of 
measurement of affinity using the Biacore SPR instrument involves the 
repeated generation of chip surfaces with covalently attached HEWL. As 
described in section 2.4.6, HEWL was attached via the introduction of N-
hydroxysuccinimide groups on to the chip surface, which then form amide 
bonds with one of six surface lysines or the amino-terminus of the HEWL. 
Each newly generated chip represents a surface with different degrees of steric 
hinderance on Obody-HEWL compelex formation. Thus, the major sources of 
experimental error during affinity calculation come primarily from batch 
variation of protein preparations and, more significantly, from the surface to 
surface variation on different chips. In the case of the error-prone library 
variants under discussion here, the affinities were determined in a medium-
throughput fashion, with all protein purified in a short space of time, using the 
same batches of buffers, host cells and other reagents, and all were analysed 
using the same chip surface over only a few days. Thus, the experimental 
errors between the determined affinities can be considered to be reduced to a 
minimum. In contrast, the affinities determined months earlier for the ancestor 
137 
 
sequence are comparable with much less precision. Hence it seems reasonable 
to accept errors large enough to make KD values of 1.2 and 4.6 μM not 
significantly different when comparing between batches, while simultaneously 
accepting a smaller 2-fold difference as significant when comparing within the 
same batch of experiments. 
4.3.2.2 Structural Analysis of Affinity Improvement 
Compared to the template gene, L200EP 06 it had three substitutions, 
two of which were considered significant; K86E, based on the 13mRL L8-
HEWL complex structure, may influence the dominant conformations of the 
4/5 loop, as well as critical residue E93, located on β-strand 5. This variant was 
the only one to show this particular substitution, which is evidence for its 
involvement in affinity improvement, but this can equally be taken as evidence 
against; a real difference as a result of this substitution should have been 
selected more often. The second substitution, M37K, shows a convergence to 
lysine that was seen in the L8 10m library and is a position that was mutated 
often. L200 EP06 was not the only variant with a lysine at this position; the 
same mutation was seen in EP11, which did not show an improvement in 
affinity. This leads to the conclusion that it was these mutations which, in 
combination, caused a 2-fold change in KD, were not sufficient in isolation. 
The third substitution was T19S. Located on the opposite side of the domain 
from the interface, this mutation was considered to be neutral.  Structural 
investigation of this variant to attempt to determine the basis for the affinity 
improvement was undertaken using x-ray crystallography, and the results are 
presented in Chapter 5. 
The poor performance of this library in terms of improvement in affinity 
raises the question of what, during selection, the dominant factor was that 
promoted retention of phage during selection. Although affinity for the target 
ligand was designed to be the major filter, other selection pressures, like the 
propensity to be displayed on phage, or effects on bacterial growth during the 
amplification phase play a role as well. Two factors which may provide clues 
are the Tm and expression levels. Compared to the ancestor type, the Tm 
reduced slightly (Figure 4.18) while expression levels in E. coli tripled (45 mg 
per litre of culture compared to 15 mg for the contemporary variants purified). 
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Domains which are very stable may be at a disadvantage when using the sec 
secretion pathway (Steiner et al. 2006), though the DSF method for measuring 
Tm results in data that lacks the upper portion of the sigmoidal curve which 
introduces uncertainty into the point of inflection, making this conclusion 
tentative 
4.3.2.3 High tolerance to mutation 
Aside from the selection for affinity, that so many different mutations 
were tolerated by the Obody scaffold while maintaining binding highlights the 
potential as a molecular recognition reagent. From this library alone, 32 
different substitutions at 25 positions are shown. These are of course in 
addition to the sequence space searched in the previous two libraries. These 
data, coupled with a more in-depth analysis of stability and survey of naturally 
evolved related domains, have the potential to inform the design of a new 
synthetic Obody scaffold with improved thermal stability parameters, as has 
been performed with other scaffolds (Mosavi et al. 2002) (Knappik et al. 
2000). 
 
4.3.3 Limited Codon Library 
Any mutational library is limited by the ability of the template domain to 
tolerate the mutations introduced and remain stable. A phage display library is 
restricted by the relative level of display for each unique variant, which is 
influenced by domain stability and the secretion pathway used. When dealing 
with large numbers of mutations, sampling of the mutational space adds a 
further sequence bottleneck that, when combined with the already mentioned 
limitations, may restrict or completely prohibit discovery of specific binders to 
any one target. In the absence of information for site-specific mutational 
tolerance, it may be beneficial to reduce the available diversity at each position 
to reflect the bias towards certain residues seen in natural protein-protein 
interfaces (Lo Conte et al. 1999), thereby also increasing the percentage 
coverage of the theoretical maximum diversity. This approach has been used to 
generate antibody phage libraries with a two (Fellouse et al. 2005) and four 
(Fellouse et al. 2004) residue complement at each position, yielding μM-nM 
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range binders. Similar result was achieved with  fibronectin type III scaffold 
(Koide et al. 2007). 
The corollary of this bias is that with the more limited sequence space 
comes an increased possibility that the required sequence for binding is 
completely excluded, or that binding is inhibited by forced inclusion of sub-
optimal residues.  With these considerations in mind, the question becomes; 
does the library benefit sufficiently from the increased percentage coverage and 
bias towards binding-promoting residues (primarily Ser, Tyr and Arg) to make 
up for the diversity penalty imposed by sequence limitation? The fact that this 
library failed to produce binders of any significance implies that, with the 
twelve residue complement and the distribution of mutations used in the 
13mLC library, it does not. It has been shown since that a library with the full 
complement of amino acids can out-compete a library with the same design but 
with a restricted complement (Hackel and Wittrup 2010). This suggests that 
while the restricted-complement approach can indeed generate binders, it 
seems to result in reduction of the probability of selecting a binder with high 
affinity. 
4.3.4 Limitations of the phage-display format 
During library generation, cloning and transformation, the diversity of 
each library goes through a series of bottlenecks. Because of the combinatorial  
PCR-based method used here for gene assemble, reaction size and quantities of 
DNA represent the first practical limitation, calculated at 3.011 x10
13
 possible 
unique variants (section 2.4.2). Once the gene library is assembled, ligation 
into pRpsp2 again imposes a bottleneck, which I calculated at a 30% success 
rate (section 4.2.2). As library-scale ligations contained 3 pmol of plasmid, this 
equates to a maximum of ~1 pmol (1.8 x 10
12
) ligated plasmids available for 
transformation. By far the most severe bottleneck is transformation. The 
method employed here for producing electrocompetent cells gave, at best, an 
efficiency of 10
9
 cfu/μg of pRpsp2, but batch variation resulted in a practical 
limit of ~10
8
 transformants. As a result, any library with a theoretical diversity 
of greater than 10
9
 will suffer sampling bias during the transformation step. 
In addition, while it is not expected that all members of a transformed 
library will be produced stably, the ability to be displayed on the surface of a 
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phage may not necessarily overlap with domain stability. For example, large 
numbers of hydrophobic residues may not prevent the domain from folding, 
but may preclude secretion into the periplasm, where m13 phage is assembled. 
For future work, it may be beneficial to investigate an alternate secretion 
signal, such as the SRP-pathway (Steiner et al. 2006), to decrease the 
proportion of pIII with no fusion partner. 
4.3.5 Surface Plasmon Resonance 
The affinities of all Obodies were determined by SPR analysis on a 
Biacore 3000 instrument using an equilibrium binding model. Attempts were 
made to individually measure kon/koff directly from the raw data, however these 
invariably gave spurious and widely varying results. One possible explanation 
is that the μM affinity ranges dealt with in the course of this project lie at the 
edge of the Biacore’s accurate range, which may cause problems during the 
model fitting process. In a related problem, in order to measure μM-range 
affinities, high concentrations of analyte are needed, resulting in a large density 
difference between the instrument running buffer and the protein sample. 
Sudden changes in density can result in large “injection spikes”, in relative 
response curves, as can be seen in the upper most curves in the SPR raw data in 
Figure 4.7. These difficulties precluded the determination of kon/koff and left the 
method employed (steady-state kinetics) the most reliable at extracting a 
dissociation constant. 
4.3.6 Conclusions 
The above results show that affinity maturation for HEWL was 
successful by demonstration of sub-μM affinity for model target HEWL, 
though the target (<100 nM) affinities were not reached. Although affinities 
have remained modest, development is tracking in a similar arc to other 
scaffolds as they were first investigated, with the first pass libraries yielding 
μM-scale binding, and better affinity only achieved after further development 
of the scaffold domain and library design.  
This allows me to state with confidence that the OB-fold is a viable 
scaffold for exploitation as an engineering scaffold, though more work is 
needed in designing better naïve libraries for new selections. Further 
improvement the process of selection is also needed. In particular, the 
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immobilisation method (adsorption on the surface of immunotubes) 
concentrates the ligand on a surface, potentially imposing steric restrictions. 
Solvent-phase panning has been described using biotinylated ligand (Barbas III 
et al. 2001) and this should be considered as an alternative method. 
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5 Structural Analysis of Engineered OB-folds 
5.1 Introduction 
This chapter presents the crystal structures of two affinity-matured 
Obodies in complex with model ligand HEWL, derived from libraries 
described in Chapter 4. In the first section, a variant from rationally designed 
library L8 10m is presented, with emphasis on the effect of the library 
mutations and their possible contributions to the observed improvement in 
binding affinity. The second section presents a variant from an error-prone 
library and attempts to rationalise the observed affinity improvement with the 
three point mutations present in the structure. 
5.2 Results - L8 10m L10 
This gene was selected for crystal trials from a panel of five unique 
variants among which it showed the highest affinity for HEWL (section 
4.2.4.3). Compared to the ancestor gene, it contained two mutations at the 
binding face and six in a flanking loop. 
5.2.1 Expression and Purification 
The gene was cloned into and expressed from pRoEx Htb with an N-
terminal His-tag. It was expressed in batches of 1 L, purified by hand using a 
HiTrap chelating column (section 2.5.3) and the His-tag removed by digestion 
with rTEV (section 2.5.5). The protein was concentrated using a 5,000 Da cut-
off membrane ultrafiltration spin device (Vivaspin) and purified in a second 
step using an S75 10/300 size exclusion column, by serial injections of 250 uL. 
Because all Obodies thus far have purified identically, the position of the peak 
at ~12 mL was taken as diagnostic for a successfully purified Obody. Initial 
small-scale purification attempts were checked by SDS-PAGE. A typical yield 
gave between 10 and 15 mg of purified protein from 1 L of culture after the 
first step of purification. Purification data are shown in Figure 5.1. 
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Figure 5.1 L8 10m L10 purification 
(A) A representative chromatogram of elution from an S75 10/300 size exclusion column. 0.5 mL 
fractions were collected and pooled across the peak at ~12 mL. (B) Representative SDS-PAGE gel 
showing purified, His-tagged Obody from two different batches. Protein markers are labelled in kDa. 
 
5.2.2 Crystallisation and Data Collection 
L8 10mL10 was not subjected to a wide condition screen, but instead was 
trialled using a fine screen constructed around the condition that yielded 
crystals of the 13mRL L8 complex (see screen in appendix A1.6), at a similar 
concentration (41 mg/mL with equimolar HEWL) in a 1 μL + 1 μL sitting drop 
format. Crystals were identified in approximately 50% of the conditions 
trialled. A single crystal was found to diffract to resolution of at least 2 Å in 
condition B7 of the fine screen (precipitant: 0.2 M HEPES pH 7.4, 9% MPEG 
5000) and a 360° dataset was collected with a phi oscillation of 0.5° at the 
Stanford Synchrotron Radiation Lightsoure (SSRL) on beamline 9-1 at 100 K, 
to a maximum diffraction of 1.95 Å resolution (Figure 5.2). 
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Figure 5.2 L8 10m L10-HEWL complex crystals and diffraction 
Grown in condition 0.2 M HEPES pH 7.4, 9% MPEG 5000, these crystals (left) were carefully broken 
into manageable fragments for diffraction testing. The image shows a sitting drop approximately 1.5 mm 
in diameter. A sample diffraction image is shown on the right. Starting from the centre of the image, 
resolution rings mark 8.0, 4.0, 2.7 and 2.0 Å.  
 
5.2.3 Model building and Refinement 
While the conditions for crystallisation were very similar to that of the 
ancestral Obody-HEWL complex, the crystal was markedly different. The unit 
cell was much larger, with the symmetry of a P212121 space group. Initially 
indexed in p222 using XDS with a long c axis and a mosaicity of 0.2 °, 
molecular replacement was performed with PHASER from the CCP4 suite of 
programs in all related space groups, using 13mRL L8 (chain D) and HEWL 
(PDB accession 193L) as search models. Only a single solution in P212121 was 
found, with 9 copies of each monomer in the asymmetric unit. Translational 
symmetry was evident in the asymmetric unit, and Patterson map peaks of 90 
at the origin, and significant peaks at x/y/z coordinates 0/0/0.33 (52), 0/0.33/0 
(36) and 0/0.33/0.33 (30) also showed pseudosymmetry. SCALA did not detect 
any twinning during scaling.  
Both to improve the parameter-data ratio and reduce the delay between 
refinement rounds, ncs relationships were determined automatically using 
Phenix auto-ncs, which split the Obody chains into two groups. All nine of the 
HEWL molecules were restrained to chain A over residue range 15-129; 
Obody chains D, F and H were restrained to chain B over residue ranges 2-52, 
60-90 and 99-106; Obody chains L, N, P and R were restrained to chain J over 
the same residue ranges, designed to exclude loops and missing segments. All 
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restraints were defined as “tight” for main chain atoms and “loose” for side 
chain atoms, assuming that the folds don’t vary much across the asymmetric 
unit, with most variation expected in the side chains. 
The model was manually mutated to reflect the correct amino acid 
sequence and iteratively refined using Refmac restrained refinement with TLS 
(each chain was defined as an independent TLS zone) and Phenix minimisation 
with simulated annealing. The final R-free was 22.97%. Geometry was 
validated with PROCHECK, with 97.6% in preferred regions, 2.4% in allowed 
regions and no residues unfavourable or disallowed regions of the 
Ramachandran plot. Refinement statistics are summarised in Table 5.1. 
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Table 5.1 L8 10m L10-HEWL complex structure statistics 
Those figures in brackets represent the highest resolution shell 
   
SSRL 
Data Collection   
  
 
Space Group 
 
P212121 
 
Unit cell (Å) 
  
 
a 
  
60.54 
 
b 
  
186.26 
 
c 
  
245.70 
 
α, β, γ 
  
90 
 
Wavelength (Å) 
 
0.95666 
 
Resolution Limits (Å) 29.76 – 1.95 (2.05 – 1.95) 
 
Measured Reflections 2,883,973 (345,369) 
 
Unique Reflections 
 
201,772 (27,775) 
 
Multiplicity 
 
14.3 (12.4) 
 
Completeness (%) 
 
99.0 (95.0) 
 
Rmerge (%)† 
 
6.4 (48.4) 
 
<I/σ(I)> 
  
24.5 (5.0) 
 
Wilson B (Å
2
) 
  
28.19 
 
Mosaicity (°) 
  
0.2 
     Molecular Replacement‡     
 
Log-Likelihood Gain 
 
17355.736 
     Refinement       
 
Resolution (Å) 
 
29.76 – 1.95 (2.01 – 1.95) 
 
Reflections 
 
191,052 (12500) 
 
R work (%)* 
 
18.80 (21.34) 
 
Rfree (%)* 
  
22.97 (27.03) 
 
Free reflections 
 
10,136 (674) 
 
Protein Atoms 
 
18,959 
 
r.m.s.d bond lengths Å 0.007 
 
r.m.s.d bond angles (°) 1.052 
 
<B factor>  (Å
2
) 
 
30.2 
† Rmerge = Σ|Iobs - <I>|/ ΣIobs 
‡ Ref. (McCoy et al. 2007) 
*R = Σ||Fobs| - |Fcalc||/ Σ|Fobs| 
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5.2.4 Library Mutations 
To determine the structural basis for the 10-fold improvement in affinity, 
the mutations in this variant were individually examined for possible 
contributions (Figure 5.3). The bulk of the mutations made at the beginning of 
this library were located in the 4/5 loop, making up six of the total 10 
mutations. Of the six mutant positions in the loop, only one (A87) was 
sufficiently ordered to be visible in the structure. This residue made a 
hydrophobic contact with HEWL in all complexes, with approximately 20-30% 
accessible surface area buried at the interface.  
Of the four residue positions in the face subjected to mutation, two 
resulted in ancestor-type reversion (K37 and S29). While there appeared to be 
little change with S29, the distance between the Z nitrogen of K37 and R61 
was increased from ~3 Å in the 13mRL L8 complex to ~5 Å in 10m L10, 
ameliorating the like-charge clash and introducing possible water-mediated 
interactions (Figure 5.3 B). Regarding the P51S mutation, no hydrogen bond 
was predicted to form between S51 and HEWL and virtual alanine scanning 
showed a marginally negative interaction. Comparison of the 13mRL L8 
structures with L8 10mL10 showed a major change in the 2/3 loop Cα trace, 
which could a be consequence of i) crystallographic contacts involving this 
loop in the L8 10mL10 structure that were not seen in 13mRL L8, ii) that the 
loop was poorly ordered in the 13mRL L8 structure, leading to larger errors in 
atom placement, and/or iii) a change in conformational restriction by the P51S 
substitution. As any actual direct contribution to binding by S51 seemed to be 
very small, it seemed likely that relaxation of conformational restrictions on the 
surrounding peptides was the dominant contributor of any change to affinity 
for HEWL stemming from this mutation. 
A56Y was more easily interpretable, as the mutation increased 
hydrophobic interactions and introduced a hydrogen bond (Figure 5.3 C). 
Virtual alanine scanning calculated an average ΔΔG of 0.82 kcal/mol for Y56, 
and the interface buried an average of 25.2% of solvent accessible surface area 
of that residue. Relative to the Obody, this region showed amongst the greatest 
difference in HEWL position at the interface as compared to the 13mRL L8 
structure (Cα shift of 2.6 Å), although the relative shift was more pronounced 
distal to the interface (Figure 5.3 A). This movement appears to be a rotation of 
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HEWL relative to the Obody about the longitudinal axis of the complex, 
centred on the hydrophobic patch (Y33, V36 and I38), of approximately 10 °. 
 
Figure 5.3 L8 10mL10 mutations 
(A) Rotation of the interface is illustrated by superposition of Obodies and comparison of the relative 
positions of the HEWLs in complex with 13mRL L8 (grey Cα trace) and L8 10m L10 (green (Cα trace), 
with distances between representative Cα atoms labelled in Å. A four-residue peptide from L8 10m L10 
is shown as a red stick diagram as a reference point. L8 10m L10 residues (red, HEWL in green) that are 
hypothesised to contribute to this shift are shown in B and C, superimposed with 13mRL L8 (blue, 
cognate HEWL also in blue). (B) Compared to 13mRL L8, the distance between K37 and HEWL R61 has 
increased by ~2 Å and an interaction is now mediated by an ordered water molecule (not shown). (C) 
A56Y, shown in red, is associated with largest structural change as illustrated by comparison of the Cα 
positions of HEWL T47.  
 
5.2.5 Interface Residues 
 The most striking aspect of the different Obody-HEWL complexes in the 
asymmetric unit is illustrated in Figure 5.4; different conformers of, Y53, K58, 
E83, E95 and F97 were observed across the nine complexes. Y53 has the least 
consistent position as compared from monomer to monomer; all Obodies in the 
asymmetric unit exhibit evidence for multiple conformations of Y53, to 
varying degrees. Occupancy was reduced to 0.5 for Y53 side chain atoms 
where the first conformer intersected with its Fo-Fc electron density map when 
A B 
K37 
Y33 
Y56 
HEWL 
T47 
C 
HEWL R61 
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contoured to 5x its sigma level. An additional conformer was added where un-
modelled Fo-Fc density exceeded a sigma of three or 2Fo-Fc exceeded a sigma 
of one. The other four residues cluster above and behind (relative to the 
binding face) the third β-strand and are hypothesised to represent multiple 
binding modes of L8 10m L10 to HEWL.  
 
Figure 5.4 Varied modes of L8 10mL10 Obody-HEWL complexation 
(A) Cartoon view of an Obody overlay (red), with the three β-strands of the binding facing to the front. 
The red cartoon is a single chain, whereas all nine monomers are represented by blue stick diagrams, 
highlighting mutant residues that overlay well. Residues which overlay poorly are shown in light blue: 
residues Y53, K58, E83, E95 and F97. These residues show clear conformational differences between the 
complexes in the asymmetric unit, particularly Y53 with evidence for multiple conformers visible on 
individual chains. (B) Sub-optimal aromatic stacking (approximately a 40 ° angle between aromatic 
planes) with R112 from HEWL may influence Y53 conformation, though R112 appears to primarily 
interact with the Obody by formation of salt bridges with E95. 
 
In the absence of homologous structures to analyse for clues into the 
importance of individual residues for binding, relative stability and incidence 
of bond formation across the asymmetric unit may be used as a proxy. Analysis 
of the nine interfaces in the asymmetric unit showed variation in terms of 
buried surface area (809 – 861 Å2, calculated by PDBePISA), contacting 
residues and bonding between the Obody and HEWL. The polar bond 
predictions are summarised in Table 5.2, binding hot spot analysis in Table 5.3. 
R35 
4/5 loop E83 
F97 
K58 
E95 
Y53 
HEWL R112 
E95 
β1 
β2 
(A) 
(B) 
β2 
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Taken as an average across all complexes in the asymmetric unit, the contacts 
between the Obody and HEWL were similar to those seen in 13mRL L8, 
though interface analysis by PROTORP showed a net gain in hydrogen bonds 
(the output was not explicit about which residues were involved). According to 
PDBePISA, the same set of residues formed intermolecular hydrogen bonds 
(though not all bonds are found in all complexes), noting that because of a two-
residue insertion into the 4/5 loop, E95 in L8 10mL10 is structurally equivalent 
to E93 in 13mRL L8. However, the complex lost one electrostatic bond 
(between D32 and HEWL R61) and R35 gained an H-bond to HEWL Q57, 
bringing the number of polar bonds made by this residue to three in the active 
site. Hot spot predictions saw a similar profile of residues selected, but showed 
some significant differences in calculated energy. Y33 and surrounding 
residues formed the nucleus of the interface, for which Robetta virtual alanine 
scanning calculated an average ΔΔG 5.6 kcal/mol, compared to 3.7 kcal/mol in 
the ancestor interface. Across the interface an over-all increase in ΔΔG was 
observed compared to the ancestral complex, especially R35 with a 4-fold 
increase (0.5 to 1.99 kcal/mol). A notable exception is E95, which was not 
picked as a contact point at all by KFC or Robetta-ala servers, even though 
PDBePISA predicted multiple polar bonds mediated by this residue. Given the 
close contact E95 makes with HEWL residues suitable for forming polar 
bonds, it seems likely that its exclusion by the hotspot detection servers reflects 
a limitation of their contact-determining algorithms, as opposed to a real lack 
of biochemical contacts across the interface. 
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Table 5.2 Polar bonds across the asymmetric unit 
Presented here are the intermolecular polar bonds for the nine Obody-HEWL complexes in the 
asymmetric unit, as predicted by PDBePISA. Obody chain IDs head each column. While the numbers per 
residue vary slightly between interfaces, the same core six residues provide the majority of predicted 
polar bonds in all nine complexes. 
Residue B D F H J L N P R Mean Type† HEWL 
contact 
Asp 32 1 1 1 1 1 1 1 1 1 1.0 H  W63‡ 
Tyr 33 2 2 2 2 2 2 2 2 2 2.0 H D101, N103 
Arg 35 3 2 3 3 3 3 2 3 3 2.8 HS D52, Q57, 
E35  
Lys 40 1 1 1 1 1 1 1 1 1 1.0 H G102 
Glu 55 1 1 1 1 1 1 1 1 1 1.0 H N113 
Tyr 56 - - - - - 1 - - 1 0.2 H T47 
Lys 58 1 - - - - - - - - 0.1 H N113 
Lys 86 - - - - - - - 2 1 0.3 H R112‡,N113‡ 
Glu 95 2 2 2 2 2 2 2 2 2 2.0 HS N113, R112 
Total 11 9 10 10 10 12 9 12 12 10.56   
† H = hydrogen bond, S = salt bridge; ‡ meditated by Obody backbone atoms 
 
Table 5.3 Hot Spot predictions for the L8 10mL10 interface 
Using three different models (see section 2.6.4.2), the nine complexes were analysed for hot spots, giving 
a total of 27 predictions for each residue (A). Contacting residues with no hot spot predictions are 
omitted. R35 may be under-represented as the calculated ΔΔG from virtual alanine scanning was very 
close to the cut-off level (2 kcal/mol) for inclusion as a hot spot. Average ΔΔG values calculated by 
Robetta alanine scanning for interface residues are shown in (B) 
 
   Hot Spots 
 
 ΔΔG (kcal/mol) 
 Leu 30 1  Asp 32 0.69 
 Gly 31 2  Tyr 33 5.54 
 Asp 32 7  Arg 35 1.99 
 Tyr 33 27  Val 36 1.04 
 Gly 34 7  Ile 38 0.58 
 Arg 35 11  Lys 40 0.71 
 Ile 38 6  Ser 51 -0.02 
 Tyr 53 6  Tyr 53 0.79 
 Glu 55 6  Glu 55 0.60 
    Tyr 56 0.82 
    Lys 58 -0.21 
    Ser 85 0.17 
    Glu 86 0.32 
 
A B 
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5.2.5.1 Waters at the interface 
Like 13mRL L8, a cavity at the interface is visible between R35 and Y33 
(Figure 5.5). In this structure six waters were clearly defined in electron 
density, raising the possibility of water-mediated interactions. Polar atoms in 
range for hydrogen bonding were available on both molecules. Comparison 
with a monomeric HEWL structure (PDB accession 193L) showed that these 
waters roughly overlaid with those found at the interface in the absence of a 
binding Obody, but did not match precisely; four were within 0.6 Å and the 
remaining two seen in the complex replaced only one in the non-complexed 
HEWL structure (Figure 5.5, inset).  
 
Figure 5.5 Water-filled cavity at the L8 10m L10-HEWL interface 
Two views of the water-filled cavity at the Obody-HEWL interface, rotated 90°, represented by a surface 
model of the ordered waters (red). HEWL is shown in green as a Cα trace, residues that can form 
hydrogen bonds with the cavity waters are highlighted as stick diagrams. A three-residue peptide (Y33, 
G34, R35) from the Obody is shown in blue. The inset figure shows the waters in isolation (red 
surface/spheres), with an overlay of ordered water molecules from HEWL in the absence of Obody (blue 
spheres). Note the additional water introduced into the interface on Obody binding (arrow). 
 
5.2.6 Summary 
The L8 10m library was mutated at specific positions and re-selected for 
binding to HEWL, giving a ~10-fold affinity improvement. One variant was 
expressed and the crystal structure solved to a resolution of 1.95 Å in complex 
with HEWL to be used to determine the structural basis of that improvement. 
R35 
R35 
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The interface as whole revealed a further optimised state, evident as over-all 
increases in calculated ΔΔG. In the complement of 10 mutant positions, one 
mutation in particular, A56Y, was identified as the most important, as it was 
closely associated with the largest structural change; the whole interface has 
rotated approximately 10° relative to the HEWL molecule in the ancestor 
Obody complex. 
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5.3 Results - L200EP 06 
This gene was selected from panel of five mutant variants derived from a 
random mutation library on the basis improved affinity. The following section 
presents expression, purification, crystallisation and the structure of the protein 
in complex with HEWL for the purpose of determining the structural basis of 
an observed 2-fold affinity improvement. 
 
5.3.1 Expression and Purification 
Expression and purification was as described in section 2.5. Briefly, the 
Obody was expressed with an N-terminal His-tag from vector pProEx in cell 
strain DH5α, purified on an IMAC column by hand (section 2.5.3.3), digested 
with rTEV (section 2.5.5) then re-purified on an S75 10/300 size exclusion 
column (Figure 5.6). Yield was approximately 45 mg from 1 L of culture. 
 
 
Figure 5.6 Purification of L200EP 06 
(A) A representative chromatogram from the purification, showing elution from an S75 10/300 size 
exclusion column. Fractions were collected and pooled across the peak beginning at ~11.5 mL. (B) A 
representative SDS-PAGE gel showing purified His-tagged Obody, expected weight of 15,400 Da. 
Protein markers are labelled according to their weight, in kDa 
 
5.3.2 Crystallisation and Data Collection 
L200EP 06 was trialled for crystallisation in complex with HEWL using 
the same conditions, including concentration, as used with L8 10mL10 (section 
5.2.2). Crystals were identified in approximately 50% of the conditions 
screened. Diffraction testing on the home source beamline at the Maurice 
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Wilkins centre identified two crystals diffracting to the detector limit (1.86 Å 
resolution at a distance of 150 mm) in condition E1 (precipitant: 0.2 M HEPES 
pH 7.0, 13% MPEG 5000), and one crystal diffracting to 2.21 Å resolution in 
condition G1 (precipitant 0.2 M HEPES pH 7.0, 17% MPEG 5000). Two 
datasets were collected, one from an E1 crystal (180 1° phi oscillation images), 
the other from the G1 crystal (Figure 5.7), with the same phi oscillation for a 
total of 159 images. Both datasets showed the same space group and a virtually 
identical unit cell (Table 5.4). Datasets were integrated with Mosflm, in 
spacegroup P222. The Matthews co-efficient for both datasets indicated a 
single complex in the asymmetric unit (2.3 Da/Å
2
, 46% solvent). 
 
 
 
Figure 5.7 Crystals of L200EP 06 in complex with HEWL 
These two clusters of crystals in conditions G1 (a) and E1 (b) were carefully broken up and fragments 
individually mounted for diffraction testing. Although scale was not formally measured, both clusters 
were approximately 0.2 mm from the centre to the end of the longest crystal. (c) A sample x-ray 
diffraction image from crystal 3 from condition E1. Starting from the centre of the image, circles mark 
7.4, 3.7, 2.5 and 1.9 Å resolution. 
 
5.3.3 Model building and Refinement 
Dataset G1 was phased by molecular replacement using Phaser from the 
CCP4 suite. All possible space groups related to P222 were searched with one 
copy each of HEWL (PDB accession 193L) and L8 10m L10 (chain B). Only a 
single solution was found in p212121 with one copy of each monomer in the 
asymmetric unit, with an overall LLG of 1612. The amino acid sequence was 
corrected by manual mutation and minimally refined, using Phenix 
minimisation with simulated annealing and Refmac, dropping the R-free to 
26.83%. The dataset from crystal E1, which was found to possess the same 
spacegroup and unit cell, was used from that point on in the refinement. The 
A 
A B C 
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structure was refined using alternating rounds of Phenix minimisation with 
simulated annealing and TLS (TLS parameters were determined using the TLS 
Motion Determination server (Painter and Merritt 2006a; Painter and Merritt 
2006b)) and Refmac restrained refinement, down to an R-free of 19.3%. The 
final model was validated with PROCHECK, which showed 96.8% of residues 
in favoured regions, 3.2% in allowed regions and no residues in unfavourable 
or disallowed regions of the Ramachandran plot. Final refinement statistics are 
summarised in Table 5.4. 
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Table 5.4 L200EP 06-HEWL complex structure statitics 
Those figures in brackets represent the highest resolution shell. 
    Crystal G1 Crystal E1 
Data Collection 
  
 
Space Group p212121 p212121 
 
Unit cell (Å) 
  
 
a 50.5 50.43 
 
b 57.86 58.33 
 
c 82.84 81.82 
 
α, β, γ  (°) 90 90 
 
Wavelength (Å) 1.54179 1.54179 
 
Resolution Limits (Å) 31.79 - 2.21 (2.33 - 2.21) 34.58 - 1.86 (1.96 - 1.86) 
 
Measured Reflections 75787 (9463) 143392 (18275) 
 
Unique Reflections 12195 (1570) 20797 (2819) 
 
Multiplicity 6.2 (6.0) 6.9 (6.5) 
 
Completeness (%) 97.7 (93.0) 99.4 (94.1) 
 
Rmerge (%)† 8.7 (44.1) 3.9 (22.6) 
 
<I/σ(I)> 15.9 (4.3) 29.2 (7.5) 
 
Wilson B (Å
2
) 32.7 26.4 
 
Mosaicity (°) 0.8 0.5 
    Molecular Replacement‡ 
  
 
Log-likelihood Gain 1611.90 - 
    Refinement 
  
 
Resolution (Å) 35.79 - 2.31 (2.37 - 2.31) 34.58 - 1.86 (1.95 - 1.86) 
 
Reflections 10404 (752) 20534 (2293) 
 
R work (%)* 21.97 (23.7) 15.59 (17.3) 
 
R free (%)* 26.83 ( (36.1) 19.33 (22.0) 
 
Free reflections 519 (31) 1341 (60) 
 
Refined Atoms 1831 2156 
 
r.m.s.d bond lengths Å 0.023 0.025 
 
r.m.s.d bond angles (°) 1.982 1.886 
  <B factor> (Å
2
) 44.25 20.443 
† Rmerge = Σ|Iobs - <I>|/ ΣIobs 
‡ Ref. (McCoy et al. 2007) 
*R = Σ||Fobs| - |Fcalc||/ Σ|Fobs| 
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5.3.4 Library Mutations 
The ancestor gene of L200EP 06 (L8 10m L200) was derived from the 
same library that yielded the second structure presented in this chapter, L8 10m 
L10 (section 5.2), and while affinities are comparable (Table 4.2), residues 
selected from the L8 10m library were different at all 10 positions. Of the four 
residues targeted on the binding face, one (P51) was retained as ancestor-type. 
The remaining three mutations were S29H (Figure 5.8 B), K37M (reverted 
back to lysine in the subsequent random mutation library, Figure 5.10) and 
A56R (Figure 5.8 A). The six mutant residues in 4/5 loop were also completely 
different, but no direct structural comparison can be made as this loop was 
disordered in all previous structures.  
In contrast to the A56Y substitution seen in L8 10m L10, arginine at this 
position on the L200EO 06 Obody does not make any hydrogen bonds with 
HEWL and Robetta alanine scanning indicates no direct impact on binding, 
although proximity to an acidic residue on HEWL hints at a possible 
electrostatic interaction (Figure 5.8). The R56 guanidine group stacks with 
F65, located on the Obody’s only α-helix. Compared to the ancestral 13mRL 
L8 structure, the backbone carbonyl group of residue R56 has been flipped 
180°, accompanied by a shift in the backbone of neighbouring residue G57. 
S29H as seen in the present structure does not make any predicted 
intermolecular hydrogen bonds (Figure 5.9). However, this may be a function 
of the charge state of histidine; proximity (3.1 Å) to an H-bond receptor in the 
form of a aspartate carbonyl oxygen suggests that if it exists partially 
protonated, as it would at pH 7.4, an H-bond may be able to form. It would also 
potentially make a long-range electrostatic interaction (distance >4 Å) with the 
side chain of the same residue. This is of course assuming that the pKa of the 
imidazole group is unaffected by neighbouring charged residues. Robetta 
alanine scanning calculated a ΔΔG of 0.8 kcal/mol, indicating a positive 
contribution to binding. 
 
159 
 
 
Figure 5.8 S29H and A56R 
The L200EP 06 Obody is shown in yellow, its cognate HEWL in green. Overlaid for comparison is the 
13mRL L8-HEWL complex, both in blue. R56 (A) stacks with F97 on the Obody’s only helix capping 
one end of the barrel. S29H, while polar groups are close, is only partially protonated at pH 7.4, so the 
interaction with the pictured HEWL aspartate carbonyl is probably primarily via polar Van Der Waals 
contact. 
 
5.3.4.1 Error-Prone Library Mutations 
Compared to the ancestral sequence, L200EP 06 contained three residue 
substitutions: T19S, M37K and K86E (Figure 5.9). None of these mutations 
resulted in the formation of direct contacts with the HEWL ligand, so 
secondary and indirect contributions were specifically looked for. 
Consideration of the L200EP 06-HEWL complex interface for the structural 
basis of affinity improvement by this library was also in light of the pre-
existing differences compared to the 13mRL L8 structure, which prevented 
complete confidence in isolation of the observed 2-fold affinity improvement 
to any of the three point mutations selected from the error-prone library. 
Indeed, such an improvement is unlikely to be represented by large structural 
changes and was expected to be a stabilisation or optimisation of existing 
interactions rather than introduction of new ones. 
The first mutation was T19S, located on β-strand one, but on the opposite 
side of the Obody from the binding face. Interpretation of this mutation as a 
component of improved binding is difficult, as structural effects of the 
substitution are probably too subtle to be detected by x-ray crystallography. 
Effects on affinity, if any, are most likely to be a motion dynamics role better 
suited to an NMR study, therefore this mutation was disregarded. 
 
A B 
R56 H29 
F97 
HEWL D101 
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Figure 5.9 Mutations in L200EP 06 
The Obody is shown as a green Cα trace in complex with HEWL, shown in blue. Mutant residues on 
L200EP 06 are highlighted as green stick diagrams. 
 
5.3.4.2 M37K mutation 
The second mutation in the L200EP 06 structure (M37K) represents a 
striking convergence to lysine (Figure 5.10) along with the sequences of both 
Obody structures already presented in complex with HEWL in this thesis 
(Figure 3.9Error! Reference source not found., Figure 5.3), reproducing the 
ater mediated interactions found in L8 10mL10. Because the utilised models 
for protein-protein interface analysis exclude explicit water molecules, the 
impact of this interaction is under-represented in the computational interface 
analysis methods used here. If one disregarded this limitation of the models 
employed, the curious durability of this particular substitution suggests an 
important role in binding, over and above simply removing the like-charge 
clash seen in the 13mRL L8-HEWL complex. 
T19S K86E 
M37K 
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Figure 5.10 M37K Mutation 
K37, originally targeted for mutation due to proximity HEWL R61, here contributes to a water-mediated 
interaction network. (A) comparison of the contact 13mRL L8-HEWL residues (shown in blue). The 
L200 EP06 structure shows that the HEWL arginine has shifted and been replaced with two ordered 
waters (B). 
 
5.3.4.3 K86E Mutation 
The third mutation, K86E, appeared to have the greatest potential impact 
(Figure 5.11). In both 13mRL L8 and L8 10mL10, K86 clearly played a role in 
binding, as indicated by the availability of a hydrogen bond donor on HEWL, 
buried surface area (82 Å
2
), hydrophobic packing with HEWL K116 and a 
highly ordered side-chain in the structures. Its replacement with a glutamate in 
L200EP 06 prevented formation of the same H-bond and hydrophobic 
interactions. Robetta alanine scanning indicated that the glutamate at this 
position is actually mildly destabilising (Table 5.6) though this is most likely 
an artefact of poor electron density leading to uncertain side chain placement. 
K86 is one of the most commonly mutated positions positively selected 
from the library, with mutations to glutamate, arginine or asparagine in 6 of 23 
unique sequences (Figure 4.13).  It borders the 4/5 loop region, so it follows 
that a tight positional restraint imposed by this residue has consequences on the 
conformation of the loop residues, as well as those flanking the loop. Indeed, 
the β-strands supporting the 4/5 loop provide a major salt bridge interaction in 
E95, which has undergone significant reorganisation during the two rounds of 
affinity maturation of which this structure is a product (Figure 5.11B) 
culminating in a 50% increase in calculated ΔΔG. 
In addition this substitution was hypothesised to influence was the 
dynamics of the 4/5 loop. The most obvious difference between L200EP 06 
R61 R61 
K37 K37 
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and the two previous structures is the ordered 4/5 loop and its involvement in 
binding. No direct contacts with HEWL were observed by the first residue of 
the loop, Q87, but H-bonds to E95 and Y53 were evident. Y53 appears to have 
stabilised considerably, with no evidence for multiple conformers as visible in 
the previous two structures. As well as a hydrogen bond to Q87, aromatic 
stacking with HEWL 112 improved, with the angle between the two aromatic 
planes considerably closer to parallel (approximately 10° from parallel, 
compared to 40 ° in 13mRL L8). The second residue, Y88 showed an extensive 
burial of hydrophobic surface (140 Å
2
 of solvent accessible surface area), 
binding into a depression on the surface of HEWL (Figure 5.11A). This 
arrangement involving E86, Q87 and Y88 would be altered significantly if the 
K86E substitution were reversed, via competition with the hydrophobic 
interaction made by K86, forcing the backbone of the residue at position 86 
into a different conformation and altering the dynamics of the loop and 
neighbouring residues. 
The importance of the aforementioned residues (E95, Y88 and Y53) in 
binding is highlighted in the computational interface analysis (Table 5.6). Both 
E95 and Y88 were picked as hot spots by Robetta virtual alanine scanning, and 
ranked 2
nd
 (E95, 6 kcal/mol) and 3
rd
 (Y88, 2.6 kcal/mol), for calculated ΔΔG, 
after Y33 (7 kcal/mol).  
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Figure 5.11 Loop mutations and their effect on the interface 
The L200EP 06 complex structure, shown as a yellow Cα trace with residues highlighted as stick 
diagrams, with the position of selected ancestor (13mRL L8) residues shown as line diagrams, positioned 
by a Cα superposition of the Obodies. HEWL is represented by a green surface, or residue. (A) Loop 
residue Q87 protrudes down into the top of the interface, hydrogen bonding to Y53 and E95, both of 
which are in contact range of HEWL residue R112. The changes in residue position are obvious by 
comparison with the ancestor-type residues. (B) The largest increase in buried surface area can be 
attributed to Y88, which lies in a grove on the HEWL surface, burying 140 Å2 . It is proposed that the 
substitution K86E contributes to the positioning of both Y88 and Q87, by altering the conformational 
dynamics of the loop and surrounding residues. E86 is present as two equally occupied alternate 
conformers, suggesting there are no stable bonds formed by this residue. 
 
 
E95 
A 
B 
HEWL R112 
Y88 
Q87 
E86 
Y53 
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5.3.5 Description of the Obody Interface. 
The L200EP 06 structure shows Obodies and HEWL chains that do not 
significantly depart from the previous structures in the core fold region; 
structural alignment of the L200EP 06 Obody with the nine monomers in the 
L8 10mL10 asymmetric unit gives r.m.s.d. values between 0.36 and 0.58 Å. 
Similarly, HEWL aligns with r.m.s.d. of between 0.22 and 0.25 Å. A water-
filled cavity is found at the interface between Y33 and R35 which closely 
resembles that shown in both previous structures, down to the position of the 
waters (Figure 3.3 and Figure 5.5), although the gap index for this complex has 
dropped to 2.1 Å
3
, indicating a greater degrees of complementarity. As 
calculated by PDBePISA the complex does not contain more hydrogen bonds 
or salt bridges (Table 5.5), although the PROTORP server shows a gain of 5 
over 13mRL L8-HEWL complex (Table 5.7). The hydrophobic patch of Y33, 
V36 and I38 at the centre of the interface overlays compares closely with the 
previous two structures, although the relative importance of V36 and I38 
appear to have decreased in favour of Y33 and K40. Polar interactions are also 
similar, with 10 polar bonds including two salt bridges predicted by 
PDBePISA. The most significant difference is an increase in buried surface 
area up to 945 Å
2
 on the Obody alone (total 1800 Å
2
), mostly attributable to 
Y88 in the 4/5 loop, which is ordered and contacting HEWL in this complex 
(Figure 5.12). The crystal form is identical to that seen in L8 10m L10, 
although with a much smaller unit cell; it is interesting to note here that axes b 
and c are almost exactly one third the length. 
 
Table 5.5 Polar bonds at the L200EP-HEWL interface 
Calculated by PISA, polar bonds are listed along with their interaction partners on HEWL. 
Residue Count Type† HEWL Contact 
Asp 32 1 H W63‡ 
Tyr 33 2 H N103, D101 
Arg 35 2 HS E35, D52 
Lys 40 1 H G102 
Glu 55 1 H N113 
Ser 85 1 H K116‡ 
Glu 95 2 HS R112 
† H = hydrogen bond, S = salt bride 
‡ Mediated by Obody backbone atoms 
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Table 5.6 Hot spot predictions of the L200EP 06-HEWL interface 
Analysis of the binding interface using the KFC and Robetta servers show predicted hot spot residues 
(A). The raw ΔΔG data from the Robetta alanine scanning server is shown in (B). 
   K-FADE K-CON Robetta   ΔΔG (kcal/mol) 
 Gly 31  Yes   His 29 0.87 
 Asp 32  Yes   Asp 32 0.63 
 Tyr 33 Yes Yes Yes  Tyr 33 7.37 
 Gly 34  Yes   Arg 35 1.84 
 Arg 35     Val 36 1.08 
 Val 36     Ile 38 0.63 
 Lys 40     Lys 40 1.32 
 Tyr 53  Yes   Tyr 53 1.66 
 Tyr 88   Yes  Glu 55 0.47 
 Glu 95     Yes  Arg 56 -0.01 
      Ser 85 -0.05 
      Glu 86 -0.09 
      Tyr 88 2.60 
      Glu 95 6.13 
      Phe 97 0.04 
 
 
 
Figure 5.12 FADE surface complementarity at the interface 
A side by side comparison of shape complementarity at the interfaces of L200EP 06 and L8 10mL10 (AB 
complex) as determined by FADE, represented by a surface model and associated Obody residues. The 
L200EP 06 interface contacts (A) differ from the L8 10mL10 interface (B) in two main regions. Y88 
illustrates the largest difference, making extensive contacts with HEWL, increasing buried surface area of 
the L200EP 06 complex by 144 Å2. Removal of K86 also seems to remove hydrophobic clashes with 
E83, potentially influencing stability of Y53 and surrounding residues. 
 
A B 
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R35 
Y56 
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R35 
Y33 Y33 
R56 
E83 
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5.3.6 Three-structure comparison 
Superposition of the all three Obody structures and comparison of the 
relative position of the HEWLs in complex reveals that L200EP 06 has a 
different arrangement then the other two structures (Figure 5.13). Similar to the 
L8 10m L10 complex, L200EP 06 association with HEWL has undergone a 
rotation of at least 10 ° about the longitudinal axis of binding, but also a lateral 
shift, centred on Y33. Examination of the HEWL structures shows the place of 
least variation in Cα position across all three structures is the pocket into which 
Y33 binds cementing this residue as the most important single hot spot in the 
interface. 
 
 
Figure 5.13 Overlay of all three Obodies and their cognate HEWLs 
13mRL L8 (blue), L8 10m L10 (red) and L200EP 06 (yellow) in complex with HEWL are overlaid using 
the Obody Cα trace (displaying only the three residue peptide Y33, G34, R35 from the Obodies). Cognate 
HEWLs (same colour key, Cα trace) show the orientation differences between their associations with the 
Obodies.  
 
For comparative purposes, the interface statistics calculated by 
PROTORP (Reynolds et al. 2009) are displayed in Table 5.7. The comparison 
highlights the iterative interface improvements, in terms of increasing numbers 
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of hydrogen bonds, increasing buried surface area and reducing gap index. 
Differences between these and the previously cited values for buried surface 
area and hydrogen bond quotients can be accounted for by different calculation 
methods used by PROTORP and PDBePISA. 
Table 5.7 Comparative interface statistics 
These data were calculated using the PROTORP interface comparison server 
 
13mRL L8 L8 10m L10 L200EP 06 
Buried surface area 840 Å
2 (14%) 860 Å2 (14%) 962 Å2 (16%) 
H-bonds 8 11 13 
Salt bridge interactions† 5 5 4 
Polar:Non-polar atoms % 43:57 44:56 38:62 
Gap Volume Index‡ 2.94 2.50 2.10 
Kd 36 μM 5 μM 610 nM 
†Salt bridge count is defined as the number of charged HEWL residues within 4 Å of an appropriately 
charged Obody residue. 
‡Gap Volume index is defined as the ratio between buried surface area and encolosed volume not 
occupied by protein, as per (Jones and Thornton 1996). 
 
5.4 Discussion 
Structural information about a potential scaffold is an invaluable source 
of insight when both designing a library and analysing resulting selections. 
This chapter presented two structures, both the product of affinity maturation 
libraries based on a single variant from a naïve library selected for affinity for 
HEWL. 
5.4.1 Affinity maturation - L8 10m L10 
The first structure of an Obody (13mRL L8, Chapter 3) presented as a 
validation for the initial library design, was used to design a new library to 
improve affinity. Rational selection of residues for mutation in the L8 10m 
library yielded several variants with diverse sequences but similar affinities, of 
which the one with the best affinity (L8 10m L10, KD 5 μM) was solved by x-
ray crystallography in complex with HEWL to determine the structural basis 
for affinity improvement over the 13mRL L8 ancestor. Immediately obvious in 
comparison was that the fold tolerates mutation well, and was capable of 
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accommodating changes to residues in both the β-strands and the loops while 
maintaining stability. 
What seemed evident from the sequence data of the HEWL-selected L8 
10m library variants was that any binding using the 4/5 loop was subordinate to 
selection of residues at the face; no consensus was evident in the loop residues 
but ample at the face positions. This was supported by the structure of variant 
L10 presented here (section 5.2) in which the 4/5 loop was almost completely 
disordered in the structure, strongly implying no contribution to binding in this 
complex. Instead the major differences were tracked to the periphery of the 
interface, where introduction of a Tyr for Ala at position 56 appears 
responsible for a rotational shift in HEWL relative to the Obody by 
approximately 10°, producing a new polar bond and some limited hydrophobic 
contact.  
Although the re-selection of ancestor-type residues at position S29 and 
K37 was surprising (section 5.2.4) considering the 10-fold increase in affinity, 
the structure offered clues why this may be the case; both positions were 
altered in their interaction with HEWL by the relative shift outlined above. 
K37 no longer clashed with HEWL R61. S29, originally identified for 
replacement with a larger residue to bridge the gap between the two proteins, 
was brought into closer contact with HEWL. Although this residue didn’t make 
significant intermolecular contacts, retention of S29 with its small, polar side 
chain may accommodate the shift imposed by Y56 on the other side of the 
interface (Figure 5.3). By itself, the average calculated ΔΔG of 0.82 kcal/mol 
of Y56 accounted for a four-fold increase in affinity. It is expected that the 
remainder of the gain can be attributed to an overall optimisation of the 
interactions across the face, as alluded to by a general increase in calculated 
ΔΔG across the interface residues (Table 5.6). 
The presence of buried waters at the interface (Figure 5.5) provided a 
clue as to why the affinity of this Obody remains only moderate (5 μM) when 
the interface statistics compare favourably with other HEWL-binding proteins 
(Table 5.7, Table 3.4). Although conserved waters in protein-protein interfaces 
are thought to contribute positively to binding (Reichmann et al. 2008), 
perturbation of the HEWL solvation shell, as shown in Figure 5.5 by the 
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Obody during binding may impose an energy penalty , especially considering 
that the waters are in a pocket bordered by hydrophobic atoms from the critical 
Obody residues Y33 and R35). 
5.4.1.1 Consideration of x-ray data 
The crystal used to solve this structure showed a surprisingly long c axis 
in the unit cell (245 Å). Statistics presented by SCALA did not show a twinned 
crystal, but a Patterson map suggested the presence of pseudotranslation in one 
axis, which was indeed reflected in the asymmetric unit of nine complexes. The 
later structure of L200EP 06 in complex with HEWL exhibited very similar 
crystal packing in the same spacegroup, although with only one complex in the 
asymmetric unit. Interestingly, the unit cell parameters calculated for the L8 
10m L10 complex structure were almost exactly three times those calculated 
for the L200EP 06-HEWL complex on two axes, strongly implying that the 
nine-complex asymmetric unit was a pseudotranslational expansion. 
This consideration impacts on my decision to treat the variation seen 
across the asymmetric unit as real; crystal packing may be the cause of the 
disorder, rather than the other way around. However, the same interface 
residues showing variable conformations in this structure were observed as 
variable in the 13mRL L8 structure, where crystallisation conditions, space 
group assignment and crystal packing were different. In the same vein, the 
increase in affinity seen in L200EP 06 seems to be correlated with stabilisation 
of the aforementioned variable residues, where the crystallisation conditions 
are very similar and the space group is the same. Additionally, in the nine 
complexes there were three dominant conformations seen in the position of 
Y53 (Figure 5.4), with evidence for further alternative side chain conformers in 
all complexes. That being said, a general note for crystal structures states that 
the conformations seen in the asymmetric unit  do not necessarily reflect the 
nature of the crystallised protein(s) in solution. So while each Obody-HEWL 
complex in the L8 10m L10 structure may not individually represent a different 
species in solution, it seems reasonable to conclude that the observed variation 
is relevant to binding. 
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5.4.2 Affinity maturation – L200EP 06 
The second approach to affinity maturation was random mutagenesis. 
Because of the random component, the beneficial (i.e. affinity-increasing) 
mutations can potentially affect binding by long-range propagation of 
conformational changes, making it difficult to isolate binding effects as the 
consequence of a particular residue change. The choice of template gene for 
investigation in this process (L8 10mL200) prevents a direct comparison with 
the ancestor gene, so 13mRL L8 was used instead. 
Because the direct ancestor of L200EP 06 does not have a structure 
available, examination of the interface avoided inferences that rely on the 
positions which are different between L10 and L200EP 06, but unchanged 
from the L200EP 06 ancestor gene. Thus, while direct comparison does give 
some information about the differences between the three Obodies that may 
account for affinity changes, it is not sufficient to say with certainty the effect 
of a particular mutation. 
5.4.2.1 Proposed source of affinity improvement 
L8 10m L200 differed from the L10 variant at every position that was 
randomised. S29 was replaced by a histidine, A56 with an arginine, K37 with a 
methionine, while P51 is retained as ancestor (13mRL L8)-type. Consequently, 
these positions, along with all of the 4/5 loop residues, were largely discounted 
as the causative agents for increased affinity in terms of the new contacts they 
introduce. Bearing that in mind, the structure suggested that a loss of one 
interacting residue (K86E) and the re-selection of another (M37K) are the 
clearest causes of affinity improvement compared to the direct ancestor, L8 
10m L200. 
Allowing the 4/5 loop to more easily assume a conformation favourable 
to binding by removing competing interactions formed by K86 may account 
for a portion of the improvement of affinity for HEWL. Even if no additional 
polar bonds are formed, direct involvement of the 4/5 loop does increase the 
buried surface area by more than 100 Å
2
, primarily by hydrophobic contacts 
between Y88 and HEWL residues R21, Y23 and G104. This conclusion must 
be considered in the knowledge that the 4/5 loop was present unchanged in the 
ancestor of L200EP 06, so the observed binding affinity improvement cannot 
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be attributed simply to the presence of the loop sequence. Instead, any 
influence by mutation of position 86 must come instead from altered dynamics 
of that loop, or surrounding residues.  
Aside from the loop residues themselves, the two β-strands (4 & 5) 
which support that loop has shifted compared to 13mRL L8, which I suggest is 
to accommodate the different 4/5 loop configuration. Two structurally adjacent 
glutamates from these strands were also involved in binding, at positions E83 
and E95. E83 did not directly take part in binding, but was identified as part of 
the cluster of residues with varied conformations in L8 10mL10 (Figure 5.4), 
suggesting that it may play a co-operative role in organisation of the 
neighbouring interface residues. Where position 86 was a lysine, as in L8 10m 
L10, the carboxyl group of E83 appeared to be flattened between the 
hydrophobic portion of the lysine side chain and F97, which almost certainly 
influenced the position of structurally adjacent residues Y53 and K55. Given 
that residues which are important for binding tend to be in states of restricted 
conformational freedom (i.e. pre-organised into binding configurations, (Li et 
al. 2004)), co-operative interactions such as these may have significant impacts 
on binding by ameliorating the loss of degrees of freedom entropy. E95, 
located on the fifth β-strand immediately after the 4/5 loop, formed a salt 
bridge with two HEWL residues in all structures. Compared to central binding 
residues Y33 and R35, arrangement of the salt bridge between E95 and HEWL 
R112  shifted by 2 Å, which also resulted in a more favourable aromatic 
interaction with Y53. 
5.4.2.2 Caveats  
Although a general conformational stabilisation of the so-called variable 
cluster seen in L8 10m L10 (Figure 5.4) is hypothesised to be involved with 
improvement of affinity, other differences that were present before the error-
prone affinity maturation library may also influence the conformational 
stability of the cluster as compared to L8 10m L10. Q87, the first residue in the 
randomised portion of the 4/5 loop, pushes down into the interface and 
hydrogen bonds with Y53, thereby influencing its conformational freedom. 
Mounted on the loop at the end of β-strand 3, R56 shows aromatic stacking 
with a phenylalanine, which may account for a minor shift seen in the 
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backbone of that loop and consequently E55 as well which bonds directly to 
HEWL. Because a structural comparison with the direct ancestor is not 
available, any improvement attributed to the K86E mutation cannot be 
deconvoluted from these pre-existing differences. I must therefore conclude 
that stabilisation of this variable cluster is the result of the combination of all of 
these mutations. 
5.4.3 Conclusion 
The over-all result is one of a general improvement across most 
interactions of their contribution to ΔG of binding, following a re-orientation of 
the Obody-HEWL interface. I propose that the shifts seen in both structure 
presented here resulted in further optimisation of the various intermolecular 
interactions, particularly at the critical hot spot residues, driven by changes on 
the periphery of the interfaces. This sort of rigid-body settling of the interface 
towards a more optimal binding configuration was the expected result from the 
two rounds of affinity maturation. 
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6 General Discussion  
Specific, customised binding reagents are vital tools in science, for 
understanding biochemical processes, sensitive detection of important 
molecules, or as therapeutics. Before molecular techniques for the routine 
manipulation of biological macromolecules became available, reagents were 
derived from the naturally occurring reservoir of selectable diversity that was 
available in the vertebrate immune system. While immunisation did, and still 
does, provide adequate tools for many applications, what became apparent was 
that antibodies in their naturally occurring forms were not competent to 
perform all of the tasks that researchers and clinicians required. Specifically, 
the large size, sensitivity to redox state and reliance on glycosylation drove 
decades of work seeking to simplify, improve and eventually replace natural 
antibodies with engineered immunoglobulin domain constructs as the 
benchmark scaffold for molecular recognition (Better et al. 1988; Huston et al. 
1988; Riechmann et al. 1988a; Riechmann et al. 1988b; Bird and Walker 1991; 
Buchner and Rudolph 1991; Vaughan et al. 1998; Knappik et al. 2000).  
Today, using developments in gene manipulation and synthesis, 
application of evolutionary principles have been used not only to improve 
antibodies, but to investigate a wide range of different protein folds as affinity 
scaffolds (Skerra 2000; Binz et al. 2005; Binz and Pluckthun 2005; Skerra 
2007a; Gebauer and Skerra 2009). Particular emphasis is often placed on 
therapeutic applications in the literature (Sidhu and Fellouse 2006; Tolmachev 
et al. 2007a; Zafir-Lavie et al. 2007; Bloom and Calabro 2009; Friedman and 
Stahl 2009), but these technologies have potential for use in any context which 
requires specific binding. While the techniques employed are in wide-spread 
use, the process of investigation remains time-consuming, expensive and 
technically challenging.  
The Oligonucleotide/Oligosaccharide binding fold unifies a large 
collection of structural superfamilies, with no sequence conservation (Murzin 
1993; Arcus 2002). It is a small, stable β-barrel fold, found performing diverse 
functions in evolutionarily diverse organisms and therefore meets the criteria 
identified as necessary  to be a candidate for engineering as a scaffold (Skerra 
2000; Binz and Pluckthun 2005). Previously, we selected as a template the 
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anticodon binding domain of aspartyl tRNA synthetase from Pyrobacculum 
aerophilum for investigation into OB-folds as molecular recognition scaffolds. 
Its ability to tolerate extensive mutation in an artificially randomised binding 
face, remain soluble and be displayed as a pIII fusion product on the surface of 
M13 filamentous phage was demonstrated. Using phage display and a library 
with 17 randomised codons, preliminary selection experiments against hen egg 
white lysozyme (HEWL) as a model protein target succeeded in converting the 
nucleic acid binding domain into a specific protein binder, with a moderate KD 
of ~40 μM. This first-pass investigation of our candidate scaffold gave results 
comparable with other synthetic scaffolds from first-pass phage display 
libraries (Nord et al. 1997; Koide et al. 1998). However, further validation of 
the fold was needed to begin to bring it up to the standard achieved by other 
scaffolds. 
6.1.1 Structural Validation and Library Improvement 
The data presented in this thesis builds on that preliminary work, to 
establish OB-folds as a viable scaffold candidate for generation of 
customisable molecular recognition reagents. First, a major flaw in the initial 
selection of the domain was that no structure was available from which to 
make definitive decisions about which residues to target for mutation. To 
address this, the crystal structure of an Obody variant from the preliminary 
selection experiment was solved in complex with its target, hen egg white 
lysozyme (HEWL), to validate both the library design and investigate the 
structural basis for binding. The structure of 13mRL L8 in complex with 
HEWL showed in atomic detail the specifics of the selected binding face 
(section 0), revealing that the critical intermolecular interactions were indeed 
mediated by mutant residues, though a significant component of binding was 
contributed by native residues. What was surprising was that although the 
13mRL L8 Obody binding face possessed all of the defining characteristics of 
a good interface, and that the statistics of the face compared favourably with 
other HEWL complexes in terms of buried surface area, gap index and 
complement of polar interactions, the measured affinity of the Obody was 3-4 
orders of magnitude lower than the other published HEWL complexes 
examined (section 3.2.4). Working on the assumption that this reflected the 
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presence of residues preventing tighter binding, affinity maturation phage 
libraries were designed based on the structure. 
6.1.2 Structure-based affinity maturation for HEWL 
Two attempts were made to use structural information as the basis for 
affinity maturation libraries. The first was a second-generation library based on 
a gene extracted from a naïve library, with 10 randomised codons, named L8 
10m (section 4.2.4). Panning against HEWL resulted in a 10-fold improvement 
in affinity. Frustratingly, this library was hampered by extensive undesired 
point mutations made during synthesis of the incorporated mutational 
oligonucleotides, so it is my belief that this library should have performed 
better than the 10-fold increase in affinity it produced (Kd ~5 μM), though it 
clearly still retained sufficient numbers of viable genes to produce a better 
binder. This problem was not re-addressed due to time and budget constraints, 
and because improvement was indeed shown, the newly selected variants were 
taken as the new benchmark for further experiments.  
The crystal structure of the L10 variant from this library was solved in 
complex with HEWL to a resolution of 1.95 Å (section 5.2). That structure 
provided fairly clear evidence for the nature of the structural changes that led 
to affinity improvement, which was proposed as the substitution of an alanine 
with a tyrosine at position 56 and a rigid-body rearrangement of the complex 
(Figure 5.13), resulting in a closer to optimal interaction, as reflected by an 
average increase in calculated ΔΔG across the interface residues. This re-
shuffling of the interface appeared to remove the like-charge interaction 
targeted by the library design, even though the ancestor-type Obody residue 
was reselected at this position (Figure 5.3). Critically, the core fold remained 
robust and essentially unchanged with the additional mutations introduced. 
 
6.1.3 Third generation structure-based affinity maturation 
The second attempt to use structural information was performed using 
the structure of the second generation Obody in complex with HEWL. One 
indication of high-quality binding is shape complementarity; the precision with 
which residues fill clefts in target proteins is important enough for binding that 
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it has been used to identify hot spots (Li et al. 2004). What was evident in both 
structures solved at the time of designing this library was a large, water-filled 
gap right next to two of the most critical residues for binding, namely R35 and 
Y33. Filling this gap would more closely match the Obody to the contours of 
the HEWL active site, which could in principle result in a significant 
improvement in affinity. The failure of this library to positively select for new 
variants provided an insight into the limitations of the binding mode that this 
particular lineage of Obody has adopted. It may be that, because of the β-sheet 
nature of the peptide inserted by the Obody into the HEWL active site, a more 
complementary shape that fills the cavity may not be energetically favourable, 
as it may require denaturation of the β-sheet character of certain residues, in 
addition to displacement of the ordered waters which would also impose an 
energetic penalty (Hendsch and Tidor 1994; Dong and Zhou 2006). 
To illustrate this point with an analogous system of binding evolution; 
selection of antibodies in the vertebrate immune system goes through two 
stages, each resulting in a polyclonal response (Rajewsky 1996). In the first 
stage, selection is done from the initial complement of naïve B-cells, resulting 
in the amplification of the subset which express antibody genes that show 
binding. The second stage occurs after re-exposure to the same antigen. Those 
lymphocytes selected in the first round go through a second round of 
proliferation and mutation of their antibody genes. The critical aspect here is 
that the highest affinity variants that come to dominate the immune response 
after re-infection are not necessarily descended from those variants which were 
the dominant after initial exposure (Malipiero et al. 1987). In other words, in 
an energy landscape of the free energy of binding, a gene sequence in a lower 
local minimum may be at a disadvantage versus those with a higher binding 
free energy when affinity maturation is attempted. This effect may be at play 
here with this particular Obody library, and the energy penalties may be too 
great to overcome through mutation of the few residues targeted. By extension, 
a different variant from the original 13mRL library may perform better. 
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6.1.4 Third generation random affinity maturation 
Drawing from affinity maturation processes seen naturally in antibodies 
(Griffiths et al. 1984), random mutation by error-prone PCR was used to 
introduce variation into a third library. Random sampling of sequence space 
over the whole protein is capable of finding mutations that optimise the 
interface which rationally-designed libraries would typically not consider. 
Considering the failure of the previous attempt based on the L10 variant from 
L8 10m (the L10 6m library) a different gene was selected; variant L200. This 
gene showed a similar affinity as L10 for HEWL (section 4.2.4.3), but seemed 
more attractive as it arose more frequently than other variants. The mutant 
residue complement in L200 also seemed to be more in line with the rationale 
of the original design of the library which produced it (L8 10m, section 3.2.5); 
bulky residues were selected where I expected them be, a like-charge clash was 
removed (replacement of K37 with methionine), and the 4/5 loop contained a 
tyrosine, which has been found to be over-represented in protein-protein 
interfaces (Lo Conte et al. 1999).  
This effort was partially successful and produced the first sub-micro 
molar Obody, measured at 600 nM (L200EP 06), which, when compared to a 
ancestor-type variant control measured using the same chip surface, is a 2-fold 
improvement in affinity. This result was called a partial success as the aim was 
to produce a binder with a KD of 100 nM or less, which was not achieved.  That 
a substantially tighter binder was not produced from a library of 10
8
 variants 
supports the, admittedly speculative, conclusion that this lineage of Obodies 
may occupy a local minimum in free energy of binding that is prohibitively 
remote from other, better minima. The scale of mutations needed, starting from 
the template sequence used here, may not be available by the methods 
employed. However, I cannot eliminate the possibility that the variants present 
in the library were simply an unlucky sampling of the sequence space. 
6.1.4.1 Structural Analysis 
The crystal structure of this variant in complex with HEWL was solved 
to high resolution (1.85 Å) and showed an interface that PDBePISA calculated 
as similar to the previous two , but with a large increase in buried surface area 
of more than 100 Å
2
, attributed to a single tyrosine (Y88). Data from an 
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alternative interface server (PROTORP) showed a steady increase, with affinity 
maturation, in the complement of intermolecular polar bonds, increase in 
buried surface area and decrease in gap index. Unfortunately, because a 
structure of the immediate ancestor complex was not available, the impact of 
the three mutations found in this variant was difficult to determine precisely. 
Instead, the structure was compared to its ancestor, 13mRL L8, and the 
cumulative increase in affinity was attributed to the mutations which occurred 
in both maturation steps it underwent. 
In a similar manner to the L8 10m L10 variant complex, the L200EP 06 
complex showed a substantial over-all shift of HEWL relative to the Obody, 
implying that a major determinant of affinity improvement was optimisation of 
the interactions already present on the binding face, in addition to the 
introduction of buried hydrophobic surface area on Y88 (Figure 5.13). This 
conclusion was supported by the an average increase of calculated ΔΔG from 
this structure as compared to the others (Table 3.3, Table 5.3, Table 5.6) 
indicating that individual residues found more energetically favourable binding 
states, which can be tentatively extrapolated to the face as a whole. For 
example, Y33, consistently identified as the most important single residue for 
binding, showed a ΔΔG of more than 7 kcal/mol, compared to the same residue 
in 13mRL L8 with less than 4 kcal/mol. This can be compared to the most 
substantial new interaction at Y88, which is calculated at 2 kcal/mol, which 
may be an over-estimate given that the electron density map was less-well 
defined then other interface residues, resulting in greater uncertainty in the 
position of the side chain atoms.  
Speculatively, the K86E substitution was proposed as a major source of 
the observed improvement from the error-prone library, by virtue of proximity 
to three major binding residues, but the data at hand are not sufficient to speak 
with certainty about the real impact that this mutation might have had. Perhaps 
more obviously, a convergence with the other Obody structures at position 37 
to lysine was noted, which established a water-mediated interaction network. 
Unique amongst the structures presented thus far there was only a single 
conformer evident in the structure. Taken by itself, this implied that a major 
driver in the evolution of L200EP 06 variant was in fact stabilisation from 
multiple binding modes down to one, as seen in the previous two structures, 
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although this can partially accounted for by uncertainty in atomic placement 
given the the moderate resolution (2.7 Å) of the 13mRL L8 structure, and the 
pseudosymmetry evident in the L8 10m L10 structure. 
6.1.5 Conclusions 
This research has shown that while considerable work towards 
optimisation of the panning process needs to be done to improve achieved 
affinities, the basic premise of this thesis is correct; engineered OB-folds can 
be used as a scaffold for mounting customised functional residues for the 
purposes of specific molecular recognition. 
While the complexation arrangement was clearly different in each 
structure, and even variable within a single complex, the conservation of the 
OB-fold β-barrel residue positions displayed to good effect the competency of 
this domain as a scaffold; where residue sequence and interactions vary, the 
core residues showed very little movement. This was also reflected in the Tm 
values of around 80°C for all selected variants (section 4.2.8), showing the 
retention of a thermostable fold even after mutation of 21 positions as in 
L200EP 06. Together, the four selected variants with a measured Tm 
constituted a survey of 23 positions, with 34 unique substitutions compared to 
the wild-type nucleic acid-binding ancestor domain. That all of these exhibited 
a thermostable fold is a potent indicator of the potential of this domain, and 
OB-folds in general, as a stable scaffold for molecular recognition work. 
There are several considerations that need to be addressed when moving 
forward with this work. First, the matter of potential applications for any 
produced Obody needs to inform the choice of fold. For example, it will 
probably be beneficial to adopt a human-sourced OB-fold as a new scaffold if a 
therapeutic binder is desired. However the scaffold presented here remains a 
viable choice for development as a research reagent, primarily due to its 
thermophilic origins. Second, the structures presented here provide the only 
experimental structural data for an engineered Obody domain. Design of future 
libraries can take advantage of this information to try to provide a better 
interface on the protein surface, by re-consideration of the selection of mutant 
positions in particular, but also point mutation of residues adjacent to the 
randomised face. For example, D32 and E95 (E93 in 13mRL L8) both formed 
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the acidic half of salt bridges in the structures presented here, but were not part 
of the original complement of mutant residues. It may be beneficial to remove 
these charged residues in some circumstances, to allow electrostatic 
interactions to be selected from among the mutant residues, instead of having 
them imposed as an existing pre-condition of binding.  
A major goal which was only partially fulfilled by this work was to show  
low nanomolar-range affinity for a model protein target, which we arbitrarily 
set at 100 nM or below. While significant (100-fold) improvement to binding 
was achieved, the best affinity measured was KD 610 nM. Future work will 
examine in detail the possible causes for this. One has already been alluded to 
in the previous chapter; the mode in which the Obodies of this lineage filled the 
substrate binding cleft may have been in a local binding free energy minimum 
too deep to realistically escape from, thus affinity maturation was only ever 
going to produce incremental gains. Naïve libraries informed by the three 
structures should provide better coverage of sequence space, and therefore 
produce better binders. 
A second possible factor is practical aspects of the phage display process 
that was used. The pRpsp2 phagemid system was adopted whole from our 
collaborators, who designed it for display of toxic proteins (Beekwilder et al. 
1999). The very tight control of expression and low copy number of this 
plasmid may negatively impact display levels of Obodies on phage particles, 
and therefore the efficiency of retention of phage due to binding over 
background retention. A smaller plasmid then pRpsps2 would also be at an 
advantage during transformation due to higher efficiency of uptake by the 
competent cells. In the same line, phage contamination was an ongoing and 
severe problem. Re-addressing the panning processes to improve sterile 
technique and minimise cross-contamination will be necessary for any future 
work. Ultimately, directed evolution is an exercise in process design, and the 
lessons learned here about the capabilities and drawbacks of the Obodies will 
be of great benefit in planning future investigations into their development. 
6.1.6 Summary 
This thesis presented three crystal structures and four gene libraries 
investigating the OB-fold as a scaffold for use as a molecular binding reagent. 
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Affinity maturation of an initial binder was undertaken by a combination of 
rational and random mutation, which was successful, although not to the 
degree that was desired. Structural analysis of three Obody-HEWL complexes 
was instrumental in allowing the determination of the critical residues involved 
in binding and the structural basis for affinity maturation, and also will provide 
a vital resource for the design of future libraries based on this, and related 
folds. 
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A1 Appendix 
A1.1 Electrophoresis standards 
A1.1.1 Precision Plus Protein Standards 
 
Shown stained with coomassie, bands are labelled with molecular weight 
in Da. 
A1.1.2 1 kb Plus DNA Standards 
 
Stained with ethidium bromide, bands are labelled with fragment length, 
in base pairs. 
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A1.2 Vectors 
A1.2.1 pProEx Htb 
 
The multiple cloning site (MCS) from pProEx Htb, showing the His-tag, 
promoter, translation initiating methionine and annealing sites for diagnostic 
primers. 
A1.2.2 pRpsp2 
 
The cloning site from pRpsp2, including signal sequence, restriction 
sites, cMyc tag, the beginning of the gIII ORF and annealing sites for 
diagnostic primers. 
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A1.3 Oligonucleotides 
No. Sequence (5` - 3`) Size (bp) Description 
005 CACCAGTGGATCCGTGTATCCTAAAAAGACC 31 pProEx Htb cloning (fwd) 
006 ACCCGGGAATTCTCAGTCTATTGGAAGCGGCTT 33 pProEx Htb cloning (rev) 
041 ATGAAATACCTGCTGCCG 18 pRpsp2 sequencing (fwd) 
042 TTCTGTATGAGGTTTTGC 18 pRpsp2 sequencing (rev) 
044 GACCGACGGACTGCGGCCGCGTCTATTGGAAGCGGCTTGGCC 42 pRpsp2 cloning (fwd) 
051 GTTGTTGCCGGTTGGGTANNKNNKTTGNNKGACNNKGGGNNKNNKAAGNNKGTGNNKGTGNNKGATAGGGAGGGGGGCGCG 81 9m mutational oligo (fwd) 
055 GTTGTTGCCGGTTGGGTA 18 Library construction (fwd) 
056 CGCGCCCCCCTCCCTATC 18 Library construction (rev) 
057 GATAGGGAGGGGGGCGCG 18 Library construction (fwd) 
060 TTTACTGGCCTCAACAAT 18 Library construction (rev) 
061 ATTGTTGAGGCCAGTAAA 18 Library construction (fwd) 
062 GGTGTGGAGATTTTCCCC 18 Library construction (rev) 
063 GGGGAAAATCTCCACACC 18 Library construction (fwd) 
068 GAGGGGGGCGCGTTTGTGCAAGTCACGCTCAAGG 34 Template modification (fwd) 
155 GGCAGCGGCGCGGTGTATCCTAAAAAGACC 30 Specific Gateway adaptor (fwd) 
156 GAAAGCTGGGTGTCAGTCTATTGGAAGCGGCTT 33 Specific Gateway adaptor (rev) 
161 ATCTGGCGTTTTTCCTGCMNNCAGMNNGACMNNCACMNNCGCGCCCCCCTCCCTATC 57 4m mutational oligo (rev) 
163 ATTGTTGAGGCCAGTAAANNKNNKNNKNNKNNKNNKGGTGTGGAGATTTTCCCC 54 4/5 loop 6m mutational oligo 
164 AGGAAAAACGCCAGATCATTTGTTTAAAGTG 31 Template modification (rev) 
165 ATCTGGCGTTTTTCCTGCCTTGAGCGTGACTTGC 34 Template modification (fwd) 
166 AGCGGATAACAATTTCACACAGG 23 pProEx Htb sequencing (fwd) 
167 TATCAGGCTGAAAATCTTCTC 21 pProEx Htb sequencing (rev) 
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168 ATCTGGCGTTTTTCCTGC 18 Library construction (rev) 
169 GCAGGAAAAACGCCAGAT 18 Library construction (fwd) 
183 GTTGTTGCCGGTTGGGTAGCGNRKTTGGGGGACTATGGGAGGGTTNNKATTGTGAAGGTGAGTGATAGGGA 71 L8 10m mutational oligo (fwd) 
184 ATGATCTGGCGTTTTTCCMNNCTCGAGATAGACMNNCACAGCCGCGCCTCCCTCCCTATCACTCACCTTC 70 L8 10m mutational oligo (rev) 
185 GGAAAAACGCCAGATCATTTG 21 Library construction (fwd) 
186 ATGATCTGGCGTTTTTCC 18 Library construction (rev) 
192 ATCAAACATCCATGGCCCAGGTG GTGTATCCTAAAAAGACCCAC 44 pRpsp2 cloning (fwd) 
193 GATGAGTTTTTGTTCTGCGG 20 pRpsp2 cloning (rev) 
207 GCGAGTTTGGGGGACTAT 18 Library construction (fwd) 
208 ATAGTCCCCCAAACTCGC 18 Library construction (rev) 
209 GTGAAGGTGAGTGATAGG 18 Library construction (fwd) 
210 CCTATCACTCACCTTCAC 18 Library construction (rev) 
211 GCGAGTTTGGGGGACTATNNKNNKNNKNNKNNKAAGNNKGTGAAGGTGAGTGATAGG 57 L10 6m mutational oligo (fwd) 
212 GTTGTTGCCGGTTGGGTADVKDVKTTGDVKGACDVKGGGDVKDVKAAGDVKGTGDVKGTGDVKGATAGGGAGGGGGGCGCG 81 13mLC mutational oligo (fwd) 
213 GATAGGGAGGGGGGCGCGDVKGTGDVKGTCDVKCTGDVKGCAGGAAAAACGCCAGAT 57 13mLC mutational oligo (rev) 
- GGGGACAAGTTTGTACAAAAAAGCAGGCTTCGAAAACCTGTATTTTCAGGGCAGCGGCGCA 61 Generic gateway adaptor (fwd) 
- GGGGACCACTTTGTACAAGAAAGCTGGGTG 29 Generic gateway adaptor (rev) 
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A1.4 Sequencing Data 
A1.4.1 OB-fold domain from aspartyl tRNA-synthetase 
The construct used as the wild-type template gene was taken from the OB-fold anticodon-binding domain from the above-mentioned gene from 
Pyrobacculum aerophilum. GenBank accession number is AE009441, gene name is PAE0703. 
5`  GTGTATCCTA AAAAGACCCA CTGGACCGCG GAAATTACTC CAAATCTCCA CGGGACTGAA GTAGTTGTTG CCGGTTGGGT 
ATGGGAGTTG AGAGACATTG GGAGAGTGAA GTTCGTGGTG GTGAGAGATA GGGAGGGGTT TGTGCAAGTC ACGCTCAAGG 
CGGGAAAAAC CCCCGATCAT TTGTTTAAAG TGTTCGCAGA ACTGAGTAGA GAGGACGTCG TGGTAATTAA AGGCATTGTT 
GAGGCCAGTA AAATTGCCAA AAGTGGTGTG GAGATTTTCC CCAGCGAGAT ATGGATTTTA AACAAGGCCA AGCCGCTTCC 
AATAGAC 
N- VYPKKTHWTA EITPNLHGTE VVVAGWVWEL RDIGRVKFVV VRDREGFVQV TLKAGKTPDH LFKVFAELSR EDVVVIKGIV 
EASKIAKSGV  EIFPSEIWIL  NKAKPLPID 
 
 
50 
100 150 200 
250 300 
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A1.4.2 Unselected Variant 13mRL U81 
5` GTGTATCCTA AAAAGACCCA CTGGACCGCG GAAATTACTC CAAATCTCCA CGGGACTGAA GTAGTTGTTG CCGGTTGGGT 
AAAGGGTTTG GTTGACATGG GGTTGTTGAA GGGGGTGACG GTGGGTGATA GGGAGGGGGG CGCGAGTGTG CTTGTCCGGC 
TCACTGCGGG AAAAACCCCC GATCATTTGT TTAAAGTGTT CGCAGAACTG AGTAGAGAGG ACGTCGTGGT AATTAAAGGC 
ATTGTTGAGG CCAGTAAACT TGTGCCGCAG GGTGTGGAGA TTTTCCCCAG CGAGATATGG ATTTTAAACA AGGCCAAGCCG 
CTTCCAATAG  AC 
N- VYPKKTHWTA EITPNLHGTE VVVAGWVKGL VDMGLLKGVT VGDREGGASV LVRLTAGKTP DHLFKVFAEL SREDVVVIKG 
IVEASKLVPQ  GVEIFPSEIW  ILNKAKPLPI  D 
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A1.4.3 L8 10m Library 
A1.4.3.1 Unselected 
Shown here is the section of the L18 10m library were point mutations were introduced during incorporation of the 183/184 mutational 
oligonucleotides, along with deletions. Based on this data, the library was estimated to have 90% of variants as truncated Obodies. 
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A1.4.3.2 Unique variants full sequences 
The five unique variants pulled from the L8 10m library panning against 
HEWL, full protein sequences. The β-strands are shown as yellow arrows, 
helix as a pink cylinder. Residues are highlighted by disagreement with 
ancestral sequence 13mRL L8, coloured according to character (yellow = 
nonpolar, green = polar, red = acidic, blue = basic). 
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A1.4.4 L10 6m library 
A close up on the mutated region from the L10 6m library, showing 11 unselected variants (1-11) and the template gene with primer used during 
assembly. Note that where the codon is TAG, the sequencing program has interpreted this as a STOP codon. However, because the TG1 E. coli strain 
has a supE genotype, this should instead be read as a glutamine. 
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A1.4.5 Error-prone library 
A1.4.5.1 Unselected Variants 
Each sequence is represented by two lines. The first highlights nucleotide changes, the second show any resulting amino acid changes. 
 
192 
 
A1.4.5.2 Selected Sequences 
Shown on the following two pages, error-prone sequences from rounds 5 (prefixed V and 3 (prefixed III) panning against HEWL, aligned with 
the ancestral sequence, L8 10m L200. Each residue highlighted differs from the ancestral sequences and is coloured according to the residue name.
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A1.5 rTEV Protease 
Recombinant tobacco etch virus (rTEV) protease was produced from 
expression plasmid pMTHdelta238, using E. coli strain Rosetta2(DE3)  
(Blommel and Fox 2007). The construct, expressed as an self-cleaving MBP-
fusion protein, was engineered for increased stability and expression. The 
expression clone was acquired from the Arizona State University Biodesign 
Institute DNASU Plasmid Repository. rTEV recognises a canonical peptide, 
ENLYFQ(G/S), and cleaves between the Q and G/S positions. 
Expression was by a modified method, courtesy of James Busby, Richard 
Bunker and Ghader Bashiri from the Maurice Wilkins Centre, School of 
Biological Sciences, University of Auckland. 
A1.5.1 Reagents 
A1.5.1.1 Phosphate Mix 
0.17 M KH2PO4 
0.72 M K2HPO4 
Filter to 0.2 μm to sterilise.  
A1.5.1.2 Autoinduction expression media (Studier 2005) 
12 g  Tryptone 
24 g  Yeast extract 
8 ml  Glycerol 
5 g  Lactose 
0.15 g  glucose 
Make up to 883 ml with water and autoclave.  When cool, add: 
100 ml  phosphate mix 
2 ml  sterile 1M MgSO4 
15 ml  25% (w/v) Aspartic acid 
2 ml  50 mg/ml kanamycin 
1 ml  25 mg/ml chloramphenicol 
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A1.5.1.3 Lysis Buffer 
50mM Tris/HCl pH 7.5 
500 mM NaCl 
1 mM tris(2-carboxyethyl)phosphine (TCEP) 
20% (v/v) Ethylene Glycol 
 
A1.5.1.4 Binding Buffer 
50 mM Tris/HCl pH 7.5 
500 mM NaCl 
1 mM β-mercaptoethanol 
 
A1.5.1.5 Elution Buffer 
50 mM Tris/HCl pH 7.5 
500 mM NaCl 
500 mM Imidazole pH 7.5 
1 mM β-mercaptoethanol 
 
A1.5.1.6 Dialysis Buffer 
20 mM Tris/HCl pH 7.5 
150 mM NaCl 
0.5 mM TCEP 
 
A1.5.2 Expression Method 
An LB/Agar plate supplemented with 25 μg/mL chloramphenicol and 
50 μg/mL kanamycin was streaked from a glycerol stock of the expression 
clone and grown at 37°C overnight. Two colonies were picked and used to 
inoculate two 25 mL cultures in non-inducing media MDAP(Studier 2005) 
which were grown overnight with constant shaking in 100 mL conical flasks at 
37°C, with the same antibiotics as above. Two 2 L baffled conical flasks with 
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500 mL Autoinduction expression media in each (and antibiotics as above) 
were inoculated with the two 25 mL overnight cultures and grown overnight 
with constant shaking at 37°C. 
The following day the cells were harvested at 8,000 g for 15 min, the 
supernatant discarded and the pellet resuspended in lysis buffer. Lysis was by 
sonication. The soluble fraction was separated by centrifugation at 15,000 g for 
20 min, filtered to 0.2 μm by syringe and loaded on to a Ni2+ charged HisTrap 
FF 5 mL column (GE Healthcare). Using an FPLC, the column was washed 
with five column volumes of binding buffer, then five column volumes of 85% 
binding buffer/15% elution buffer (75 mM imidazole). Bound protein was 
eluted with an elution buffer gradient, from 15-100% over 50 mL, collecting 2 
mL fractions. 
Fractions located in the protein peak (as determined by inline UV280 
absorbance) were pooled and dialysed overnight in 6-8,000 Da dialysis tubing 
into 2 L dialysis buffer. The dialysed protein was quantified by UV280 
absorbance, adjusted to 2 mg/mL with dialysis buffer then to 1 mg/mL with 
100% glycerol and snap frozen in liquid nitrogen as 1 mL aliquots. Stored at 
-80°C. 
 
 
A1.6 Crystal Screen 
Condition MPEG 5K (%) Buffer (0.2 M) pH 
1 5 HEPES 7.0 
2 7 HEPES 7.0 
3 9 HEPES 7.0 
4 11 HEPES 7.0 
5 13 HEPES 7.0 
6 15 HEPES 7.0 
7 17 HEPES 7.0 
8 19 HEPES 7.0 
9 21 HEPES 7.0 
10 23 HEPES 7.0 
11 24 HEPES 7.0 
12 25 HEPES 7.0 
13 5 HEPES 7.4 
14 7 HEPES 7.4 
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15 9 HEPES 7.4 
16 11 HEPES 7.4 
17 13 HEPES 7.4 
18 15 HEPES 7.4 
19 17 HEPES 7.4 
20 19 HEPES 7.4 
21 21 HEPES 7.4 
22 23 HEPES 7.4 
23 24 HEPES 7.4 
24 25 HEPES 7.4 
25 5 HEPES 7.8 
26 7 HEPES 7.8 
27 9 HEPES 7.8 
28 11 HEPES 7.8 
29 13 HEPES 7.8 
30 15 HEPES 7.8 
31 17 HEPES 7.8 
32 19 HEPES 7.8 
33 21 HEPES 7.8 
34 23 HEPES 7.8 
35 24 HEPES 7.8 
36 25 HEPES 7.8 
37 5 TAPS 8.0 
38 7 TAPS 8.0 
39 9 TAPS 8.0 
40 11 TAPS 8.0 
41 13 TAPS 8.0 
42 15 TAPS 8.0 
43 17 TAPS 8.0 
44 19 TAPS 8.0 
45 21 TAPS 8.0 
46 23 TAPS 8.0 
47 24 TAPS 8.0 
48 25 TAPS 8.0 
49 5 TAPS 8.4 
50 7 TAPS 8.4 
51 9 TAPS 8.4 
52 11 TAPS 8.4 
53 13 TAPS 8.4 
54 15 TAPS 8.4 
55 17 TAPS 8.4 
56 19 TAPS 8.4 
57 21 TAPS 8.4 
58 23 TAPS 8.4 
59 24 TAPS 8.4 
60 25 TAPS 8.4 
61 5 TAPS 8.6 
62 7 TAPS 8.6 
63 9 TAPS 8.6 
64 11 TAPS 8.6 
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65 13 TAPS 8.6 
66 15 TAPS 8.6 
67 17 TAPS 8.6 
68 19 TAPS 8.6 
69 21 TAPS 8.6 
70 23 TAPS 8.6 
71 24 TAPS 8.6 
72 25 TAPS 8.6 
 
A1.7 IUPAC Nucleotide codes 
Code Base 
A Adenine 
C Cytosine 
G Guanine 
T (or U) Thymine (or Uracil) 
R A or G 
Y C or T 
S G or C 
W A or T 
K G or T 
M A or C 
B C or G or T 
D A or G or T 
H A or C or T 
V A or C or G 
N any base 
. or - gap 
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A2 Appendix – digital media 
The accompanying CD contains data files for the three structures, and the 
unpublished manuscript detailing the initial work on Obodies. 
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